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Abstract
BACKGROUND: A long-standing challenge in the post-genomic era of Bioinformatics is
the prediction of protein-protein interactions, and ultimately the prediction of protein functions.
The problem is intrinsically harder, when only amino acid sequences are available, but a solution
is more universally applicable. So far, the problem of uncovering protein-protein interactions
has been addressed in a variety of ways, both experimentally and computationally.
MOTIVATION: The central problem is: How can protein complexes with solved three-
dimensional structure be utilized to identify and classify protein binding sites and how can
knowledge be inferred from this classification such that protein interactions can be predicted for
proteins without solved structure? The underlying hypothesis is that protein binding sites are
often restricted to a small number of residues, which additionally often are well-conserved in
order to maintain an interaction. Therefore, the signal-to-noise ratio in binding sites is expected
to be higher than in other parts of the surface. This enables binding site detection in unknown
proteins, when homology based annotation transfer fails.
APPROACH: The problem is addressed by first investigating how geometrical aspects of
domain-domain associations can lead to a rigorous structural classification of the multitude of
protein interface types. The interface types are explored with respect to two aspects: First,
how do interface types with one-sided homology reveal convergently evolved motifs? Second,
how can sequential descriptors for local structural features be derived from the interface type
classification? Then, the use of sequential representations for binding sites in order to predict
protein interactions is investigated. The underlying algorithms are based on machine learning
techniques, in particular Hidden Markov Models.
RESULTS: This work includes a novel approach to a comprehensive geometrical classifica-
tion of domain interfaces. Alternative structural domain associations are found for 40% of all
family-family interactions. Evaluation of the classification algorithm on a hand-curated set of
interfaces yielded a precision of 83% and a recall of 95%. For the first time, a systematic screen of
convergently evolved motifs in 102.000 protein-protein interactions with structural information
is derived. With respect to this dataset, all cases related to viral mimicry of human interface
bindings are identified. Finally, a library of 740 motif descriptors for binding site recognition—
encoded as Hidden Markov Models—is generated and cross-validated. Tests for the significance
of motifs are provided. The usefulness of descriptors for protein-ligand binding sites is demon-
strated for the case of “ATP-binding”, where a precision of 89% is achieved, thus outperforming
comparable motifs from PROSITE. In particular, a novel descriptor for a P-loop variant has
been used to identify ATP-binding sites in 60 protein sequences that have not been annotated
before by existing motif databases.
OUTLOOK: A number of promising continuations starting from this work have been spun off.
The interface classification alleviates the investigation, whether protein interfaces are more con-
served than the rest of the surface. Macromolecular complex assembly algorithms benefit from
the available information of possible geometric associations of subunits. Text-mined results from
interaction disrupting mutagenesis experiments can improve interface descriptors by providing
additional information on the sequence diversity of interfaces. Finally, interface descriptors can




The identification of general principles in protein-protein interactions is of paramount impor-
tance for understanding the molecular mechanisms of the cell since proteins are the cell’s key
biochemicals. They are omnipresent as they are involved in all processes of the molecular ma-
chinery. An integrative approach that covers the entirety of known protein-protein interactions
helps to understand the complex aspects of metabolism and its disorders that lead to diseases.
An invaluable source of information of interacting proteins are three-dimensional complexes
of proteins that are in physical contact. See Figure 1.1. These structures demonstrate how
protein-protein interactions work on atomic level. Given a three-dimensional complex of high
resolution, it is possible to identify the atoms and residues that are involved in the interaction,
that is, the interface. Chapter 2.2 deals with the definition and identification of interfaces in
detail.
a) b) c)
Figure 1.1: Three-dimensional structures: the figure shows the crystal structure of thymidine
kinase from Herpes simplex virus type I (PDB id 1kim). It contains two chains, yellow and
green, that are in physical contact. Their respective interfaces are colored in orange and dark-
green, respectively. The complex is a homodimer and has been classified as P-loop containing
nucleoside triphosphate hydrolase. Each chain consists of alpha helices and a single beta sheet.
a) The interface residues are shown as sticks in orange and dark green. Water molecules are
shown as red spheres. b) an enlarged view on the rectangular area shown in a). c) As a) but
the chains are displayed in surface representation. Nitrogen atoms (positively charged) and
oxygen atoms (negatively charged) are shown in blue and red, respectively. The electrostatic
complementarity is a major contributor to the binding free energy of interacting proteins, see
Chapter 2.2 and [McCoy et al., 1997].
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The great insight that is provided by atomic resolution data comes to the price of relatively
rare availability. On sequence level much larger collections of protein-protein interactions exist
due to better possibilities to set up large scale experiments in a high throughput manner. The
hardship of the protein purification process and the determination of correct crystallization
conditions are just two reasons, why structure determination is slowed down. Still, recent
advances and world wide combined efforts led to a continuous growth of the primary database
of protein structures, the Protein Databank (PDB, Berman et al. [2000]). The promising growth
rate leads to data sets that are sufficiently large for reliable statistics. The growth of PDB is
subject to discussion in Chapter 2.5.1.
Another related problem is that the available three-dimensional structures are distributed
unevenly in protein fold space: while structures of some protein families of interest have been
determined many times, others are not represented at all. The same aspect holds for the
coverage of interface types. Awareness to this problem grew constantly and led to a number of
structural genomics projects, an international effort to determine the three-dimensional shapes
of all important protein folds [Chandonia and Brenner, 2006].
1.1 Definition of open problems
1.1.1 Open problem 1: A structural classification of domain-domain
interactions
Proteins interact in highly specific ways. To account for the vast diversity of protein-protein
interactions [Nooren and Thornton, 2003b], a classification into interface types is needed [Aloy,
2007]. Such an interface type classification facilitates the possibility to derive general principles
for each interface type. Furthermore, if the interface classification is organized in a hierarchical
tree-structure, it is possible to detect principles in a bottom-up fashion, thus increasing the
generality.
For the analysis of protein interactions, a number of protein-protein interaction databases
exists. However, it remains an open challenge to create an interaction database that classifies
family-family interactions by geometric association.
Open problem 1: classification
The goal is to generate a classification of domain-domain interactions from all available
multi-domain complexes with structural information. The domain-domain interactions
are not only to be distinguished by their constituting domains’ families but also by
their geometric associations, leading to interface types. For each interface type the
interacting residues shall be identified and visualized in structure and sequence. The
algorithm should trade-off between classification accuracy and computational expense.
The motivation for such a database is manifold: It can be seen, how many interfaces a domain
has and which one is used to bind to which partner. For a given family-family interaction, it
is interesting to see if alternative geometric associations are possible. As an example, consider
Figure 1.2: The long chained cytokine family interacts in a variety of ways with the fibronectin
type III family. Each interface has a different set of residues that is involved in the interaction.
The knowledge of possible geometric associations helps in the process of structure based assem-
bly of protein complexes: Instead of assuming a single possible domain-domain association [Aloy
et al., 2004], a more comprehensive algorithm would consider all alternatives. Aloy and Russell
pioneered the work of using three-dimensional complexes for predicting protein-protein interac-
tions on sequence level [Aloy and Russell, 2002, Aloy et al., 2003, Aloy and Russell, 2004, Aloy
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et al., 2004]. In the realm of protein interaction prediction a database of structural interaction
templates is useful, especially when homology modeling allows the comparison of the interface
conservation. A novel solution to problem 1 is presented in Chapter 3.
Figure 1.2: Fibronectin type III binding in many ways to cytokine (central, grey). The image is
composed from several PDB files that each contribute with a different interface. (PDB ids 1i1r,
1axi, 1hwh, 1f6f, 1kf9, 1p9m, 1f45, 1bp3, 1pgr, 1a22 and 3hhr). The interfaces are shown on the
surface in the color of the respective fibronectin-domain. The cytokine surface has a total of 13
interfaces to bind fibronectin type III.
1.1.2 Open problem 2: Convergently evolved motifs
Related to the interface type classification is the problem of finding multi-functional interfaces
that are able to bind to different, non-homologous proteins. Conversely, non-homologous pro-
teins being able to bind to the same type of interface (that is, analogous proteins) can help
to reveal cases of convergent evolution and competitive binding. Further, detecting analogous
proteins is helpful in the identification of drug targets, when one analogue is of bacterial origin
and exhibits differences to the eukaryotic analogue [Galperin et al., 1998].
Cases of convergent evolution in enzymes have been reported anecdotically, but a systematic
approach has not been undertaken. In this work, the objective is to find all cases of convergently
evolved binding interfaces in non-homologous proteins, for which three-dimensional structures




Open problem 2: Convergently evolved motifs The objective is to discover
binding sites that exist in non-homologous proteins that are able to bind to the same
or equivalent interfaces of homologous proteins. The idea is to identify all cases that
are discoverable from the complexes that are deposited in the PDB. Similarities, that
is, convergences between the interfaces of the non-homologous proteins can then be
studied on residue and atom level. For viral proteins that mimic interfaces in their
hosts, the crucial residues responsible for the mimicry shell be identified.
The novel aspect of the solution to this problem lies in the attempt to discover analogous proteins
in an indirect way: since similarities in non-homologous proteins are very difficult to detect, the
approach taken here is based on the alignment of the common binding partner.
1.1.3 Open problem 3: Structural interface motifs for protein inter-
action prediction on sequence level
Protein-protein interaction prediction is a long standing problem in Bioinformatics and it has
been approached in numerous ways. This work describes for the first time, how an interface type
classification gives rise to sequential interface motifs in an automated fashion. These interface
motifs can then be used to run sequence searches, pinpoint interacting regions in sequences and
provide the setup for interface homology modeling.
Open problem 3: Protein interaction prediction
Given an interface type classification that is derived from domain-domain interactions
(problem 1), sequence motifs are to be constructed from conserved interface regions
in order to predict interactions. A representation is to be found that accounts for
the dispersion of interfaces. Further, the representation shall allow for a well-founded
probability score of the matches of the sequences motifs in sequence databases in order
to judge the statistical significance of a hit. The motif descriptors should undergo
validation.
A comparison of existing sequence motif search approaches is presented in Section 2.4 whereas
a novel approach to problem 3 is presented in Chapter 5.
1.2 Overview
An overview of the relation between the open problems and related resources is given in Figure
1.3. The approach taken in this work resides in structure space. The conventional counterparts
in sequence space are presented to the left. The red area marks problem 1,2 and 3. The figure
also illustrates the duality of sequence space and structure space.
Central resources are databases of known protein-protein interactions. A number of exist-
ing databases are presented in Section 2.1.4. In structure space, protein-protein interaction
databases are derived from protein complexes and multi-domain proteins that have been de-
posited in the PDB.
Domain definitions for sequences and structures provide a more modular view on inter-
actions. Relevant background information for domain definitions and respective databases is
provided in Section 2.1.4. Domain assignments to protein-protein interaction data helps to pro-
vide domain-domain interactions. In sequence space this step additionally requires experimental
work or statistical analysis of frequently occurring domains in known protein-protein interac-
tions [Sprinzak et al., 2003, Rhodes et al., 2005, Ng et al., 2003]. In contrast, in structure space
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the step of identifying interacting domains is mainly restricted to structural domain assignments
and simple geometric distance measurements.
A central step in Figure 1.3 is the structural comparison of interactions. It is the basis for
problem 1 and problem 2, and hence a prerequisite for problem 3. It involves the structural
alignment of domains, a topic for which existing solutions are discussed in 2.1.9. Analogously,
multiple sequence alignments are useful in highlighting well conserved features in a family of
proteins. Also, multiple sequence alignments are fundamental to sequential domain definition.
They are elucidated in Section 2.1.7.
While many steps of the work-flow in this work are located in the structure space, they
have corresponding counterparts in the sequence space. Sequence information is generally more
abundant but provides no information about structural aspects. Cross-links between the two
universes exist: Structures can help to annotate sequence databases, likewise provide structural
protein-protein interaction databases more insights to existing sequence. Multiple sequence
alignments can be bench-marked by structural alignments. An application of structural inter-
action databases in sequence space is protein-protein interaction prediction based on homology.
Lastly, problem 3 aims to provide a sequence search method that extracts structural information
and hence is complementary to conventional sequence search methods as those derived in the
left part of the figure.
All relevant procedures for solving problem 1, 2 and 3 are explained in detail in Chap-
ter “Background”. Therein, recent advances are presented for multiple sequence alignment,
structure alignment, domain definitions, protein-protein interaction databases, interface type




Figure 1.3: The approach taken in this work resides in structure space. The conventional coun-
terparts in sequence space are presented to the left. The arrows depict the flow of information
between resources. Comparable steps in sequence space (left) and structure space (right) are
lined up beside each other. The red marked area shows the topics that this work focusses
on. The figure is simplified in that for example databases that combine structural and sequen-
tial knowledge (for example HSSP [Schneider et al., 1997]) are not shown. DDI abbreviates






One central goal of Systems biology is the exploration of metabolic pathways by analyzing the
interplay of its constituent molecules. Every pathway involves proteins. Hence, exhaustive
knowledge about the interactions of these proteins is a prerequisite to understand the molecular
machinery of the cell. A large amount of experiments to detect protein interactions have been
carried out [Fu, 2004, von et al., 2002]. They are often time consuming and cost intensive,
afflicted with false positives and far from complete. Complementary to experimental techniques
are computational approaches that analyze and predict protein-protein interactions. Molecular-
biological data resources are essential for the computational approaches. In the recent decades,
these volumes have experienced a tremendous growth. For example, data for millions of genes
and gene products exist, tens of thousands of three-dimensional protein structures are stored
and hundreds of genomes were completely sequenced. Traditionally, homology based annotation
transfer is the method of choice to provide information about the function of a protein, including
its interaction behavior. However, not only the amount of biosequences increased tremendously.
A study of proteins from the recent decade [Friedberg, 2006] shows that the diversity of proteins
increases as well. The author states, that homology-based annotation transfer is not applicable
to many proteins because the number of protein families without annotation grows rapidly.
Moreover, the divergence within families has been larger than expected due to a recent influx
of sequence data from marine microorganisms [Venter et al., 2004].
Approximately five million non-redundant proteins are known at amino acid level at present.
Large scale endeavors like the Human Genome Project and Celera Genomics’ human genome
sequencing project [Lander et al., 2001, Venter et al., 2001] contributed a large amount of data
to the publicly available sequence databases. Additionally, Craig Venter’s “Sorcerer II Global
Ocean Sampling Expedition” is expected to contribute several millions of protein sequences
[Rusch et al., 2007]. Despite this availability of comprehensive databases on primary protein
sequence information, only incomplete data is available about protein-protein interactions. For
example, the 25.000-40.000 human proteins are potentially able to form 800 million interactions,
out of which up to 200.000 are estimated to occur [Bork et al., 2004]. As of March 2007,
the literature documents 37.000 interactions [Mishra et al., 2006, Mathivanan et al., 2006].
Inference of human protein-protein interactions from yeast or prokaryotes (where protein-protein
interactions data is easier to obtain and hence, more abundant) is not straightforward. A
more complex proteome in human obfuscates a direct correspondence to counterparts, so-called
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orthologs, in simple organisms. Given the need for exhaustive functional knowledge about
proteins, many efforts have been made to unravel protein-protein interactions with reliable, fast
and inexpensive computational methods. To that end, most often sequential information is
utilized (such as genetic context, phylogenetic profiling, sequence signatures, see Section 2.3).
Only few attempts employ one of the most valuable sources of protein-protein interaction data -
complexes of solved three-dimensional structure. Recent advances in X-ray crystallography and
Nuclear Magnetic Resonance spectroscopy techniques enabled a rapid growth of stored structures
in the Protein Data Bank (PDB, Figure 2.10). As of July 2007, more than 45000 PDB structures
are deposited, out of which 41000 are protein structures. The three-dimensional information
of proteins is a valuable source for protein function prediction. The availability of such a
large repository of proteins with atom coordinates provides the basis of the field of structural
bioinformatics. The knowledge of exact positions of atoms in a protein and its ligands provide
a new quality of detail: protein functions and interactions, in particular catalytic mechanisms,
can be revealed at atomic level. This way, important residues, that is those that contribute
with a large amount to the binding free energy, are identified. The residues that play a role in
the protein function are often found not only in single proteins but also in related proteins with
unknown structure. Traditionally, the protein at hand is often characterized to a large extend
before a structure is solved. It often has been under investigation and consequently, information
about the interactions, gene expression data and engagement in metabolic pathways might be
known from independent experiments. This paradigm is changing since the advent of structural
genomics. Through the automatization of many steps in the crystallization procedure many
structures of a genome have been solved where the proteins are still poorly annotated with
respect to their function. Function prediction for these proteins then extends to structural
methods, such as structural motif search.
2.1.2 Motivation
The detection of protein-protein interactions is closely related to the identification of binding
sites in proteins. Albeit protein-protein interactions can be found without identifying respon-
sible binding sites, binding sites often carry a significant information signal, through which an
interaction can be predicted. Computational methods exist that either predict mere interaction
or protein binding sites or both, see Tables 2.9 and 2.10. The successful prediction of bind-
ing sites can help to guide experimental works for example through site-directed mutagenesis:
residues that are predicted to be important for the interaction can be mutated to alanine. This
way the putative interaction will be interrupted and the effects can be observed. The predicted
interaction is thereby confirmed experimentally.
Information about binding sites can play a role in drug discovery. Traditional drug design was
based on trial-and-error methods and involved a large number of chemical substance testings on
animals. Since the advent of rational, structure based drug design a different approach is taken:
virtual screens of molecule libraries are performed based on the three-dimensional structures of
target proteins in order to inhibit a crucial interaction, which this protein is performing. This
approach requires knowledge about the location of the binding site, the interaction partners and
the functional context. Yet a large amount of drug targets remain undiscovered as their binding
sites are still unknown.
Moreover, protein-protein docking algorithms benefit greatly from the correct prediction
of binding sites. Docking predicts the preferred orientation of two molecule to each other,
Conventionally, a finite subset of possible docking poses is investigated by introducing rotational
and translational granularity. Yet, an exhaustive search through all possible orientations and
conformations of two proteins in three-dimensional space is generally not feasible at present. The
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identification of binding sites enables pruning of the search space and can reduce the problem
to a computationally manageable task.
Finally, interaction predictions are the key to mapping global interaction networks. Sev-
eral types of interaction networks exist: metabolic pathways, regulatory modules and signaling
cascades. It has been recognized that interacting proteins perform a certain function together,
for example the synthesis of a metabolite. Consequently, knowing the function of a protein’s
interaction partners may provide clues about the functions of the protein itself. The complete
set of interactions in a model organism is referred to as interactome. Though most effort on
protein-protein interaction detection has focused on the model organism Saccharomyces cere-
visiae (baker’s yeast) [Uetz et al., 2000, Schwikowski et al., 2000, Ito et al., 2001, Gavin et al.,
2002, Krogan et al., 2006], preliminary interactome-projects are initiated for several other or-
ganisms: Homo sapiens [Rual et al., 2005, Stelzl et al., 2005], Escherichia coli [Butland et al.,
2005], Caenorhabditis elegans [Li et al., 2004a], Drosophila melanogaster [Giot et al., 2003],
Helicobacter pylori [Rain et al., 2001] and Plasmodium falciparum [LaCount et al., 2005]. It has
been recognized that most proteins interact with few partners, whereas a small but significant
proportion of proteins, the ’hubs’, interact with many partners. That is, the distribution of
protein connectivity obeys the power-law and these protein interaction networks are considered
scale-free. Since the topology of interaction networks is dominated by hubs, their importance for
the cell has been validated in lethality experiments [Jeong et al., 2001]. Generally it is believed
that hubs are not only more vital but also more conserved than proteins with low connectivity.
Kim et al. [2006a] distinguished into single interface hubs (Figure 2.1a) and multiple-interface
hubs (Figure 2.1b). The authors pointed out that especially the latter account for conservation
and vitality. Awareness of all different interfaces of a protein is therefore paramount.
a) b)
Figure 2.1: Two kinds of hubs, shown in gray. a) A hub with a single interface. The existence of
hubs with a very large number of partners can rationally explained from a structural perspec-
tive: a single interface is subsequently used to contact the interaction partners, a phenomenon
that frequently occurs in signaling cascades or housekeeping proteins such as post-translational
modification [Aloy and Russell, 2006]. b) Multi-interface hubs. They often are part of large
protein complexes.
An interesting aspect about interactomes is their ability to reveal global topological and
dynamic features that relate to known biological properties [Han et al., 2004]. Hence protein-
protein interaction networks may help to elucidate the functions of individual proteins, notably
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a task of utmost importance. Systematic approaches to infer protein functions from a corpus of
known protein-protein interactions have been devised [Vazquez et al., 2003, Deng et al., 2003,
Hishigaki et al., 2001, Schwikowski et al., 2000]. Since protein-protein interactions regulate a
wide variety of important cellular pathways, information about these interactions improves our
understanding of diseases. They provide the basis for new therapeutic approaches as the binding
sites of interacting proteins represent a popular class of targets for drug discovery.
2.1.3 Experimental and in silico interaction detection
A large amount of approaches exist to identify protein interactions. They differ in methodology,
accuracy and expressive power: A first rough distinction of methods is experimental vs. in
silico. The former include Phage display, Yeast-two-hybrid (Y2H), Tandem affinity purification
(TAP), Enzyme-Linked Immunosorbent Assay (ELISA) and mutagenesis experiments. For a
more complete list of methods, see [Fu, 2004]. These methods vary strongly in terms of expressive
power of their results and the results can be viewed as increasing levels of information detail: the
spectrum ranges from functional association (co-expression) over co-localization (fluorescence
microscopy), complex membership (TAP), physical interaction prediction (Y2H) to binding site
prediction (including interacting amino acid ranges/hotspots). Ultimately, as pointed out by
Aloy and Russell [2006], the crucial detail about interacting molecules is provided exclusively by
methods that determine the three-dimensional coordinates of the involved atoms, such as X-ray
crystallography and Nuclear Magnetic Resonance (NMR) experiments.
Both experimental and in silico techniques have their strengths and flaws. They can be
viewed as complementary, as both are far from complete and 100% accurate. Predictive in
silico methods generally are limited to suggestions and produce hypotheses about candidate
interactions. These may guide experiments, for example site-directed mutagenesis, thus con-
firming or rejecting the predicted interactions. In turn, the volume of experimentally known
protein-protein interactions plays an important role in the establishment of general principles
of protein-protein interactions. Computational methods attempt to distill these principles and
then check for their applicability to unknown proteins. Also, weak experimental evidence can
be supported by bioinformatics approaches such as homology based annotation transfer. In
general, integrative approaches that combine independent prediction methods seek to increase
the confidence level.
It has been observed that the accuracy of in silico and large scale experimental methods are
comparable [Aloy and Russell, 2006, Sprinzak et al., 2003]. The currently available experimental
approaches, however are time and labor intensive. As for yeast-two-hybrid, it has been observed
that the coverage is incomplete. The large-scale screens contain many false positives and false
negatives, evidenced by the surprisingly small overlap of predicted interactions. Consequently
there is a growing need for the development of computational tools that are capable of effectively
identifying such interactions.
Recently, the advent of structural systems biology and structural genomic projects has pro-
vided a large amount of three-dimensional structures. In contrast to single proteins, crystal
structures of complexes are yet difficult to obtain by over-expression and purification tech-
niques. Further, the crystallization process itself is harder as well. Yet, a large number of
genuine protein-protein interactions are structurally solved and available in the Protein Data-
bank (PDB, Berman et al. [2000])
2.1.4 Domain-domain vs. protein-protein interactions
Proteins are composed of units that are structurally independent - so-called domains [Janin and
Chothia, 1985]. A protein domain is considered to be a distinct functional and/or structural
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unit. A domain in a structural context refers to a segment of a polypeptide chain that can fold
into an independent three dimensional structure. Hydrogen-bonds are predominantly created
between residues that belong to the same domain. A protein consists of one or more domains.
Those residues at which the chain can be cut without disturbing the topology are considered the
domain boundaries. Sequence descriptors for families of domains can be derived from available
structural data, for example SUPERFAMILY [Gough et al., 2001].
As often these domains are evolutionary conserved, there are various approaches to de-
tect them on sequence level: PFAM [Sonnhammer et al., 1998], ProDom [Corpet et al., 1998],
SMART [Letunic et al., 2006], TIGRFAMs [Haft et al., 2003], PIRSF [Wu et al., 2004], PAN-
THER [Mi et al., 2005]. Sequence descriptors for conserved domains capture thus conserved
sequence alignment blocks and do not necessarily coincide with the structural definition above.
An underlying assumption of this work is that protein interactions are mediated by inter-
acting domains. In turn, if two domains are known to bind to each other, proteins composed of
these domains are also able to bind.
Exceptions to domain-based protein-protein interactions have been addressed, for exam-
ple disordered regions and short motifs. Despite this, domain interactions and protein inter-
actions have been shown to be in a strong mutual relation to each other: Preferential domain
bindings can be used to predict protein-protein interactions. For example, interacting multiple
domain proteins with known three-dimensional structure provide clues about favorable domain-
domain interactions. Two candidate proteins are likely to interact, if domains can be identified
in either protein, that are known to be interacting [Rhodes et al., 2005, Ng et al., 2003].
Vice versa, protein interactions lead to domain interaction predictions. The feasibility of this
approach was demonstrated in Deng et al. [2002]: There, two large scale yeast-two-hybrid data
sets provided the initial data for potential protein-protein interactions. Sequential domain de-
tection was performed on the interacting pairs. Subsequently, Maximum Likelihood Estimation
was used to infer interacting domains that are consistent with the observed protein-protein in-
teractions. Similarly, Sprinzak and Margalit [2001] demonstrated, how to detect domain-domain
interactions given a set of protein-protein interaction. In this set, domains were identified and
overrepresented sequence-signature pairs are determined. This provides suggestions about the
domains that are responsible for the interactions. Complementary, co-evolution analysis has
been used to infer domain-domain interactions in the yeast interactome [Jothi et al., 2006]. The
authors reported that correlated mutations are more frequent in interacting domains than in
non-interacting domains. As an application of this observation the authors were likewise able
to predict the domain pairs that are most likely to mediate the protein interaction.
Due to the modular nature of proteins and domains being the building blocks, it is straightfor-
ward to group similar domains rather than similar proteins into families. Similarity is measured
on the basis of their function, their structural and sequential similarity. Family definitions com-
monly require its domains to be homologous, that is, they evolved from a common ancestor.
The biological rationale is that homologous domains through the course of evolution preserved
recognizable sequence patterns and did not entirely alter their function. The idea of homol-
ogy based annotation transfer is a central part of many bioinformatics tools in general and
for protein-protein interaction prediction methods in particular. This aspect is elaborated in
Section 2.3.4.
2.1.5 Domain-domain and protein-protein interaction databases
A broad spectrum of databases containing domain-domain interactions and protein-protein in-
teractions have been developed. Protein-protein interaction data has been gathered and stored
in a number of interaction databases. The data usually stems from experimental methods such
11
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as yeast-two-hybrid or tandem affinity purifications, see Section 2.1.3. Protein-protein inter-
action databases predominantly derive data from experiments and literature. The databases
include interaction data for complete protein chains. These undergo some form of curation,
since experiments report many false positives.
IntAct. IntAct [Hermjakob et al., 2004] is an open source database for molecular interactions
where 44% of its binary interactions are protein-protein interactions. The data is extracted from
2100 publications describing 7000 experiments. The semi-automated data retrieval is based
on 1200 controlled vocabulary terms. Subsequently, experts hand-curate the automatically
retrieved protein-protein interaction data.
BioGRID. BioGRID is a database with focus on a few species (mainly Saccharomyces cere-
visiae, Homo sapiens, Drosophila melanogaster and Caenorhabditis elegans, see Figure 2.2).
Interactions are distinguished in physical (direct contact) and genetic (takes place when the ac-
tion of one gene is modified by one or several other genes). Redundancy of the data is removed
to create a single mapping of protein interactions.
Figure 2.2: Species for which interaction data has been collected in the BioGRID database.
HPRD. The Human Protein Reference Database contains annotations for more than 2750
human proteins. Apart from interaction annotations, it additionally includes annotations for
post-translational modifications, enzyme-substrate relationships and disease associations. The
database was derived through manual curation by expert biologists interpreting more than
300.000 published articles. Interactions are classified in in vivo, in vitro, and two-hybrid.
The MIPS database. The database at Munich Information center for Protein Sequences
(MIPS) [Mewes et al., 2006] provides protein sequence-related information based on whole-
genome analysis. Sequence annotations exist for fungal model organisms, human and yeast.
Protein-protein interactions have been collected from results of carefully performed individual
experiments. Though focus has been laid on yeast, mammal protein-protein interactions have
been added [Pagel et al., 2005]. Many applications use the MIPS database as a gold standard
12
2.1. INTRODUCTION
since it contains a small refined set of hand curated protein-protein interactions. These inter-
actions are kept separated from high throughput results and are therefore considered of high
confidence.
The Database of interacting proteins - DIP. DIP [Xenarios et al., 2001] also contains ex-
perimentally determined protein interactions including high-throughput methods such as yeast-
two-hybrid, DNA and protein micro-arrays, and tandem affinity purification-mass spectronomy
analysis of protein complexes. Further, data is obtained from the literature and PDB. It pro-
vides a subset (DIP-core) that has been checked for reliability by several quality assessment
techniques [Deane et al., 2002].
NetPro. The NetPro database [Connections, 2005] is comparable to MIPS in that it contains
manually collected protein-protein interaction data. It is an annotated database containing
22.000 protein-protein interactions. These were extracted from PubMed abstracts by a semi-
automated method and then cross-checked by human experts. The database lists predominantly
mammalian interactions, in particular Homo sapiens (more than 15.000 interactions). Further-
more, it can be distinguished between direct and indirect interactions. Evidence lines in the
original papers are provided for convenient validation and sequence data is available. It is there-
fore possible to run sequence similarity searches against it and check for interologs, a technique
that is explained in detail in Section 2.3.4.
MINT - a Molecular INTeraction database MINT [Zanzoni et al., 2002] contains 4568
experimentally verified protein-protein interactions. It includes information on enzymatic mod-
ifications, kinetics and binding constants. Both direct and indirect relationships are considered
The Biomolecular interaction database - BIND. BIND [Bader and Hogue, 2000] includes
high-throughput experimental data as well as complexes from PDB. A special feature of BIND
is that it can distinguish different functional types of interactions. Despite BIND being one of
the early protein interaction databases, development has been ceased.
The STRING database. STRING [von Mering et al., 2005] is a large integrative approach
that collects evidence for interactions from all sorts of analyses/predictions and experiments.
The sources are conserved genomic neighborhood, phylogenetic co-occurrence, co-expression
analysis, literature co-occurrence, high-throughput experiments and database imports. These
information have been extracted from several databases and by means of literature mining. Fur-
ther interactions are transferred automatically across species by two different methods: the first
method assumes that all orthologous pairs from two families interact where a single interaction
instance between these families is known. The second method transfers interaction annotation
of single instances to orthologs by means of reciprocal sequence similarity. For a set of query
proteins, a network of interacting proteins is drawn, where the edges reflect the type of inter-
action. The advantage is that for a given interaction, the combined evidence from independent
sources increases the confidence about the interaction to be genuine. Despite the integrative
approach, STRING does not collate interactions derived from protein complexes with known
structure. Furthermore STRING is not capable of predicting binding sites.
Table 2.2 summarizes the most common resources for protein interaction data and lists the
number of interactions in each database. These databases mainly contain experimental data
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that have undergone varying degrees of human quality checks. The proteins in the databases
are possibly multi-domain proteins.
In analogy to the previous subsection, interacting proteins can be studied either as complete
units (that is, on chain level) or by domains. This is reflected in the summary tables of interaction
databases, Tables 2.2 and 2.3: the former contains databases on protein level, the latter mainly
presents databases on domain level.
With the exception of PRISM, the structural databases are based on structural domain def-
initions. In order to detect these domains given the three-dimensional coordinates of a protein,
several techniques—both manual and automatic—have been developed: the Structural Classi-
fication Of Proteins (SCOP) database, the CATH database (referring to the four hierarchical
levels Class, Architecture, Topology and Homologous superfamily), the Homologous Structure






SCOP Murzin et al. [1995] - mainly manual classi-fication
CATH Pearl et al. [2003] SSAP manual checking
HOMSTRAD Mizuguchi et al. [1998] STAMP, COMPARER examined individually
FSSP Holm et al. [1992] Suppos, DALI fully automatic
Table 2.1: Structural classification methods and the structural alignment techniques, they are
based on. The classifications strongly vary in their degree of automatization. At the core of the
each classification method are structural alignment tools are. They are briefly mentioned and
further discussed in Subsection 2.1.9.
Structural alignment techniques are central in the classification as they provide measurements
for the structural similarity of two proteins or domains. Clustering techniques can then group
the proteins into distinct classes.
Note that domains are defined slightly different, when structural information is available:
Boundaries can be assigned on the basis of spacial information rather than sequence conserva-
tion. The projection of these definitions and the grouping of equal family-family pairs give rise
to mutual exclusive classifications: protein interaction are viewed in terms of whole families that
interact with each other rather than interactions between individual proteins. The advantage is
that a large number of interactions can be classified in a much smaller number of family-family
interactions. Many of them employ the same residues or are otherwise similar. For example,
PRISM employs a categorization of 3.799 structural interface types from [Aytuna et al., 2005].
In this recapitulatory manner, one can derive general principles about how the interactions
between protein families are organized on a large scale. Commonalities between interactions
of the same type can be identified. It has been hypothesized that if two domains are found
to interact, their homologs will also interact, and moreover, will do so in a similar way [Aloy
et al., 2003]. The first part of this assumption provides the underpinning for methods to predict
protein-protein interactions given a structural template. In fact, a number of accompanying
prediction methods for the mentioned databases were derived already, see column “Prediction”
in Table 2.3.
PSIMAP/PSIBASE The first protein interaction family map was created by Park et al.
[2001]. Individual protein domain interactions where classified by domain assignments into
family-family interactions using SCOP. Sequential interaction data was taken from MIPS whereas
14
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Author Database Interactions Curation
Stark et al. [2006] BioGRID 116.000 manual
Hermjakob et al. [2004] IntAct 68.165 2.200 manual, rest
automatic
Xenarios et al. [2001] DIP 55.733 automatic
Bader and Hogue [2000] BIND 83.517 manual
von Mering et al. [2005] STRING 730.000 automatic
Zanzoni et al. [2002] MINT 71.854 manual
Mewes et al. [2006] MIPS 4.568 manual
Mishra et al. [2006] HPRD 3.710 manual
Connections [2005] NetPro 22.000 manual
Table 2.2: Protein-protein interaction databases derived predominantly from experiments and
literature. The databases include interaction data for complete protein chains. These often
include some form of curation, since experiments report many false positives. The NetPro
database is unique as it is a manual curated database created by literature mining with evidence
references to the source publications.
structural information was used from the PDB. The scale-free shape of the family interaction
graph could be demonstrated: the interaction map exposes few versatile families, whereas most
families interact only with one, two or three other families. This family-family classification was
extended in the PSIMAP and PSIBASE databases [Bolser et al., 2003, Dafas et al., 2004, Gong
et al., 2005].
SCOPPI SCOPPI [Winter et al., 2006b] is a derivative of the approach taken in PSIMAP. It
is also based on a rigorous family-family interaction classification, but additionally distinguishes
interface types (Problem 1). SCOPPI is in detail described in Chapter 3. It has been used for
protein-protein interaction prediction method using the structural interolog method (explained
on page 19).
iPfam. The iPfam database [Finn et al., 2004] was amongst the first interaction databases that
aimed for regional information of the interface, not derived from computational prediction nor
experimental studies but from multi-domain and multi-chain complexes in PDB. The database
iPfam is, as the name suggests, built using the PFAM database. The PFAM domain boundary
definitions were mapped on the structures using the UniProt to PDB mapping [Golovin et al.,
2004].
3did database. Beside the collection of domain-domain interactions in proteins from high-
resolution three-dimensional structures, 3did [Stein et al., 2005] offers an overview of how similar
in structure are interactions between different members of the same protein family. Additionally,
the database contains yeast interactions and Gene Ontology annotations.
PIBASE. In contrast to other structural databases, domain definitions in PIBASE [Davis
and Sali, 2005] are taken from both SCOP and CATH. It provides a collection of structural and
functional protein properties imported from various sources including MODBASE, SwissProt,
GO, OMIM, and InterPro. PIBASE clusters interacting domains by bindings site topology.
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3D Complex. 3D Complex [Levy et al., 2006] is a hierarchical classification of whole protein
complexes of known three-dimensional structure. Each class contains members with similar
quaternary structure. The collection provides the basis for a statistical analysis of protein
oligomerization. Complexes are represented as graphs with domains as nodes and interactions
as edges. It allows to derive non-redundant sets not only on sequence or domain level but also
on the basis of quaternary structures.
PRISM. The database of Protein Interactions by Structural Matching (PRISM, [Ogmen et al.,
2005]) is unique in the structural classification databases in that it does not employ structural
domain definitions. Rather it is derived from a non-redundant dataset of interface structures. An
interface is derived from a multi chain PDB structure where interacting residues are identified
as those with a pair of atoms (each from opposite chains) with a distance smaller than the
sum of their van der Waals radii plus a threshold of 0.5 Å. Additionally, scaffold residues, i.e.
those with their Cα within 6 Å of an interface residue of the opposite chain are included.
The 21.000 interfaces are clustered using geometric hashing. PRISM’s interface types are taken
from chain-chain interactions. However it has been pointed out, that for the investigation of
interaction types, domain-domain interactions are more appropriate: the protein repertoire uses
a combination of domains to account for the large diversity of functions Chothia et al. [2003].
A domain as a structural and evolutionary unit provides a simpler view on binding sites than
chains that are multi-domain proteins.
Conserved Binding Mode database (CBM). Likewise, CBM [Shoemaker et al., 2006] is
a domain interaction database, but additionally has information of the geometric association of
the domains. It can furthermore assist in constructing topological networks from connections
derived from a biological context. Finally, CBM categorizes protein interaction surfaces and
thereby allows homology modelling of interfaces. The domain definition is taken from NCBI’s
Conserved Domain Database [Marchler-Bauer et al., 2002].
SNAPPI-DB. SNAPPI-DB [Jefferson et al., 2007] is a feature rich domain-domain interaction
database with domain definitions from SCOP, CATH and Pfam. It provides a programming API
for convenient retrieval of domain-domain interactions. The clustering of interfaces has been
done using the iRSMD method of Aloy et al. [2003]. The iRMSD focusses on the orientation of
the centers of mass of the interacting domains. The disadvantage of the iRMSD approach is that
it is insensitive to the location of the actually interacting atoms. This circumstance is explained
further in Section 4.7.2. The interfaces are taken from the biological units from PQS rather
than PDB’s asymmetric units. SNAPPI-DB links to InterPro, Gene Ontology and SwissProt.
2.1.6 Methodologies for protein-protein interaction prediction
In order to solve problem 3, the prediction of protein-protein interactions, a variety of approaches
have been suggested. An overview about the different methodologies for protein-protein inter-
action prediction is presented below.
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Reference Database Domain def-
inition
Interactions Prediction




Shoemaker et al. [2006] CBM CDD 2.784 -
Finn et al. [2005] iPfam Pfam 3.019 -
Davis and Sali [2005] PIBASE SCOP, CATH 2.387 Davis et al.
[2006]
Park et al. [2001],
Dafas et al. [2004],
Gong et al. [2005]
PSIMAP/PSIBASE SCOP 93.000 (not
clustered)
-
Teyra et al. [2006] SCOWLP SCOP 60.664 (not
clustered)
Stein et al. [2005] 3did Pfam 3.304 Aloy and
Russell [2003]










Table 2.3: Structural domain-domain interaction databases. The databases are derived from
3D atomic detail structures. Hence they are—though not fully representative for the entire
interaction space— of high confidence. The column “Prediction” contains references to works
that used the classification database to predict domain-domain interactions.
Phylogenetic Profiling
Phylogenetic profiles express the presence/absence patterns of
domains in species [Pellegrini et al., 1999]. The underlying
hypothesis is, that if domains occur in the same species they
are more likely to be functionally associated. This association
hints to a possible interaction. In order to produce a phy-
logenetic profile, a table is created with domains as columns
and species as rows. It is checked whether a certain domain
is present in a certain species by performing an all against all
Domains
1 2 3 4
Species A 3 3 3 -
Species B 3 - 3 3
Species C - - - 3
Species D 3 - 3 3
Table 2.4: Domains 1 and 3 have
identical phylogenetic profiles
sequence similarity search. Phylogenetic profile similarity can then be derived by a suitable
binary vector distance measure. See Table 2.4: Domains 1 and 3 occur in the same species,
namely in species A, B and D. They are therefore likely to interact with each other. Clearly,
this attempt requires fully sequenced genomes in order to be sure a domain does not occur.
Also, this method does not bring new results for those genes that are present in all species.
However, phylogenetic profiling is becoming increasingly applicable as the amount of completed
genomes rises with a supra-linear rate. As of September 2007, more than 650 genomes are fully
sequenced and published, of which there were 538 bacterial, 70 eukaryotic and 47 archaea or-
ganisms. Moreover, more than 2000 ongoing genome projects are currently taking place (data
according to the GOLD database Liolios et al. [2006]).
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Genomic context (Gene adjacency)
Genomic context analysis deals with frequently reoccurring
neighborhood relations of pairs of proteins on chromosomes
in different species. In prokaryotic species, neighboring genes
can be transcribed on one operon. The genes of an operon
are translated at the same time and therefore have a similar
expression pattern. Genes from the same operon often are





Table 2.5: Genomic context: Chromo-
somal sequences are depicted for four
species
havior are possible, similar as with phylogenetic profiles.
The method of genomic context is illustrated in Table 2.5: Genes that frequently appear in
chromosomal vicinity can be identified, here the red and the green genes are candidates for
a functional relation: they are always found to be beside each other. This might indicate a
functional association and hence a possible direct interaction. An overview of genomic context
methods is given in Galperin and Koonin [2000].
Gene fusion
Gene fusion events have been observed between genes that
often interacted together and thus were conveniently com-
bined to a single gene with multiple domains, see Table 2.6.
This phenomenon is also refered to as “Rosetta Stone”. It
Species 1
Species 2
Table 2.6: Gene fusion
has been successfully used to detect protein function and protein-protein interactions [Marcotte
et al., 1999].
Sequence signatures
Domain profiles and short motifs (for example from InterPro
[Mulder et al., 2005]) have been used to produce sequence
signatures. Sequence signatures of pairs of proteins that are
known to interact can reveal the interaction mediating do-
mains. Domain-pairs that are thus known to be interaction-
mediating can help to predict interactions in other proteins, Table 2.7: Sequence signatures
an approach that is taken by Sprinzak and Margalit [2001]. The principle is exemplified in
Figure 2.7: There, all the presented interacting protein pairs contain the domains depicted by
a yellow star and a brown oval, in the left hand side and the right hand side of the interaction,
respectively. These domains can be assumed to be the reason for the interaction.
Linear Motifs
Linear motifs are short stretches of loop regions not be-
longing to a globular domain. Linear stretches are in-
terfaces that are sequentially consecutive. They often fit
into clefts and are able to arrange its structure (induced
fit). The PxxP-Motif binding to SH3 domains is a famous Figure 2.3: Linear motifs
example for a linear motif. Figure 2.3 illustrates a linear motif (black) that was found in three
different proteins (red, green and blue). The three proteins are all able to bind the yellow protein




A three-dimensional structure of interacting proteins
or domains is of great value for homology modeling of
interactions. The structure serves as a template for ho-
mologues. Note that for these homologues sequence in-
formation is sufficient to predict a possible interaction.
More details are provided in Section 2.3.4. A struc-
tural template for homology modeling of an interaction
Figure 2.4: A structural template for ho-
mology modeling of an interaction
is shown in Figure 2.4: A is the GTPase RhoA, B is the Rho-GTPase-activating protein
(RhoGAP). Below, sequences that are homolog to the template’s components can be mod-
eled against the template.
Machine learning
The general approach of a learning task—in particular in the context of supervised learning—
is a formalization process which goal it is to automatically relate input data samples to some
output labels. The samples are labeled according to a category. Samples are either whole do-
mains or proteins, sequence stretches or surface patches. They can be described by features,
that is quantified properties, for example those listed in
Section 2.2. Features can be of structural or of sequen-
tial nature, depending on whether the structure of the
sample’s origin is known. The entirety of features con-
stitute the feature space. A number of machine learning
formalisms require the data samples to be arranged in
fixed size feature vectors: an ordered list of features is
used to describe each data sample. The feature vector
representation of data is geared towards the usage with
support vector machines, decision trees or neural net-
works. To sets of data are exposed to a learning system:
first, the training data which is used to train the system,
that is to set all its parameters. Second, the learning
system is then applied to the test data, that is samples
that are not labeled. The result is that the test data
is classified. A common problem in machine learning is
over-fitting : The learning system’s goal is to generalize
the training data’s main features in order to cope with
unseen data. However if the learning process is too long
Figure 2.5: Machine learning: features can
be extracted from sequence segments or from
surface patches (shown in red). They are col-
lected in a feature vector of fixed length. A
positive data sample for a protein-protein in-
teraction is a patch or segment that is in-
volved in the interaction, its label (y) is then
1.
or the training data is sparse there is a danger to adjust to very specific random features. In
this case, the learning system performs well on training data (learning by heart) but performs
worse on unseen data.
In order to measure the accuracy of a learning system, some randomly chosen samples are spared
from the training data to see how the learning system would classify them. The systematic rep-
etition of this process is referred to as cross validation. Note that cross validation does not need
external validation data.
The problem of protein-protein interaction prediction is posed as a binary classification problem:
the learning system has to decide whether a sample is interacting or not. Formally, the training
data D is thus a set of labeled feature vectors:
D = {(x1, y1), (x2, y2), . . . , (xm, ym)} (2.1)
where the feature vectors xi ∈ IRn, the labels yi ∈ {0, 1} and m is the size of the training data
set. This principle is visualized in Figure 2.5. As an example consider the encoding of features
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like conservation (c), physico-chemical properties like polarity (p), charge (a) and hydropathy
(h) each assigned to a surface patch. The surface of a protein has been divided in overlapping
patches, each containing a fixed number of residues. If patches were identified to participate in
an interaction, they are labeled positive, otherwise negative. A positive feature vector could thus
be composed using x1 = [c1, p1, a1, h1, 1]. Note that the information on geometric constellations
of amino acids is lost with this kind of representation.
Mirror trees and correlated mutations
In a number of studies it has been shown that it is possible that interacting proteins co-
evolve. An example is insulin and its receptors [Fryxell, 1996]. A mutation in one side
of the interface is compen-
sated by a complementary
mutation in the counter-
part. As a consequence, the
phylogenetic trees are sim-
ilar, hence the term “mir-
ror tree”. Correlated mu- Figure 2.6: Mirror trees and correlated mutations
tations have been analyzed in large scale in a structural context [Kim et al., 2004]. Further,
they indicate not only key players in interactions but account for the specificity of an interaction
[Ramani and Marcotte, 2003]. Pazos and Valencia [2001] used this principle to detect contact
maps between protein families. Valencia and Pazos [2002] provides a broad overview of sequence
based interaction prediction methods involving mirror trees and correlated mutations. Figure
2.6 shows in blue and red the sequences (horizontal lines) of two protein families, respectively.
The arcs below the sequences in blue, red and gradient blue-red indicate correlated mutations.
Note that correlated mutations can occur within a protein (red and blue arcs) or between two
interacting proteins (gradient). Phylogenetic trees of the sequences are shown to the left and
the right. Since in the shown example they are made from sequences that underwent the same
pattern of correlated mutations, they are shown as equal.
2.1.7 Protein sequence analysis techniques
Sequence analysis techniques play a wide spread role in bioinformatics in general and in protein
function annotation in particular. The different processes presented in the overview in Figure
1.3 require that similar protein sequences are grouped together, for example for the generation
of motifs. A possible solution for problem 1, the classification of interface types, involves an
alignment of family members. Likewise, a fundamental step towards the solution of problem 3,
the generation of interface profiles, is to collect all instances of an interface type and to create
correspondences between equivalent residues.
The structure and the function of a protein are best explored experimentally. Yet, given
the vast amount of proteins, their often multiple functionality and the laborious, time and cost
expensive procedures, it is clear that computer aided analysis is a complementary approach to
protein analysis. Gene and protein sequences are comparatively easy to obtain using DNA-
sequencing techniques and mass-spectroscopy, respectively.
When scoring the similarity of sequences, the objective is to reflect the biological and statis-
tical observations in known sequences. This is frequently done with substitution matrices that
provide character-to-character probabilities for all possible amino acid mutations. Commonly
used substitution matrices are the BLOSUM and PAM matrices [Henikoff and Henikoff, 1992,
Dayhoff et al., 1978], see the respective references for further detail.
Multiple sequence alignments are either based on a set of pairwise alignments or try to opti-
mize alignment conditions for many sequences simultaneously. Common programs that perform
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Name Description Alignment Type Reference
MSA Dynamic programming Local or Global Lipman et al. [1989]
ClustalW Progressive alignment Local or Global Thompson et al. [1994]
Kalign Progressive alignment Global Lassmann and Sonnhammer [2005]
MUSCLE Progressive/iterative align-
ment
Local or Global Edgar [2004]
MAFFT Progressive/iterative align-
ment
Local or Global Katoh et al. [2005]
T-Coffee More sensitive progressive
alignment
Local or Global Notredame et al. [2000]
Table 2.8: Multiple sequence alignments. The table contains early, fundamental works (MSA
and ClustalW) and programs that represent the current state of the art.
multiple sequence alignments are Clustal-W, Kalign, MSA, MUSCLE, MAFFT and T-Coffee.
They are summarized in Table 2.8.
As an example for a multiple sequence alignment, see Figure 2.7. The first part of a non-
redundant selection of members of the G protein family (GTPases, SCOP family c.37.1.8) is
displayed. For all sequences, structures are available and their SCOP-domain identifier is given in
the alignment (format d<PDB-id><chain><domain-number>). The alignment shows an example
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PG Conformationally special magenta
C Cysteine yellow
Figure 2.7: A multiple sequence alignment generated with MUSCLE, displayed with Jalview
[Clamp et al., 2004]. The alignment shows the first part of a non-redundant selection of the
G-protein family (SCOP id c.37.1.8). The coloring is according to Jalview’s Zappo scheme (see
legend) with the saturation reflecting the conservation of the column. The sequences are highly




2.1.8 Motif search approaches
A solution to problem 3 requires the creation of motifs As shown in Figure 1.3, multiple sequence
alignments can be used to derive sequence motifs. Sequence searches using motifs are a powerful
way to detect functionally important residues in uncharacterized sequences. Motif sequence
analysis hence deals with short stretches of conserved amino acids that are found in a group of
proteins. Such a group can share a similar biochemical activity, where the pattern is located
at the active center. For example, the Eukaryotic Linear Motif server (ELM, [Puntervoll et al.,
2003]) contains small segments of 3-10 residues. These residues play critical roles in protein
interactions, post-translational modifications and trafficking.
Though not primarily used for protein-protein interactions, motif search has been successfully
used to detect functionally important residues in proteins.
Also, conserved motifs can help to set initial seeds when comparing several sequences. PHI-
BLAST (pattern-hit initiated BLAST) uses this technique to recognize greatly diverged but
homologous family members Zhang et al. [1998].
A well known example for a motif is the zinc-finger motif, where a few residues, mostly
histidines, are involved in binding zinc. Also, motif descriptors have been developed and applied
to detect post-translational modification sites, signal-peptides and re-entrance membrane regions
[Emanuelsson et al., 2007, Viklund et al., 2006]. Motifs can be roughly distinguished in structural
and sequential motifs. The former are defined primarily by their shape, and descriptors involve
three-dimensional information such as atom coordinates, hydrogen bonds or backbone angles
[Milner-White et al., 2004, Ausiello et al., 2005]. This way, only relevant parts of a functional site
can be described. A comprehensive resource of structural motifs for catalytic sites in enzymes
is the Catalytic Site Atlas [Porter et al., 2004]. The CSA is a database that documents enzyme
active sites and catalytic residues in enzymes of 3D structure for which structural templates are
constructed. It also provides a classification of catalytic residues.
Structural motifs do not necessarily constitute a consecutive stretch in sequence and corre-
sponding residues are not necessarily conserved in sequence. Hence it is often difficult to find a
significant sequence representation. The focus in this work is on sequence motifs and sequential
representations of structural motifs. Sequence motifs are frequently obtained through sequence
analysis of functionally related sequences: sequences are collected and grouped in terms of their
sequence similarity and/or known functional similarity. Often a multiple sequence alignment is
performed. As a result, highly conserved regions or particular columns of residues are identified.
Alternatively, overrepresented stretches of sequences are identified [Neduva and Russell, 2006].
Sequence motif programs focus on sequence conservation regardless of their reason of conser-
vation. This yields to conserved columns that predominantly stem from protein cores. For a
detailed analysis of surface and core residue conservation see Section 2.5.2.
2.1.8.1 Significance of sequence motifs
In order to assess the statistical significance of molecular sequences, various methods have been
developed, most prominently BLAST [Altschul et al., 1990] and those based on the work of
Samuel Karlin and Steve Altschul [Karlin and Altschul, 1990]. However, sequence comparisons
with short motifs are difficult to evaluate because the usual significance assessments are inappro-
priate [Puntervoll et al., 2003]. Often, further filters are employed to eliminate false positives.
The probability that a motif matches in a sequence can be determined by the frequencies of
the individual amino acids. Given an expression that is equivalent to a non-repetitive regular
expression R = (R1, R2, . . . , Rn) with Ri ⊆ A, where A is the alphabet of amino acids. The
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For example, a regular expression M.[ILVM] (where the dot stands for any amino acid) has a
probability p(M)×1×(p(I)+p(L)+p(V )+p(M)). The motif probability gives a good estimate
of false positives. A more sophisticated model of motifs includes gaps. Note that motifs that
allow for gaps increase the chance of random hits. Gapped motifs of the form aa1d1aa2d2aa3
are the subject of research in [Smith et al., 1990]. Here, d1 and d2 are the distances in terms
of residues between the amino acid stretches aa1, aa2 and aa3. The probability for this kind of
motif to match is discussed in [Smith et al., 1990], too.
2.1.8.2 Motif representations
When a motif is observed, the challenge is then to describe the relevant parts of the motif in a
well-suited representation. Common representations for these motifs include regular expressions,
position specific scoring matrices, and profile-Hidden Markov Models.
Regular expressions. Regular expressions are a fundamental model in computer science. It
allows to create words (here: sequence stretches) from letters of a restricted alphabet (here:
the amino acids or nucleotides). Alternatives for a certain position or a group of letters can be
expressed. This allows to encode physico-chemical groups of residues, for example Phe/Tyr/Trp
describes a position at which there is one of the three aromatic amino acids phenylalanine,
tyrosine, or tryptophane. Repetitions of a single or several letters are possible. In regular
expressions for motifs, often an arbitrary residue is allowed to be repeated. This corresponds
to non-involved spacer regions between motif-specific residues. As an example for motifs, con-
sider the P-loop motif ([Walker et al., 1982]): The motif is an ATP/GTP binding site motif
found in many nucleotide-binding proteins. These proteins share a local feature of few residues,
Ala/Gly-X-X-X-X-Gly-Lys-Ser/Thr, where X indicates arbitrary amino acids and “/” indicates
alternatives.
PROSITE states:
From sequence comparisons and crystallographic data analysis it has been shown that an appreciable pro-
portion of proteins that bind ATP or GTP share a number of more or less conserved sequence motifs.
The best conserved of these motifs is a glycine-rich region, which typically forms a flexible loop between
a β-strand and an α-helix. This loop interacts with one of the phosphate groups of the nucleotide. This
sequence motif is generally referred to as the ’A’ consensus sequence or the ’P-loop’.
The remaining sequence of P-loop proteins often is highly diverse, yet their function as
nucleotide binding can be indicated by a match of the regular expression that encodes the above
residue constraints. (PROSITE-Pattern PS00017)
Position Specific Scoring Matrices. Position specific scoring matrices, also refered to as
profiles or weight matrices, are a statistical representation of a multiple sequence alignment.
Given a multiple sequence alignment with sequences of length n, an n × 20 matrix is created
with each column containing the 20 frequencies of the amino acids at this particular position. If
an amino acid is not present in a certain column (that is its frequency is 0) but the theoretical
possibility of its occurrence should be accounted for, pseudo-counts are introduced. Further,
sequence weights can be introduced to counterbalance a biased sequence selection, for exam-
ple the over-representation of sequences from one phylogenetic sub-branch. The application of
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PSSMs in sequence analysis is similar to dynamic programming as used in multiple sequence
alignments. Match scores are a function of the given amino acid from the sequence and of the
frequency of that amino acid in the profile. PSI-BLAST [Altschul et al., 1997] iteratively creates
PSSMs from the matched sequences of a database.
Profile Hidden Markov Models. Hidden Markov Models (HMMs) are a statistical frame-
work, that can be represented as a graph, where nodes represent states and edges represent
transition probabilities between states. Each state has additionally attached an emission prob-
ability distribution to emit symbols. HMMs have been previously applied successfully in speech
recognition. The approach has the advantage that it is well-founded in probability theory. Fun-
damental HMM related work in the context of Bioinformatics has been done by Anders Krogh
[Krogh et al., 1994] and Sean Eddy [Eddy, 1998].
Hidden Markov Models are widely applied in sequence analysis, predominantly for domain
detection (Pfam, SMART, TIGRFAMs, PIRSF, SUPERFAMILY, Gene3D and PANTHER)
and detection of transmembrane helices (TMHMM, HMMTOP, PRO-DIV [Krogh et al., 2001,
Tusnady and Simon, 2001, Viklund and Elofsson, 2004]). Other applications are gene-finding
[Krogh, 2000, Birney et al., 2004], signal-peptide recognition [Käll et al., 2004] and the detection
of re-entrance regions in transmembrane proteins [Viklund et al., 2006]. The overall architecture
of the HMM is equal in all these applications: the construction starts with a multiple sequence
alignment of proteins or DNA. This multiple sequence alignment reflects the profile of the
selected sequences and the resulting HMM is therefore called a profile HMM. Each column
is represented by the emission probability distribution of the corresponding match state. If
insertions between two positions can occur, the transition probability of the first match state
to its accompanied insertion state is set accordingly. Gap extensions are modeled by self loop
transitions in the insert state. Likewise, if deletions are allowed in the matched sequences,
the deleted residue is modeled by a path through the profile HMM which circumvents the
corresponding match state: The alternative probability to go to a deletion state instead of a
match state is set according to how likely it is that a certain residue is deleted. From the deletion
state there are possible transitions to the following match state and to the next deletion state.
A gap-less profile which would not allow insertions nor deletions suffices with a simple Markov
chain of match states. In that case the transition probabilities would be one.
Given a trained profile HMM and a sequence, the probability that the sequence can be
emitted by the HMM is determined by the joint probabilities of all possible paths that could
emit the given sequence. The Hidden Markov Models are refered to as “hidden”, since for an
emitted sequence it is not clear which residue was emitted by which match state. The Markov
property refers to the fact that outgoing transition probabilities have no relation to previous
events, that is the model works without memory. This property holds mainly for modeling
families of protein sequences.
Variations of linear profile Hidden Markov Models exist. Notably, Friedrich et al. [2006]
introduced two kinds of match states, one for interacting and non-interacting residues. HMMer2
[Bateman et al., 1999], used for building the Pfam database, includes a new kind of model that
allows additional transitions in order to allow local alignments. The model also is able to match
permutated segments. These modifications will be discussed in detail in Chapter 5.
2.1.9 Protein structure analysis techniques
The counterpart to sequence alignments in structure space are structural alignments, see Figure
1.3. Since many proteins that share the same function also share the same structure, it is helpful
to classify proteins by structural similarity. To this end it is necessary to superimpose two or
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Figure 2.8: Profile Hidden Markov Models. They are composed of three kinds of states: match
states (squares), insertion states (diamonds) and deletion states (circles). States are connected
by transitions. Each transition is associated with a probability, depending how likely the transi-
tion is according to some observed training data. Match states are associated with an emission
probability distribution over amino acids, that is they can emit a residue with a certain likeli-
hood. In the example given, the four match states preferably produce A or V, A, any residue
and C, respectively. The probability distributions are illustrated by the vertical bar diagrams
below the match states.
more structures and quantify the similarities. This procedure is a form of protein comparison
based on the similarity of shape. Structural alignments are useful also for other cases: in order
to investigate interaction modes in two dimers that have one domain in common, it is necessary
to adjust the two complexes by aligning on the common domain. Yet another application of
structural alignments are the comparison of two conformational states of a protein or domain.
Structural alignments of proteins lead to sequence alignments. The equivalences of residues,
that is the pairing of amino acids that occupy the same space, provide a means of evalua-
tion whether they are playing the same role in the protein, either for function or for stability.
Therefore these structurally derived sequence alignments serve as a gold standard for sequence
alignment tools, as for example in the BAliBASE database [Thompson et al., 2005].
When comparing two proteins or motifs of two proteins, it is common to use sequence align-
ments. Occasionally, structural features are shaped by differently arranged secondary structural
elements. In these cases sequence order in equivalent positions is not preserved. The importance
of sequence order independent methods has therefore been emphasized by Tsai et al. [1996].
A fundamental paradigm in bioinformatics is that protein structure is better conserved
than protein sequence, that is, numerous cases of proteins with very similar folds and three-
dimensional architecture exist, although their sequence similarity is low. On the other hand, high
sequence similarity generally implies high structural similarity. This relation is illustrated in Fig-
ure 2.9. The application of structural alignments is therefore especially useful when comparing
remote homologues, which sequences would not reveal homology or residue correspondences.
Likewise, it is expected that local structural conservation is possible. A series of systematic
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structure alignments of a structural motif to target structures is therefore a frequently applied
technique to annotate residues.
Figure 2.9: Relation between sequence similarity and structural similarity. Many examples with
high structural similarity despite low structural similarity exist (red marked area). Reprinted
from http://www.jenner.ac.uk/YBF/DanielleTalbot.ppt
A structure alignment can be formalized to the problem of finding the maximum common
substructure in two point-sets with corresponding points being in equivalent positions. This
problem is shown to be NP-hard., that is a sound and complete alignment algorithm will not
operate in polynomial time.
The outputs of a structural alignment is aiming for the optimal rotation and translation of
the atomic coordinate sets of one protein onto the other. It establishes equivalences between
amino acids and atoms that occupy the same space after the superposition.
The minimal root mean square distance (RMSD) between the structures provides a quan-








where δi is the distance between a pair of equivalent atoms, that is, Cα as well as the other
backbone atoms and Cβ in order to account for similar side chain orientations. Hence, if two






(vix − wix)2 + (viy − wiy)2 + (viz − wiz)2 (2.4)
Although the RMSD is widespread, alternative measures for quantifying structural similarities
exists: for example the
aRMSD the best RMSD calculated over all aligned alpha-carbon atoms
bRMSD the RMSD over the highest scoring residue pairs
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wRMSD (“weighted” RMSD) down-weights regions of weak similarity which are mainly
loop regions that can have large relative displacements.
These variants of the RMSD were introduced by Taylor [1999]. Frequently used programs for
structural comparison are DALI, SSAP, CE and MultiProt. Their underlying principles are
shortly described in the following:
DALI The distance alignment matrix (DALI, [Holm and Sander, 1996]) is a well-established
method to compare two structures. Structural features of the two proteins are compared by
comparing their respective distance matrices of Cα-atoms. Secondary structure features appear
in the distance matrices as diagonals that are parallel or anti-parallel to the main diagonal. When
these features happen to be similar in both proteins, their folds are approximately similar. The
comparison of the two matrices is done by aligning a series of 6x6 sub-matrices, thus comparing
geometric similarities of heptapeptides. Cα-atom coordinates are used as a suitable protein
representation. This reduces the complexity of the protein on average by a factor of 10. DALI
accounts for sequence order independence of structural features because of the all-against-all
distance comparison.
SSAP The Sequential Structure Alignment Program (SSAP, [Orengo and Taylor, 1996]) uses
double dynamic programming to produce a structural alignment based on atom-to-atom vectors
in structure space. Instead of the Cα-atom coordinates typically used in structural alignment,
SSAP constructs its vectors from the Cβ-atoms for all residues in order to take into account the
rotameric state of each residue as well as its location along the backbone. SSAP implies so-called
double dynamic programming: For each residue a distance vector to its nearest non-contiguous
residues is constructed. A series of matrices is then constructed containing the vector differences
between neighbors for each pair of residues with distance vectors. Dynamic programming on
every matrix reveals local alignments. These are summed into a final global matrix, on which a
second dynamic programming process is applied.
By applying the structural alignment procedure to the available structures in an all-against-
all manner, it is possible to produce a hierarchical fold classification. Doing so using SSAP, the
CATH (Class, Architecture, Topology, Homology) database has been constructed [Pearl et al.,
2003].
Combinatorial extension As with DALI, combinatorial extension (CE, [Shindyalov and
Bourne, 1998]) works on fragment pairs. CE creates a similarity matrix of fragment pairs
(aligned fragment pairs). The similarity between fragments is evaluated by structural positions,
solvent exposure, hydrogen bond patterns and dihedral angles. Aligned fragment pairs are only
considered if they fulfill a number of criteria. This way the computational complexity is reduced.
From the similarity matrix, the final global alignment is derived.
An alignment path is calculated as the optimal path through the similarity matrix by linearly
progressing through the sequences and incrementally extending the alignment with the next
possible high-scoring fragment pair. Again, CE has been used to generate a hierarchical fold
classification database.
MultiProt The main incentive behind MultiProt [Shatsky et al., 2004] is to address the
problem of aligning a family of structures rather than performing mere pairwise alignments.
The algorithm detects all structurally similar fragment pairs with respect to a pivotal structure.
The length of structural matches of a certain range within the pivotal structure is then extended.
Common geometric cores are identified by introducing regions that are consecutive with respect
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to sequence. Those regions that contain similar fragments from many different proteins are
considered for the seed of the final global multiple alignment. Note that the approach is sequence
order independent. The authors demonstrate that this property helps to analyze binding sites
and to align protein-protein interfaces [Shatsky et al., 2004]. The special ability to produce
alignments of protein-protein interfaces has been used to create the MAPPIS database [Shulman-
Peleg et al., 2005, 2007].
2.2 Characterization of protein interfaces
General principles of protein-protein interactions have been proposed [Jones and Thornton,
1996]. The authors define measures for interface size, shape complementarity, protrusion, seg-
mentation and secondary structure. It is important to notice that in the vast diversity of protein
interactions these characteristics differ strongly. Given the structure of two interaction candi-
date proteins, these measures both help to determine the binding ability as well as to identify
the actual binding site. This knowledge driven approach has inspired many machine learning
approaches described in Section 2.3. Further important criteria for protein interactions have
been proposed and are discussed in the sequel.
Duration of interaction. A fundamental distinction between interactions is by their dura-
tion, that is whether they occur in permanently or transient. Nooren and Thornton [2003b]
further distinguish between weak and strong transient interactions, where the former follow a
principle informally termed “kiss-and-run” while the latter are in contact and their connection
is disrupted through some trigger. A slightly deviating definition, expressing the duration as
well as the functional aspect, divides protein-protein interactions in obligate and non-obligate.
Obligate interactions are permanent interactions of proteins that can not occur individually. As
an example consider the alpha- and beta-chains from hemoglobin. Both chains do not play any
role by themselves, but they are only functional upon complex formation.
Evolutionary Conservation. Structurally and functionally important residues are often well
conserved. It is reasonable to assume that a vital protein-protein interaction is unlikely to be
haphazardly exposed to mutations. The loss of an interaction can have fatal consequences for
the organism or implies—in most cases—a evolutionary disadvantage. Consequently, functional
interfaces are commonly associated with a lower mutability than other, non-functional parts
of the protein surface. The identification of binding sites based on evolutionary conservation,
however, remains controversial. While some authors claim a stronger conservation of interfaces
then the remainder of the surface [Nooren and Thornton, 2003b, Bordner and Abagyan, 2005],
others question the statistical significance [Caffrey et al., 2004]. It is not sufficient to base
binding site detection solely on conservation scores. However, selective pressure often leads
to the conservation of important protein features, such as binding behavior. It is therefore
reasonable to involve evolutionary conservation scores (as used by for example Li et al. [2004b]
and Bordner and Abagyan [2005]).
Hydrophobicity. Surface patches with high hydrophobicity are energetically unfavorable in
an aqueous environment. Their occurrence has been linked to binding sites and [Gallet et al.,
2000] proposed an interface detection method that predicts binding sites by analyzing the hy-
drophobicity distribution in sequences. Especially permanent interactions between globular
proteins were found to involve more hydrophobic residues: It has been found out, that the
largest hydrophobic surface patches at least to some extend engage in protein binding. This
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approach has been outperformed by several techniques that employed further features. Accord-
ing to Nooren and Thornton [2003b], hydrophobicity has less discriminative power for transient
interactions, as transient interactions are often established by hydrogen bonds from polar side
chains.
Correlated mutations. A mutation in one side of the interface is sometimes compensated
by a complementary mutation in the counterpart. Correlated mutations often are the result of
co-evolving proteins. They have been analyzed in large scale in a structural context [Kim et al.,
2004]. Further, they indicate not only key players in interactions but account for the specificity
of an interaction [Ramani and Marcotte, 2003]. Pazos and Valencia [2001] used this principle to
detect contact maps between protein families.
Hotspots and hot regions. Ma et al. [2003] found out that structurally conserved residues
(hot spots) distinguish between binding sites and exposed protein surfaces. Further, Keskin
et al. [2005] analyzed computational hotspots and their surrounding. According to the authors,
hotspots reside in tightly packed, structurally conserved regions that contribute dominantly to
the stability of the interaction.
Sequential patterns: Conserved sequence motifs in and around the interacting residues are
indicators for interaction sites, see also Section 2.1.8.
Secondary structure: Interface residues can be classified according to the secondary struc-
ture they are part of, that is alpha-helices, beta-strands, turns and loops. Less common are 310
helices and π-helices. Secondary structure elements are commonly determined in protein struc-
tures using the DSSP algorithm [Kabsch and Sander, 1983], which is based on an electrostatic
definition to identify hydrogen bonds. Further, less regular structural motifs exist [Milner-White
et al., 2004].
Electrostatics: The calculation of the electrostatic potential of protein-protein complexes
showed that protein-protein interfaces display electrostatic complementarity [McCoy et al.,
1997]. Electrostatic surfaces of proteins can for example be calculated by solving the Poisson-
Boltzmann Equation [Fogolari et al., 2002]. Frequently, binding sites are identified by opposite
charges in opposite interfacing patches.
Hydrogen bonds: The bonds formed by hydrogen atoms between a hydrogen-bond donor and
a hydrogen-bond acceptor are—except covalent bonds—the strongest contributors to binding
energies.
Water bridges: Bridging water molecules are those forming two hydrogen bonds, one to each
interface side (face). A large scale analysis of so-called wet-spots can be found in the SCOWLP
database by Teyra et al. [2006].
Buried surface: The size of an interface. A probe sphere of size 1.4 Angstrom (the approxi-
mate size of water) is rolled around the van der Waals surface of a protein. The area is measured
for the interacting proteins before and after complex formation. The difference of the two areas
yields the size of the buried surface.
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Shape complementarity: Interacting proteins often have their surfaces arranged in such a
way, that large surface patches are in direct contact with each other. Especially enzymes that
select their substrates very specifically exhibit a high degree of shape complementarity with
respect to their substrates. This phenomenon was observed by Emil Fischer, who proposed
the “lock and key” model in 1894 Fischer [1894]. To account for conformational flexibility of
protein-protein interactions, the “induced fit theory” has been proposed [Koshland, 1958] as a
modification to the lock and key model: substrates are not rigidly docking to their enzymes but
constantly perform small rearrangements of their side chains.
Note that shape complementarity (as well as surface criteria, hydrogen bonds etc.) is a purely
structural feature in the sense that it does not translate directly into sequence representations.
Therefore, shape complementarity is not directly usable in predictions, where only sequences are
given. However, shape complementarity can be the result of a long evolutionary process involving
mutations on one side and compensatory mutations on the opposite side of the interaction. These
correlated mutations (see above) are detectable on sequence level.
Intra/inter-chain interactions: Domain-domain interactions can be observed between dif-
ferent proteins or within the same protein.
Hetero/homo-dimer: Protein dimers can be built from equal or different domains. Many
proteins occur as homodimers. The distinction between homodimers and hetero-dimers can be
made on various levels, such as sequence-level, family-level or superfamily-level.
These factors influence the formation of protein-protein complexes. The authors suggest a
rough classification into four different types of protein-protein complexes: homo-dimeric pro-
teins, hetero-dimeric proteins, enzyme-inhibitor complexes, and antibody-protein complexes.
The comparison between the complexes highlights differences that reflect their biological roles.
It will be of great interest to determine the most relevant characteristics for the particular pur-
pose of binding site prediction. Accordingly, the classification in Section 3 will be geared towards
this purpose.
2.3 Comparison of existing approaches to protein interac-
tion prediction and binding site detection
A large amount of approaches exist to identify protein interactions. They differ in methodology,
accuracy and expressive power: A first rough distinction of methods is experimental vs. in
silico. An overview about the former is given in [Fu, 2004]. Experimental methods are far
from complete. The first high-throughput yeast-two-hybrid experiments for protein-protein
interaction detection was carried out by [Uetz et al., 2000] in Saccharomyces cerevisiae, followed
by [Ito et al., 2001]. More recently, comparable large scale experiments were carried out by Gavin
[Gavin et al., 2002] and Krogan [Krogan et al., 2006]. These studies showed that the majority
of proteins form complexes. Moreover, the combined effort to collect exhaustive protein-protein
interaction data poses a great step towards complete interactomes [Rual et al., 2005]. However,
their accuracy has been under debate: It is estimated that high throughput experiments are
afflicted with 30-60% false positives and 40-80% false negatives [Aloy and Russell, 2006]. A
reliability assessment of protein-protein interaction data using co-localization and coinciding
functional annotation is suggested in Sprinzak et al. [2003].
Furthermore, overlap between these protein-protein interaction datasets were surprisingly
small [Goll and Uetz, 2006]. To improve the confidence about protein-protein interactions,
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methods are commonly combined. Deane et al. [2002] describe a method that validates large
scale protein-protein interaction data with small scale experiments, using the information about
paralogous interacting proteins. The integration of protein-protein interaction datasets from up
to six sources including computational predictions allows to attach confidence levels [von Mering
et al., 2005].
2.3.1 Comparison of specific implementations for protein-protein in-
teraction prediction
Protein-protein interaction prediction is a very active field of research. The Tables 2.9 and 2.10
contain a list of approaches that either deal with binding site prediction, interaction prediction
or both. The focus has been laid on methods that are relevant to the approach in this work.
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MIPS/PDB Statistical significance Empirical Potentials (rel-
ative observed contacts
between residues)










































Table 2.9: Comparison of protein interaction prediction methods. Abbreviations
used in the table: CV - Cross validation; SVM - Support Vector machines; PSSM -
Position specific scoring matrix; ASA - accessible surface area; AA - amino acids;










































































Structure based protein-protein interaction prediction


















































Score for Surface dots,
smoothened with neighbors,
above threshold → interface
residues, distance of Cα atoms
below threshold→ patches




X-ray PDB, 1500 inter-
actions
SVM patch hydrophobicity, desol-
vation energy, residue ASA,
conservation
























map (counts for domain
binding)










SVM 9×20 Propensity vector
around interacting residue
3/3 3,5,10 CV heavy atom
distance ≤ 5Å
Table 2.10: Comparison of protein interaction prediction methods that predict interactions of proteins, provided the structures of the
proteins of the test set are solved.
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The provided estimations for accuracy are very difficult to compare. A crucial factor for the
accuracy is the similarity between training and test set. Ofran and Rost [2003a] made sure to
have no observable homologs in both training and test set. This explains the low coverage in
their results. On the other hand, a method that is able to perform well on a test set that is in
no relation to the training set is likely to cope best with unseen data in general.
However, other definitions consider a surface patch a true positive, if it at least overlaps to
a certain percentage with the true interface. This measure was used by for example Bordner
and Abagyan [2005] and Bradford and Westhead [2005], unfortunately with different overlap-
thresholds.
The works of [Yan et al., 2004, Koike and Takagi, 2004, Sprinzak et al., 2003, Shen et al.,
2007, Chen and Liu, 2005, Espadaler et al., 2005, Li and Li, 2005, Aloy and Russell, 2003, von
Mering et al., 2005, Pazos and Valencia, 2001, Marcotte et al., 1999] are displayed in Table 2.9.
These efforts have been published with great impact and can be considered the most successful
approaches to protein-protein interaction prediction so far.
Each row in Table 2.9 contains information on materials and methods, features used for bind-
ing site/interaction prediction and the validation techniques employed. Table 2.9 lists methods
that predict interactions without the knowledge of the protein structure, whereas the methods
of Table 2.10 involve structural knowledge. As it can be seen in Table 2.9, support vector ma-
chines are frequently used for the prediction of interactions. In general, the majority of methods
follows the standard scheme of supervised learning, as discussed in Section 2.1.6. The algorithms
generate a function that maps inputs to desired outputs. Hence, it is possible to compare their
training data, learning methods and validation details. Training data was derived from interac-
tion databases discussed in Section 2.1.5. Some methods focus on binding site prediction [Yan
et al., 2004, Obenauer and Yaffe, 2004, Li and Li, 2005], others on the prediction of interactions
without explicitly determining the binding site, for example [Albert and Albert, 2004, Gomez
et al., 2003]. Further, represented features and the exact definitions of an interface are compared,
where applicable: the vast majority of techniques uses a distance based threshold, sometimes
atom dependent (distances between heavy atoms, Cα atoms or van der Waals distances). The
different evaluation techniques, that is, cross validation with incomparable test sets, comparison
to random prediction) led to very divergent accuracy estimations. The single columns of Table
2.9 are discussed below.
2.3.2 Data Resources
It is necessary to mention that data sources are generally error prone. Experimental data (such
as yeast-two-hybrid) contain false positives and false negatives. Weak and transient interactions,
often the most interesting in signaling cascades, are difficult to obtain. For example, tandem
affinity purification includes two or more washing procedures. As a result, this technique is not
suitable to detect transient interactions.
The PDB as one of the most central data resource in interaction prediction has been afflicted
with a number of shortcomings such as crystal contacts, bias towards crystallizable structures
(not representable for proteomes), bias towards funded research, engineered/cleaved proteins,
and incompleteness (sparse or no data for some domain-domain interaction). Awareness and
careful compilation of data sets are key and probably the reason, why data sets in protein
interaction studies tend to be hand picked. On the other hand, the three-dimensional structures
provide atomic detail of interactions. These details carry valuable information for protein-
protein interactions and can be formalized as features. Moreover, a large number of complexed
transient interactions are available.
Some of the employed data interaction resources are of “low resolution” as they do not
generally provide insight into the actual interfaces [Sprinzak et al., 2003, Bock and Gough,
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2001, Gomez et al., 2003].
It is interesting to see, that structural data is not the only way to provide interface profiles:
[Obenauer and Yaffe, 2004] derived the knowledge of interacting residues from peptide library
experiments instead. The collection of binding peptides on a certain interface can then be
used to distill the characteristic residues. These were then represented in a position specific
substitution matrix.
2.3.3 Statistical learning methods and represented features
There are many ways to represent key features in proteins. On sequence level, regular expres-
sion, position specific substitution matrices (PSSMs) and hidden markov models (HMMs) are
frequently used.
The choice of protein feature representation corresponds to the statistical method for gener-
ation and usage: Profiles represented as HMMs and PSSMs are derived from multiple sequence
alignments. Search engines like PSI-Blast and HMMer score local sequence similarity to the
profile. This idea is elaborated by [Obenauer and Yaffe, 2004, Espadaler et al., 2005, Li and Li,
2005]. Likewise, [Sprinzak and Margalit, 2001] employ the correlation of “sequence signatures”
in interacting proteins in order to infer responsible domains. The difference to the aforemen-
tioned methods is that the complete sequences (domains) are used, not just the interface regions.
Note that this approach is not capable of binding site prediction (see according column in Table
2.3). It also has less potential for discovering specific domain-domain interactions, since cru-
cial disruptive mutations in interfaces are neglected whereas complete domain similarities are
established by domain parts that are irrelevant for the interaction. The advantage, on the other
hand, lies in the richer amount of protein-protein interaction data that these learning systems
can train on—in fact, all data-sets mentioned in subsection 2.1.5.
Feature vector based approaches are dominating protein-protein interaction prediction meth-
ods, compare to Table 2.3. In sequence based methods, often a feature is the characteristics
(often propensities) of the sequential neighborhood around an interacting residue. The actual
quantified feature differs in the compared approaches, they can be:
1. Physico-chemical properties of amino acids
2. Frequencies of amino acids
3. Frequencies of amino acid segments (of size 3 or 4, as in [Chen and Liu, 2005, Gomez
et al., 2003])
4. Frequencies of domains (as employed in [Yan et al., 2004, Sprinzak and Margalit, 2001])
Note, that amino acids encodings commonly require 20 dimensions per amino acid, for
example, Yan et al. [2004] construct 9×20=180 feature bits. In this encoding scheme, the
sequential order information is lost, since neighboring dimensions in the feature vector do not
necessarily correspond to neighboring residue positions. However, as motif-related studies show,
the sequence order in motifs is conserved rather than shuffled. This is a consequence of the
genetic modification mechanisms, that only allow for segment-wise shuffling (recombination) or
point-wise mutations. for example, a pattern search with the P-loop motif is far more significant
than any of its permutations. A way to construct features that account for sequence order
preservation is by considering the frequency of short segments, the third criteria of the list
above. Each possible segment is a feature. [Chen and Liu, 2005] and [Gomez et al., 2003] use
segments of size three and four, respectively. Since in principle all combinatoric possibilities for
amino acids should be considered, 20s features are possible, where s is the size of the segment.
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Feature vectors of that size are infeasible for s > 2 as the high-dimensional feature space bears
the risk of over-fitting (see above).
Hence, the two segment frequency approaches restrict amino acids to be one of seven or six
physico-chemical types only, which then leads to feature space dimensions of 73 = 1296 and
64 = 343, respectively.
In structural methods, a mapping into feature space is usually defined on interacting and
non-interacting surface patches. This mapping usually exceeds sequential features by criteria
like curvedness, hydrophobicity, shape complementarity, physico-chemical surface properties
[Bradford and Westhead, 2005, Bordner and Abagyan, 2005].
Below, some issues of the statistical learning methods are discussed.
Negative protein-protein interaction data. Cross-validation techniques require positively
and negatively labeled training and test data vectors. Unfortunately, negative results about non-
interacting proteins are rarely reported in literature or protein-protein interaction databases
[Jansen and Gerstein, 2004]. Therefore, often random protein pairs are fed to the learning
systems as negative samples, which introduces potential errors for the learning procedure and
for estimation of a method’s accuracy. This leads to imperfect benchmarks. Slight improvements
have been achieved by considering non-interaction for mutually exclusive co-expression or co-
localization patterns. This in turn compromises the learnability, since these proteins could
potentially interact [Ben-Hur and Noble, 2006]. The lack of a gold standard for negative protein-
protein interaction data is intrinsic to cross validation of protein-protein interactions, and a
remedy is yet an open challenge [Aloy and Russell, 2006].
Results lack explanation. SVM and Neural Networks often create results that are very
difficult to explain. A trained classifier with optimized parameters is inadequate to describe the
reason, why test set samples where labeled positive or negative. Decision trees provide a list of
criteria a positive sample must fulfill. Often, decision trees become cluttered and complicated
when too many decisions are allowed. As a remedy, feature reduction mechanism weed out the
irrelevant criteria and make the results explainable with less decisions.
Feature vectors are of rigid size. Feature vectors are by definition of the same size for all
samples (see Equation 2.1). As a consequence, a single identified binding site is often encoded
by several positively labeled feature vectors (as in the surface patch approaches or sequential
neighborhood approaches). The disadvantage is that the connectivity pattern of the binding
site in its entirety is lost. Alternatively, the binding site is represented in a indicative bit vector
of dimensionality that equals the amount of different binding sites. Again, over-fitting and low
adaptability to unseen samples hinders this approach.
Moreover, validation techniques for surface patches are blurred, since the learning system la-
bels a set of patches as interface. A prediction is considered “correct”, when a certain percentage
of the true interface overlaps with a set of positively labeled patches.
Diversity of protein-protein interaction difficult to learn. Nooren and Thornton [2003b]
point out that protein interfaces are highly diverse. Moreover, the data sources differ in diversity
and size. Notably many of them are rather small. Many features that have been formalized
for interacting proteins have distinctive power only for some kind of interactions such as shape
complementarity and conservation for the case of enzyme-inhibitor interaction. Depending on
the precise amount of training data, it is often infeasible to learn all kinds of interactions at once
just by having a diverse training data set. The task of predicting protein-protein interactions can
be broken down to different, independent classes of protein interactions. For example Ofran and
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Rost [2003a] and Neuvirth et al. [2004] restrict themselves to the class of transient interactions.
Principles that rule the transient interactions are rarely indicators in permanent interactions
and vice versa (for example polar contacts, hydrophobicity).
Sequential vs. structural features. Surface patches are superior to sequence neighborhood
vectors in describing the actual binding site. A training data sequence window might involve
residues far away from the interface and thus irrelevant to the binding behavior. Because of the
use of these irrelevant residues, sequence windows may produce many false positives. Yan et al.
[2004] therefore further filters those sequence windows from the test set with positive labeling
by a Bayesian Classifier. Interestingly, Koike and Takagi [2004] compared results before and
after adding structural features. They add some but limited predictive power, according to the
authors.
Two-sidedness of interfaces. The two-sided nature of interfaces is elaborated in some ap-
proaches: Espadaler multiplies the P-scores for both motif-matches thus obtaining a P-score for
the whole interface expressing statistical significance. Li and Li [2005] also considered interaction
pairs.
2.3.4 Homology detection methods and the exchange of annotation
amongst homologs
In order to elucidate the function of an unknown gene, a standard procedure is to search for
homologous sequences of that gene and adopt the annotations, if available. Homology based
annotation transfer is a prevalent and routinely applied tool in bioinformatics. Likewise, homol-
ogy based transfer of interaction information through interologs has been attempted previously
[Walhout et al., 2000, Yu et al., 2004, Aloy and Russell, 2002]. The idea is, that two proteins
are assumed to be interacting if they have homologs in other species that are known to be in-
teracting. Yu et al. [2004] quantitatively assess the degree to which interologs can be reliably
transferred between species and report that a joint sequence identity > 80% is required.
Various methods in Table 2.9 are based on homology based transfer, for example Aloy and
Russell [2003], Gomez et al. [2003], Chen and Liu [2005]. These methods perform a domain
assignment on the proteins, which then are translated into features. In [Shen et al., 2007] it
is pointed out, that methods, that do not rely on successful domain assignments, are more
universal.
2.3.5 Validation
Prediction methods are notoriously hard to judge in terms of accuracy. Cross validation, val-
idations against trusted interaction data and comparison to randomized prediction are most
common. Other standard approaches to estimate the accuracy are the calculation of ROC
(Receiver operating characteristic) analysis and contingency tables. Albert and Albert [2004]
argued, that these procedures are ill-suited for the prediction of interactions since the expected
number of false positives and false negatives are large and these methods are very sensitive to
a priori errors. Table 2.9 contains a column “Accuracy” which states an accuracy estimation
by the authors by using the evaluation technique listed in the sixth column. It can be observed
that the provided values are of great variety due to different accuracy measures and different
test sets. This compromises the comparability of the methods’ accuracies. Accuracy measures
and test set conditions are discussed in the sequel.
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Accuracy measures A multitude of ways exist and are applied when validating the accuracy
of an approach. The diagram below illustrates the relation between a prediction and reality and
the according values that are used to measure the fit.
Terms and concepts that are commonly used in the accuracy validation process are listed below:
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Sensitivity (SNS)/Recall Sensitivity is refered to as Recall in Information Theory, where it










Receiver operating characteristics (ROC) The receiver operating characteristic (ROC),
or simply ROC curve, is a plot of sensitivity vs. (1 - specificity). The area under this curve
is the ROC score (used for example in [Gomez et al., 2003]).
In order to provide the accuracy characteristics of a method, often sensitivity/specificity
and recall/precision are mentioned. A method usually can be parameterized and this way, true
positives can be increased to the expense of the true negative rate and vice versa. This leads
to a plot which curve areal can be interpreted as a combined accuracy value for a method.
Alternatively, the F-measure (the harmonic mean of precision and recall) can be provided.
During validation with other sources it is striking, that the overlap of predicted protein-
protein interactions has been small. For example Aytuna et al. [2005] report 25% overlap with
BIND and 14% overlap with DIP, which the authors consider reasonable. Optimal confirmation
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is only possible by supportive experiments or literature validation. Note that often due to the
large number of predicted interactions only a very small percentage could be validated with
available interaction databases, as for example in Espadaler et al. [2005]. The authors avoid
to consider the non-validated interactions as false positives. Therefore, an estimation of the
accuracy is not performed by the authors.
A special problem lies in the accuracy measure of methods involving surface patches: during
cross validation, patches are considered true positives if they overlap to some amount with a
true interface patch. This hinges on both patch size and the overlap percentage threshold. Often
they are set differently and render the methods incomparable.
Differences in the test set compilations The composition of test sets is crucial in the
validation process. Generally, test sets are randomly selected from the labeled data. In order to
predict truly unseen interactions, test sets should exclusively contain proteins that are dissimilar.
This is the approach is the hardest learning task. It is taken by Ofran and Rost [2003a] and
explains their low recall. In contrast, Shen et al. [2007] uses a training set with 32.000 sequences
and has no conditions regarding the similarities to the sequences in the test set (400 sequences).
It is possible that a large part of the test set could have been predicted to interact by homology
based predictions from the training set. Bock and Gough [2001] express their accuracy by a
number the authors refer to as “Inductive accuracy”. It is defined as the percentage of correct
predictions in novel test sets. Novel here means that it contains only samples that have not
been used during learning. Since 50% of the DIP was used as training and 50% for testing, and
nothing is said about the partition, it is possible that the training set and testing set contain
interologs. In this case the learning task is easier than in the case of [Ofran and Rost, 2003a].
The genomic context analysis by Marcotte et al. [1999] has been a milestone in comparative
genomics. It featured a novel method for interaction prediction by purely computational means
using genomic sequences. The authors define true positives if the two members of a predicted
interaction agree on SwissProt keywords. However, given that some SwissProt keywords are
unspecific (for example “Bait region” or “ATP-binding”), simple agreement in SwissProt key-
words is not necessarily an imperative way to define truly interacting proteins. It is therefore
questionable, how the different methods define true positives. That is, if all mentioned methods
are bench-marked with a gold standard for true positives, the comparability of the methods can
be improved.
It should also be noted that the test sets can sometimes solely contain proteins that are
known to interact, see for example [Sprinzak et al., 2003, Gomez et al., 2003]. The prediction is
then about the part of the protein, that is actually mediating the interaction.
To summarize, the diversity of measures, the different set ups for test sets and the strongly
varying values can only give a crude impression about the performances. A true comparison
necessitates a standardized benchmark and a unified summary measure.
2.4 Comparison of existing motif search algorithms
Several published motif search algorithms are discussed in the sequel. Most approaches for
discovering motifs originate in multiple sequence alignments.
BLOCKS/eMOTIF/MOTIF.
As for the BLOCKS program [Henikoff and Henikoff, 1991], blocks of length 10 to 55 are ex-
tracted from ungapped alignments of up to 400 protein sequences. Similarly, the eMOTIF-server
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[Nevill-Manning et al., 1998] extracts conserved patterns, but these are generally shorter. An-
other program that additionally handles intervening sequence stretches that are not considered
as part of a motif is the MOTIF program [Smith et al., 1990]. MOTIF requires the patterns
to be contained in a number of input sequences and not to be internally repeated. It always
generates motifs, even for random sequences. To evaluate the statistical significance of a motif,
the program is combined with a Gibbs sampler.
PROSITE
Bairoch developed a method to predict the biochemical function of proteins given their amino
acid sequence [Bairoch, 1992]. He collected sequences of similar function and deduced the
pattern of amino acids responsible for the function, allowing for some variability. The extracted
motifs are subject to function annotation by means of literature and structural information. The
collection of motifs has been systematically used to annotate functions to protein sequences, for
example in the UniProt database [Wu et al., 2006].
MEME
is based on the expectation maximization algorithm [Bailey et al., 2006]. It has been used to
identify transcription factor binding sites, that is, stretches of sequences that are known to be
short and degenerate.
ELM
is a resource of linear motifs that were identified to be functional . “Siteseeing” (annotation of the
linear motifs) is performed by the ELM consortium hand curators. The process involves BLAST
searches, SwissProt analysis, multiple sequence alignments and consultation of experimentalists.
Regular expressions are derived and context-based rules and logical filters are applied to reduce
the amount of false positives. In a similar attempt, DiLiMot [Neduva and Russell, 2006] detects
overrepresented short stretches of sequences in interacting proteins.
InterPro
is a meta search algorithm. It is not a pure motif search tool in that it integrates various search
tools spanning protein families, domains and functional sites. The integrated resources are
PROSITE, PRINTS, ProDom, Pfam, SMART, TIGRFAMs, PIRSF, SUPERFAMILY, Gene3D
and PANTHER [Bairoch, 1992, Attwood and Beck, 1994, Letunic et al., 2006, Haft et al., 2003,
Wu et al., 2004, Gough, 2002, Yeats et al., 2007, Thomas et al., 2003].
PRINTS
is a collection of so-called protein fingerprints. The difference to ordinary motifs is that PRINTS
groups several stretches of motifs, that might be separated along the sequence. Still these
sequentially dispersed pieces might form a structurally contiguous patch. Multiple sequence
alignments are compiled from the SwissProt database. By iteratively encoding identity matrices
of conserved regions and comparing them to SwissProt sequences again, fingerprints are refined
in a PSI-BLAST like manner. Finally, Attwood and Beck [1994] argue that by allowing the
creation of fingerprints at superfamily-, family- and subfamily-specific levels it is possible to
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Table 2.11: A list of motif based databases/search algorithms.
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The above-mentioned motif related approaches are summarized in Table 2.11. The majority
of approaches are non-structural in that they extract their motifs from purely sequential data.
Only the works of Espadaler et al. [2005], Li and Li [2005] and MSDmotif make use of structural
information, whereas only Meta-MEME and PRINTS can handle dispersed motifs. Moreover,
none of the mentioned motif construction algorithms are based on a interface type classification,
that provides as many sequences for an interface type as possible. Open problem 3 can therefore
be refined to the task of constructing dispersed motifs from structural data using an interface
type classification.
It should be noted that PROSITE indirectly benefits from available structures since the new
insights from structures also can lead to the detection of motifs. The manual curation process
of PROSITE allows to include these motifs if encodings as regular expressions are possible.
2.5 Preliminary analysis of available protein structures
2.5.1 Annual growth of PDB and size of solved structures
As with other molecular biological databases, the protein databank of structures has experienced
an enormous growth in recent years. The annual growth is depicted in Figure 2.10. Of the more
than 41.000 structures, more than 86% were contributed by X-ray crystallography.
Moreover, the size of the submitted complexes increased over the last decade. The larger
a complex, the more domain-domain interfaces it provides. Recent large complexes are for
example the GroEL chaperon with 49 subunits or the E. coli ribosome with 33 subunits. Figure
2.10b) displays the tendency of large PDB structure submission.
2.5.2 Preliminary analysis of conservation of core and surface residues
Residues are conserved for different reasons: core residues are conserved because a mutation
would severely compromise the protein’s overall stability, cause a decrease in activity or interfere
with the genuine folding process. These severe changes would hardly be acceptable in the course
of evolution. Additionally, some surface patches appear to be more conserved than others. It is
argued that these surface patches are important for the proteins function. An analysis of 80 high
resolution single chain proteins revealed that the conservation for core residues is 0.10 whereas
for surface residues it is 0.41 (measured in terms of the von-Neumann entropy, 0 expressing
100% conservation and 1 maximal entropy). The natural explanation of is that depending on
the position of a residue, the residue has restricted possibilities to mutate during evolution. The
distinction between surface and core residues in the context of conservation is important, when
a judgment is to be made whether an interface is conserved or not.
The selection of proteins is taken from Garbuzynskiy et al. [2004]. These proteins fulfill
some criteria that allow a precise analysis while minimizing selection bias: 80 non-homologous
single-domain proteins without modified residues, without serious errors in connectivity, without
disulfide bonds and ligands were obtained. The proteins are from all four general SCOP-classes.
As an example, see Figure 2.12. The conservation of the displayed inorganic pyrophosphatase
(PDB 1pyp) exhibits the discussed phenomenon: the core is well conserved and the surface is
predominantly variable with a conserved patch.
None of the investigated proteins had a surface that was on average better conserved than
the core. In particular it is interesting to see the distribution of residues by conservation level
(Figure 2.14): The core residue conservation follows an asymmetric bell shaped distribution
that is generally higher conserved than the distribution of surface residue conservation. The
surface calculation was done with NACCESS that implements the Lee and Richards probe
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method [Lee and Richards, 1971]. Note that the distinction between surface and core residue
is not straightforward and depends on the relative solvent accessible surface area. If a residue
is predominantly buried, that is its relative solvent accessible surface area is below 20%, it
is considered a core residue. The conservation was calculated using the structural homologs
provided by the HSSP database [Schneider et al., 1997].
This behavior can also be observed in interacting proteins of different functional categories.
Nooren and Thornton [2003b] investigated a set of homodimers, enzyme-inhibitor complexes,
antibody-antigen complexes and other hetero-dimers for their interaction properties. The au-
thors concluded that interfaces are of great diversity in terms of size, binding constants, hy-
drophobicity, shape complementarity etc. Here this data set is further analyzed for their surface







1cho b.47.1.2 Eukaryotic proteases Trypsin-like serine proteases Cow (Bos taurus)
1cse c.41.1.1 Subtilases Subtilisin-like Bacillus subtilis, carlsberg
1stf d.3.1.1 Papain-like Cysteine proteinases Papaya (Carica papaya)
1tab b.47.1.2 Eukaryotic proteases Trypsin-like serine proteases Cow (Bos taurus)
1tgs b.47.1.2 Eukaryotic proteases Trypsin-like serine proteases Cow (Bos taurus)
2ptc b.47.1.2 Eukaryotic proteases Trypsin-like serine proteases Cow (Bos taurus)




1cho g.68.1.1 Ovomucoid domain III-like




CI-2 family of serine protease
inhibitors
CI-2 family of serine protease
inhibitors
Leech (Hirudo medicinalis)
1stf d.17.1.2 Cystatins Cystatin/monellin Human (Homo sapiens)
1tab g.3.13.1 Bowman-Birk inhibitor, BBI Bowman-Birk inhibitor, BBI
Adzuki bean (Phaseolus an-
gularis)
1tgs g.68.1.1 Ovomucoid domain III-like
Kazal-type serine protease in-
hibitors
Pig (Sus scrofa)
2ptc g.8.1.1 Small Kunitz-type inhibitors BPTI-like toxins Cow (Bos taurus)





V set and C1 set domains (an-
tibody variable and constant
domain-like)
Immunoglobulin Mouse (Mus musculus)
2jel b.1.1.1/2
V set and C1 set domains (an-
tibody variable and constant
domain-like)
Immunoglobulin Mouse (Mus musculus)
1jhl b.1.1.1
V set domains (antibody vari-
able domain-like)
Immunoglobulin Mouse (Mus musculus)
1nca b.1.1.1
V set and C1 set domains (an-
tibody variable and constant
domain-like)
Immunoglobulin Mouse (Mus musculus)
3hfm b.1.1.1
V set and C1 set domains (an-
tibody variable and constant
domain-like)
Immunoglobulin Mouse (Mus musculus)
Antigens
1fdl d.2.1.2 C-type lysozyme Lysozyme-like Chicken (Gallus gallus)
2jel d.94.1.1 HPr-like HPr-like Escherichia coli
1jhl d.2.1.2 C-type lysozyme Lysozyme-like
Pheasant (Phasianus colchi-
cus)
1nca b.68.1.1 Sialidases (neuraminidases) Sialidases (neuraminidases)
Influenza A virus, different
strains
3hfm d.2.1.2 C-type lysozyme Lysozyme-like Chicken (Gallus gallus)
Table 2.12: PDB entries used in the analysis of the conservation of surface and core residues.
Entries were selected from different groups of proteins according to Nooren and Thornton [2003b]
in order to cope with the vast diversity of proteins.
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2.5.3 Definitions of interfaces in protein-protein interactions
The primary data source in this work is a collection of three-dimensional atom coordinates
of interacting protein domains. An early step in the analysis of protein-protein interaction is
the identification of interacting atoms, residues and domains. In order to identify interactions,
several criteria that contribute to the binding free energy have been taken into account ([Berg
et al., 2002]):
• hydrogen bonds between domains,
• van-der-Waals radii of atoms of opposite domains,
• electrostatic contacts,
• hydrophobic effects and
• mediating solvents.
The latter two play a role in estimating the strength of an interaction, but are less appro-
priate for an interaction definition that is simple to calculate. The former three criteria can be
calculated in dependence of the involved atom types and their respective distances. The con-
tributed energy of van-der-Waals contacts decreases quadratically and is commonly neglected
above a certain threshold.
By defining protein-protein interfaces, it is important to realize that intermolecular contacts
can occur solely as the result of protein crystallization (also termed crystal contacts/artifacts).
Tsai et al. [1996] attempt to distinguish between genuine interfaces and these crystal artifacts by
requiring at least ten interacting residues. The number was chosen so to optimize the trade-off
between neglecting small interfaces and eliminating protein interactions that do not occur in
vivo. A large effort to separate crystal contacts has been made in the compilation of the database
of Protein Quaternary Structures (PQS, [Henrick and Thornton, 1998]). Hence, assuming a
successful separation of real and crystal contacts allows also to include small interfaces.
Bolser et al. [2003] investigated the impact of varying distance thresholds and contact count
thresholds on the number of superfamily-superfamily interactions. The authors deduce from a
systematic screen over the two parameters, that most contacts of domain-domain interactions are
within 4 and 5 Å. As a result, the “5-5 rule” is suggested: at least five pairs of atoms within 5 Å
define an interface. To test the robustness of different definitions, Tsai et al. [1996] compare five
distance based interface definitions: two residues from opposite chains are considered interacting:
• if their Cα atoms are within 9 Å
• if their Cβ atoms are within 9 Å
• if any two atoms are within 5 Å
• if the distance of any two atoms is less than the sum of their van der Waals radii + 0.5 Å
• if their van der Waals energy is under -0.5 kcal/mol
The authors state:
The set of choice is quite consistent, regardless of the choice of criteria.
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Additionally, Tsai et al. [1996] introduce the concept of neighboring residues: though not in
direct contact but their Cα atoms are within a threshold of 6 Å. Those residues constitute the
scaffold of a binding site and are deemed important for binding site analysis.
Conte et al. [1999] introduced another widespread definition of protein interfaces: interface
atoms are those that lose solvent accessibility upon complex formation. The authors distinguish
further between interface atoms and contact atoms, where the latter are in direct contact and
form a subset of the former. The methods reviewed in Table 2.10 employ interface definitions,
that have been described above. Yan et al. [2004] and Bradford and Westhead [2005] use the
difference of solvent accessible surface before and after complex formation. This definition and
the 5-5 rule were shown to correlate strongly [Huang et al., 2004]. Herein, it is shown that in 98%
of the compared interfaces (exhaustive with respect to PDB), the residue overlap is above 80%.
Similar to a generous distance-based interface definition, scaffolding non-contact residues will
also be considered as interface according to the solvent access definition: In a solvent occluding
cleft, atoms can be up to 5.8 Å apart (the atoms van der Waals radii + twice the solvent radius,
usually 1.4 Å). Hence, atoms with a distance of around 5 Å occlude the solvent without being
in direct contact.
The final criteria for interface definitions depend on the objective. Here, the purpose is
to identify interface-related residues, that is including scaffold residues. This motivates the
adoption of the 5-5 rule as interface definition for the presented work.
2.6 Outline
This work is arranged in three main chapters. Following this introduction, Chapter two describes
the structural classification of domain-domain interactions - SCOPPI. Here, for each family, all
domain-domain interactions are collected. Each domain-domain interaction is then clustered
according to their geometric association: Keeping the domain under investigation fixed, two of its
interfaces are considered similar, if the bound domains’ orientations are comparable and hence,
the domains interact through equivalent residues. All similar interfaces of a domain define an
interface type. Further characteristics are associated to each interface type. The implementation
of a web-frontend is described. Many results can be derived from such a classification. It
provides insights to all the structurally known interfaces of each domain. Multi-interface and
single interface domains can be distinguished. The importance of this distinction has been
stressed recently [Kim et al., 2006a].
The classification allows a rigorous investigation of those interfaces in a domain, that are
able to bind to different, non-homologous domains. These non-homologous domains may have
evolved binding motifs independently, which is the central subject of Chapter three. It is
motivated by the fact that enzymes like subtilisin and trypsin, despite their sequential and
structural dissimilarity, are able to bind the same inhibitors through the same interface (in this
case the catalytic triad His-Asp-Ser). An exhaustive screen about these cases is described and a
database of all results is compiled. Single examples are discussed and particular focus has been
laid on viral mimicry of interacting host-proteins.
Another possibility that is created by the interface classification builds the base of Chapter
four: the investigation of structure-sequence relationships in interface types. An interface type
often contains conserved residues and the collection of all its instances provides the basis for
the generation of motifs. Motifs can be structural or sequential. Interface types translate to
structural motifs, but the construction of sequential motifs is desirable. As argued above, they
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are more universally applicable. The approach of sequence motif construction from structural
interaction data is demonstrated and extended to protein-ligand interactions. Problems like
sequential discontinuity and sparse data are addressed and various cross validation methods are
performed. Tests for statistical significance of motif hits are provided. In a case study, the
generated “ATP- binding” interface motifs are shown to be a powerful and sensitive search tool,





Figure 2.10: According to the PDB holding list, the PDB was populated by 41095 structures (as
of July 31, 2007), primarily produced by X-ray crystallography. The annual growth is depicted
in Figure a). b) Tendency of submission of PDB structures with at least 5 domains. The rate
of “complex complexes” is comparable to the rate of growth of PDB in general. Many of the
multi-domain complexes contain multiple copies of the same domain, such as the largest of all
PDB structures: the GroEL chaperone and the ribosome. The crystallization of heterogeneous
complexes, that is those with at least 5 different subunits is also shown. c) Venn diagram
reflecting the contributions of the different 3D structure solving techniques. The majority of
complexes stems from X-ray crystallography. d) Crystal structure of GroEL, submitted in May
2003 (PDB 1pcq) comprising 49 subunits and nearly 60.000 atoms. Amongst the more diverse
structures are the large ribosomal subunits with 27 different domains and several complexes
from the respiratory chain in the mitochondrial membrane.
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(a) PDB entries by kingdom (b) PDB entries by genus
Figure 2.11: Species in PDB. The chain-wise taxonomy annotation of the PDBeast table from the
Molecular Modeling database (MMDB, [Wang et al., 2007]) was used to analyze the distribution
of species. The grouping by kingdom and genus is done according to the NCBI taxonomy. a)
Metazoa and Bacteria constitute the largest part of the PDB. All other kingdoms like viruses,
archaea, fungi and plants are represented with smaller shares. b) The 20 most common genera
are depicted. Most frequent species are Homo Sapiens and Escherichia Coli. Note that human
entries make for 20%, whereas only 3.4% stem from yeast (Saccharomyces).
Figure 2.12: Surface conservation vs. core conservation. a) Front view of the surface, predom-
inantly variable residues b) Back view, well conserved residues surround the catalytic cleft. c)
Cartoon representation. The core is clearly more conserved than outer residues.
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(a) Surface vs. core residue conservation (b) Propensities
(c) Surface Propensities (d) Surface Propensities, scaled
Figure 2.13: a) The conservation distribution of surface and core residues. On average, a protein
exposes only few (5%) very highly conserved residues to the surface. On the other hand, the
bulk of surface residues are medium to low conserved, whereas a large part of core residues are
relatively well conserved. Figures b) - d) depict residue propensities. b) Surface propensities
are compared to core propensities. Hydrophobic residues such as leucine, isoleucine, valine and
phenylalanine are more frequent in the core. Polar residues (aspartate, glutamate, lysine) and
glycine are frequently found on the surface. The black bars are general propensities taken from
the sequences of the Gene Ontology database (270.000 entries). c) The surface residues split
up according to their conservation level. Again aspartate, glutamate, lysine and in particular
glycine account for the most frequent, conserved residues. d) Same as c) but residue frequencies




(a) Enzymes (b) Inhibitors
(c) Antibodies (d) Antigens
Figure 2.14: Detailed analysis of surface vs. core residue conservation. The phenomena of core
residues being generally better conserved than surface residues is consistent through all classes
of proteins. The inhibitors expose a stronger signal in the highly conserved surface interface
residues. Yet this signal stems from some generally very highly conserved inhibitors (Small





This chapter describes a solution to problem 1, the classification of interfaces. A systematic
classification of protein-protein interfaces is a valuable resource for understanding the principles
of molecular recognition and for modelling of protein complexes. Here, a classification of the
domain interfaces according to their geometry is presented. The proposed algorithm uses a
hybrid approach involving both sequential and structural features. The accuracy is evaluated
on a hand curated data set of 416 interfaces. The hybrid procedure achieves 83% precision and
95% recall, which improves the earlier sequence-based method by 5% on both terms.
Virtually all the domain interfaces of known structure are classified, resulting in nearly 6000
distinct types of interfaces. In 40% of the cases, the interacting domain families associate in
multiple orientations, suggesting that all the possible binding orientations need to be explored
for modelling multi-domain proteins and protein complexes. In general, hub proteins are shown
to use distinct surface regions (multiple faces) for interactions with different partners.
It is shown in this work that any evolutionary analysis on interfaces can be skewed by multiple
binding orientations and multiple interaction partners. Moreover, the collection of all known
binding sites of a domain helps to improve the analysis of surface conservation vs. binding site
conservation. The taxonomic distribution of interface types suggests that ancient interfaces
common to the three major kingdoms of life are enriched by symmetric homodimers. The
classification results are on-line at www.scoppi.org.
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3.1 Introduction
Protein tertiary and quaternary structures often provide a deep insight into the function and
its underlying mechanism. Though the number of available structures is growing rapidly in-
cluding multi-domain proteins and protein complexes, solving large protein structures is still
challenging. If the structures of the component domains and subunits are known, systematic
docking [Inbar et al., 2003] or multimeric threading [Lu et al., 2003] may be tried, but both
approaches require enormous computation for a genome-wide application. Aloy and colleagues
proposed that close homologs tend to interact in similar orientations [Aloy et al., 2003]. This
observation provided a theoretical basis for a breakthrough in modelling protein 3D complexes
by combining interactions from known structures [Aloy et al., 2004]. However, some proteins
associate in multiple orientations even between close homologs, as shown in lectins [Prabu et al.,
1999] and bacterial chemotaxis-related proteins [Park et al., 2004]. The multiplicity of bind-
ing orientation is, in fact, shown to be wide spread among different domain families [Kim and
Ison, 2005]. Cataloguing all the known interfaces may provide an alternative base for modelling
protein tertiary and quaternary structures.
Numerous studies have focused on the characterization of interfaces using physico-chemical
properties, shape, packing density and binding energy [Hubbard and Argos, 1994, Janin and
Chothia, 1990, Jones and Thornton, 1996, McCoy et al., 1997, Conte et al., 1999, Valdar and
Thornton, 2001, Bahadur et al., 2003, Gao et al., 2003, Ofran and Rost, 2003b]. The relative
orientation between domains or proteins has been studied mostly for particular families of in-
terest [Argos, 1988, Bashton and Chothia, 2002]. Though there are several extensive analyses
on the binding orientations [Aloy et al., 2003, Littler and Hubbard, 2004], systematic classifica-
tions have been rare [Tsai et al., 1996, Keskin et al., 2004, Kim and Ison, 2005]. The paucity
of interface classifications is primarily caused by the fact that most interfaces are fragmented
and both interacting proteins needs to be compared simultaneously. Classic studies on inter-
face characterization have benefited from a larger and unbiased data set, resulting in improved
prediction methods [Mintseris and Weng, 2005, 2003, Aytuna et al., 2005].
The potential utility of the representative interface types is diverse. For example, the classi-
fication provides a convenient framework for screening common interface motifs shared among
homologous and even unrelated folds [Keskin et al., 2004, Henschel et al., 2005]. For docking,
the efficiency can greatly improve by restricting to only a few types of known orientations in-
stead of exploring all the possibilities. The improvement of docking algorithm is facilitated by
a more comprehensive benchmark data set [Chen et al., 2003]. Along the progress of structural
genomics, genome-wide modelling of proteins will be realistic with reasonable accuracy in the
near future [Vitkup et al., 2001, Xie and Bourne, 2005, Pieper et al., 2006]. Comparative mod-
elling of interfaces or complexes is expected to follow a similar path. The utility of interface
classification will become more significant as guidance for modelling protein complexes [Aloy
and Russell, 2004].
The presented work elaborates and improves the previous work by Kim and colleagues [Kim
and Ison, 2005] in several ways, which classified the geometry of domain-domain association
using the patterns of interface residues mapped on the aligned sequences.
• The presented classification method is primarily based on structural alignments, while the
previous work depends on sequence alignments.
• The classification accuracy significantly improved from 78% recall and 90% precision in
[Kim and Ison, 2005] to 91% and 92% by a fully structural method. A hybrid approach
using both sequence and structure-based method achieves an accuracy of 83% and 95%
with far less computation than the fully structural method.
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• The number of interface types increased by 40% with increasing number of multi-domain
structures.
• The utility of the classification is shown by studying hub proteins, the conservation of
interfaces and the interface evolution across the three kingdoms of life. How the classifi-
cation database can be used to search for convergently evolved motifs and for predicting
interactions between proteins, is shown in Chapters 4 and 5, respectively.
• All the classifications are both stored as relational database and on-line available with a
convenient query environment.
3.2 Development of the interface classification algorithm
3.2.1 Algorithm design decisions and definitions
Nussinov and colleagues classified interfaces based on the common structural features shared
among the interfaces from various folds [Tsai et al., 1996, Keskin et al., 2004]. The presented
method focuses on the diversity of binding orientations between two families, which makes the
approach distinct and complementary to Nussinov and colleagues’ work. A face is defined as a
set of interface residues on a single domain contacting with the another domain. Accordingly, an
interface consists of two interacting faces. Instead of classifying interfaces as a whole, the type
of faces in each family is classified and then the two types of interacting faces are combined to
determine the interface type. The independent clustering of faces makes the classification task
highly efficient and straightforward. As the same type of face represents equivalent surfaces
of a domain family, the resulting interface type encodes the three dimensional geometry of
association. If a domain is in contact with several other domains simultaneously, such a multi-
faced domain has the same number of faces as the number of its partners and each face is treated
independently.
3.2.2 Work-flow
The work-flow that leads to the generation of a systematic interface classification is shown in
Figure 3.9. The data acquisition from structural databases such as PDB or PQS and domain
assignments (shown in the upper part of the figure) is explained in Section 3.2.3. The identifi-
cation of interfaces, a precondition for the classification of interactions is described in Section
3.2.4. Sections 3.2.5 and 3.2.6 deal with the comparison of interactions and the subsequent
clustering, respectively.
The complete algorithm that includes all steps for the assignment of interface type classes
to all domain-domain interactions is given below in pseudo-code:
00: Assign SCOP family definitions to all multi-domain entries in PQS
01: For each SCOP family f in PQS:
02: For each domain instance of f:
03: identify interaction partners (interacting domains)
04: Store domain-domain interaction in the format
05: (domain1/family1 - domain2/family2)
06: IL_f := List of all interactions regarding f
07: RIL_f := Representatives of IL_f after sequence clustering
08: For each ddi1 in RIL_f:
09: For each ddi2 in RIL_f:
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Figure 3.1: Overview of the interface classification
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10: structural alignment of ddi1 and ddi2 \
on the two domains belonging to f
11: calculate angle-based similarity of ddi1 and ddi2
12: calculate atom-overlap-based similarity of ddi1 and ddi2
13: generate entry in distance-matrix
14: save distance matrix
15: perform hierarchical clustering on distance matrix
16: produce clusters of interactions, given a cutoff
17: For each cluster:
18: For each interaction ddi in cluster:
19: For each interaction represented by ddi:
20: Assign face type (cluster id) to the domain that belongs to f
The implementation of steps 00, 01, 02 and 06 involve queries to a relational database. In turn,
step 04 and 20 dump results into the SCOPPI database.
3.2.3 Data acquisition
The protein structures are taken from the Protein Quaternary Structure (PQS, http://pqs.
ebi.ac.uk) database [Henrick and Thornton, 1998]. PQS offers coordinates for likely quaternary
states of structures contained in the PDB, by providing explicit coordinates for likely multimers
and avoiding non-genuine, crystal contacts. SCOP domain definitions are used to group the
domains into families and superfamilies [Andreeva et al., 2004]. All the binary domain-domain
contacts are checked in the multi-domain or multi-subunit entries of PQS. In total, more than
70,000 domain interfaces are collected from PQS. The domain pairs are grouped into more than
2900 distinct SCOP family pairs or 2000 superfamily pairs (Table 3.2 on page 75, Figure 3.9 on
page 56).
The interactions are classified into 4 groups: 1) homo-intra 2) homo-inter 3) hetero-intra
and 4) hetero-inter. The homo- or hetero- is assigned depending on whether the interacting
domains are from the same family or from different families respectively. Interaction type intra
is assigned to domain pairs from the same chain and inter to pairs from different chains.
Out of the 2403 SCOP families (version 1.69), a few families have been excluded because of
either weak biological interest or incompatibility with PyMOL script or MultiProt. For example,
most domains of collagen-like peptides family (k.3.1.1) have are too small for a structural align-
ment (by MultiProt). Immunoglobulin family (b.1.1.1) is also excluded as the binding partners
can be any foreign proteins. The unclassified families are less than 0.5% of the total families,
thus the influence on the result should be marginal.
3.2.4 Domain-domain interface identification
Domain interfaces can be defined in various ways such as the burial of accessible surface area
(ASA), interatomic distances or van der Waals energy, which are shown to be consistent to each
other [Tsai et al., 1996]. In this work, interface residues are defined as the residue pairs showing
any inter-atomic distance within 5Å. See the extensive discussion in Section 2.2.
As the interfaces are highly diverse in terms of size, affinity and shape, no simple criterion
is sufficient to discriminate specific and non-specific interfaces such as crystal packing artifacts
[Conte et al., 1999, Ponstingl et al., 2000, Nooren and Thornton, 2003b, Bahadur et al., 2004].
In general, interface area (∆ASA) is known as the most significant predictor. According to
size, Vajda and Camacho categorized interfaces into large (∆ASA ≥ 2000Å2), medium (1400 ≤
∆ASA < 2000Å2) and small (∆ASA < 1400Å2) [Vajda and Camacho, 2004]. In case of domain
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interfaces, the interface area can be smaller than protein interfaces because a single interface
between proteins may consist of several domain interfaces, thus the interface size cut-off is set
as ∆ASA > 800Å2.
The interface area (∆ASA) is calculated as ∆ASA = ASAA + ASAB − ASAAB , where
ASAA and ASAB are the accessible solvent areas (ASA) of the two isolated domains and
ASAAB is that of the bound form. The ASA is calculated by NACCESS, implementing the Lee
& Richards algorithm [Lee and Richards, 1971].
3.2.5 Pairwise interaction comparison
To measure the similarity of two faces, two geometric features are introduced - face overlap and
face angle as well as a sequence-based one - interface tag (Figure 3.2). The scale of measurement
is set to decrease for more similar faces so that the features are appropriate for clustering.
3.2.5.1 Interface tag and interface tag distance
An interface tag (IFT) represents each face and is generated by mapping the face residues onto
the aligned sequences. The resulting IFT is a vector consisting of 1’s and 0’s with gaps, where
1’s represent interface residues and 0’s indicate non-interface residues. The distance between
two IFTs is measured by DIFT , where DIFT = 0 for identical patterns and DIFT = 1 for faces
without common interface residues [Kim and Ison, 2005].
The interface tags (IFTs) of each family are generated in a similar way as in the previous
work [Kim and Ison, 2005]. The face residues are defined as the residues containing at least one
atom contacting with the other domain within 5Å of distance cut-off. The interface tag (IFT) is
generated by mapping the face residues onto the aligned sequences by MUSCLE [Edgar, 2004]
for each family. After the alignment, the interface residues are converted to 1’s and non-interface
residues to 0’s. The resulting IFT becomes a vector of 1’s and 0’s with gaps e.g. 10-01110-00 for
an aligned sequence, Ms-aHCWk-im (interface residues in uppercase and non-interface residues
in lowercase). As all the domain sequences are aligned simultaneously in a family, the lengths
of IFTs are the same within the same family.
The difference of IFT patterns is measured as the cosine distance of the two IFT vectors,
where the positions containing gaps on either of the two IFTs are ignored.
DIFT (u, v) = 1−
u · v
|u||v|
As the elements of each vector consist of only 1’s and 0’s, the distance becomes 0 between
identical IFT pairs and 1 between IFT pairs without any common interface residue.
3.2.5.2 Face overlap distance and face angle
There are two geometric features–face overlap distance and face angle to measure the distinct-
ness between two faces. The two features were calculated after structural alignment of the two
interactions on the common family with MultiProt [Shatsky et al., 2004]. The face overlap
distance (DO) measures the spatial overlap of the interface atoms between two faces. The face
angle (DA) measures the angle between the two centroids of the faces and the common centroid
of the two domains.
Both face angle and face overlap were computed by Python scripts using PyMOL (http:
//www.pymol.org). The PyMOL selection algebra conveniently allows to calculate the atom
selection of a face and the associated coordinate set.
Face overlap distance (DO) is measured as
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|IA|, |IB | are the number of intersection atoms and |fA|, |fB | are the total number of atoms
in each face respectively. The intersection atoms of one face are defined as the atoms within
3Å from the other face atoms. Accordingly, a face fully subsumed by the other yields the face
overlap distance, DO = 0.
face angle (DA) measures the angle between the two centroids of the two faces and the
common centroid of the two domains. The centroid was determined by using the Cα carbons of
the face residues or the domain residues for computational efficiency.
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(a) Two Faces (b) Interface Tag
DIFT = 1− 4√10√10 = 0.6
(c) Face Overlap (d) Face Angle
Figure 3.2: Three different features measuring the similarity between two faces. (a) Two faces
in I Set Domain family (green and magenta) interacting with Fibroblast Growth Factor (gray)
in different binding orientations. The faces of I set domains are shown in spheres. (b) Interface
tag (IFT) - the interfaces residues (uppercase) are mapped by 1’s and others (lowercase) as 0’s
on the aligned sequences. The common patterns of interface residues are in red boxes. The IFTs
are simplified just to illustrate the minimal characteristics. In reality, the length of an IFT is
the same as its aligned sequence. (c) Face overlap - the interface atoms are highlighted at the
intersection of the two faces after superposition of two I set domains (d) Face angle - the angle
between the centers of the two faces and the common center of the superposed I set domains.
60
3.2. DEVELOPMENT OF THE INTERFACE CLASSIFICATION ALGORITHM
3.2.6 Hierarchical clustering
The previous chapter describes the interaction comparisons that result in two distance maps for
each family, based on the two distance measures DO and DIFT . Hierarchical clustering can then
be applied at a specified face overlap or face angle cut-off. The hierarchical clustering was im-
plemented in Python using the orange package for scientific computing www.ailab.si/orange,
[Demsar et al., 2004]. The selection of the best cut-off is not straightforward. The distance
matrices can be visualized as heat-maps after column reordering according to some clustering.
Some families exhibit crisp interfaces, which result in clearly distinguishable squares in the
heat-map. Other families do not display this phenomenon.
After clustering the faces from each family, the face type is denoted as family id:cluster id,
that is b.34.2.1:03. The types of interfaces are assigned simply by combining the two types of
interacting faces. For example,(b.34.2.1:03, d.93.1.1:02,inter) is assigned for the pair of faces
b.34.2.1:03 and d.93.1.1:02 from different chains.
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  5623−32119A1 51812−67404B
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 74287−31979A  5367−32124B
  5406−32124P 93049−60874B
 93043−60871A 45138−91032B2
 45101−91028A1 18952−32143A
 19727− 32144 13680−72633A
 13619−72630A 41609−98304A
 44289−32065A 67583−32024C
  7020−32128A1 23023− 32153
 89600− 32152 21953−99229A
 79813− 32149 79841− 32147
 41170−79763C1 41064−79758A
  8876−31995B 76941−61684D
 77901−61731D    26−99767A1
 54224−32048A 48300−78485B1
  9176−32049A 15610−32063A
 72166−61570C 14015−62487A
 43003−32030C  9184−32037C1
 67584−32024C  4734−32109A
 52962−98750A 10089−32019A
 80950−76424A1 56414−32068D1













 86299−31976B1  8857−31995B
 86381−72179A 11667−88377A
 90100−64987B  2812−93076A
 42774−72912A 79820−85594A1
 50307−32046A 90100−64986A
   802−79250A 13704−72633A
 13638−72630A 31166−32098A
 79895−85595D3  5422−32124B
 10120−32019A 80240−73786B1
 13997−62487A  5628−32119A1
 79826− 32149 26002−66984A1
 27469−32115A 60576−73360D2
 60110−73335B1   763−32086C
























































































































































































































































































































































































































































































 62835−31899A   192−31885B
 30952−74296C 31024−74296A
 24877−31839B 24877−31839A





 10012−31914B  9990−31913A
 25949−78209A 62846−31899A
 62866−31900B 49014−31910B































































































































































































c.37.1.1 (Nucleotide and nucleoside kinases) c.37.1.11 (RecA protein-like (ATPase-
domain))
Figure 3.3: Distance matrices for various P-loop families displayed as heat-maps. The heat-
maps were calculated using R [R Development Core Team, 2007]. The heat-maps and the
associated dendrograms show, that the choice of cutoff and the corresponding classification is
not straightforward. The heat-maps were generated for a set of distance matrices. A dendrogram
is associated to each heat-map. The rows of the matrix were reordered to match the dendrogram.
Some families allow for a straightforward interface type assignment (c.37.1.20), whereas other
families (for example c.37.1.8) have many multiply overlapping interfaces, that are not trivial
to classify.
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3.2.6.1 Non-redundant set of interfaces
A series of non-redundant interface sets are generated at different sequence identity thresholds
from 50% to 100% with 5% interval. First, a set of non-redundant (NR) sequences are generated
at each threshold for each SCOP family using CD-HIT [Li et al., 2001]. Then, all the domains
are represented by the NR domains at a given threshold. Second, non-redundant interfaces are
generated by collating the domain pairs with the same pair of representative domains within the
same interface type. Inter-molecular and intra-molecular interfaces are not merged but treated
separately.
3.2.7 Considerations regarding the computational cost of the algo-
rithm
Clustering all the faces solely based on geometric features needs enormous computation. Several
SCOP families contain more than one or two thousand domains, where each requires about 0.5
- 2 million structural comparisons. Multi-faced domains add more complexity by several folds
as each face should be compared independently. As the known structures are highly redundant,
a hybrid approach is applied to reduce the amount of computation. First, faces of highly similar
IFT patterns are merged into stage I face clusters at DIFT < 0.1 to remove redundancy. A
representative face is chosen in each stage I face cluster. Second, the representative faces are
clustered using the geometric feature of face overlap distance (DO) or face angle (DA), resulting
in stage II face clusters. The types of the non-representative faces are assigned those of their
representatives.
Note that by saving distance matrices (using Python’s object serialization module pickle in
algorithm step 14 in Section 3.2.2), it is possible to keep everything necessary for the compilation
of distance matrices separate from the benchmarking (step 15-20). The benchmarking part is
run many times with different clustering thresholds and linkages. Albeit both parts of the
algorithm are of the same complexity class—that is, quadratic with respect to interactions in
the current family—the computationally expensive part resides in lines 00-14, in particular line
10, the structural alignment. Therefore, this part is calculated only once per family, whereas
the comparably fast hierarchical clustering with different thresholds is run starting with the
generated distance matrices.
The amount of computation is highly dependent on the size of a family, the length of domains
and the redundancy of data. The algorithm as shown in Section 3.2.2 is of quadratic complexity
with respect to the number of interactions associated to each family (nested loop in lines 8-13).
More than 80% of the families have less than 100 faces, where each family is reasonably com-
putable within several CPU hours even using a fully structural method. The real bottleneck are
the large families having thousands of member domains or faces. There are about thirty families
of nearly a thousand or more faces. As an illustrative example, the ferritin family (a.25.1.1)
Method Features used computational costa recall precision
Sequence Structure (CPU days)
IFT yes no small (< 1) 78% 90%
Overlap no yes large (> 3000) 91% 92%
Hybrid (IFT+Overlap) yes yes medium (∼ 32) 83% 95%
a The amount of computation depends highly on the family size distribution, the length of domains and the
redundancy cut-off. The value in this table is estimated for the currently available structures in PQS and
SCOP 1.69
Table 3.1: Comparison of different classification methods
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has 992 domains and is involved in more than 2400 interactions. There are more than 4800
faces but only 114 representatives at the redundancy cut-off DIFT < 0.1. Assuming 1 second
for each structural alignment by MultiProt, the overlap method requires 4800×4799/2 compar-
isons amounting to ca. 4 months. The hybrid method requires only 114 × 113/2 comparisons
amounting to ca. 2 hours. For all the families in PQS, the hybrid method took 32 CPU days on
a 12-node PC cluster, while the overlap method would take more than 3000 CPU days (Table
3.1). The calculation jobs were distributed family-wise using the Python interface of MPI, see
details in Appendix A.1.
3.3 Data visualization using SCOPPI
3.3.1 Idea, Usage and Features
The idea of SCOPPI is to investigate domain–domain interfaces in proteins of known structure.
SCOPPI presents a multiple sequence alignment of domains within a SCOP family. Interface
residues are highlighted in the aligned sequences, which affords a geometrical classification of
binding sites, the unique feature of SCOPPI.1 Various other interface characteristics such as
permanent or transient nature of the interaction, interface size (the loss of accessible surface
area upon complex formation, ∆ASA), domains on the same or different polypeptide chains and
number of interacting atoms and residues are available.
3.3.1.1 Query options
SCOPPI can be queried for a SCOP family, superfamily, one or several PDB identifiers or a
keyword. For keywords entered, SCOP family and superfamily description, PDB headers and
InterPro abstracts [Mulder et al., 2005] are searched. SCOPPI can be further browsed by SCOP
family descriptions alphabetically and by the Gene Ontology hierarchy [Ashburner et al., 2000].
All queries will finally result in the display of sequences or screen-shots of interacting domains
along with interface characteristics. Some of the possible query options by the user are described
in Figure 3.4
3.3.1.2 Data view
A typical query result is presented in Figure 3.5. The data is organized in a table: Each
row represents one domain–domain interaction, and each column depicts one property of this
interaction. In the default view, SCOPPI shows resolution and 4-letter code of the source file,
sequences of the two domains in full length with highlighted interacting residues, the face types
for both domains, the interaction type and a link to GoPubMed [Doms and Schroeder, 2005].
Both sequence columns are grouped by SCOP family. If SCOPPI was queried for a family
and not for a PDB identifier, this family always appears on the left. The ‘View’ selector to
the very left above the result table is used to obtain different views on the data: To access all
interaction properties including the SCOP unique identifier for each domain, it can be changed to
’All’. ‘Structures’ presents a view without sequences, but with screen-shots for each interaction.
Images are clickable to obtain a larger version. A query result with the “Screenshot” option
switched on is shown in Figure 3.6.
1By the time of creation. Since, other geometrical classifications have been devised: Shoemaker et al. [2006],
Jefferson et al. [2007], Teyra et al. [2008]
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Figure 3.4: SCOPPI features. The various query possibilities are described.
3.3.1.3 Display of sequences
Interacting residues are displayed in upper case letters, non-interacting in lower case. The
default coloring highlights interacting residues for better identification. It can be changed with
the ‘Color’ selector to assign different colors to different face types. A simple conservation
overview is provided by assigning a color to each residue depending of the frequency in the
column of the multiple sequence alignment. Conservation coloring: For each family, the number
of occurrences of a particular residue divided by the length of the column is calculated for each
column of the multiple sequence alignment and then assigned to every residues of that type. If
all residues in a column are glycines, every glycine gets a score of 1 therefore, and if 30% were
alanines, glycines would get 0.7 and alanines 0.3. Ten rainbow color shades ranging from bright
red (≥ 0.9) to purple (< 0.1) display the assigned score. Please note that conservation scores
are calculated based on the currently displayed sequences, so they will change with different
redundancy levels or ∆ASA cut-offs. A sample conservation coloring is given in Figure 3.7.
Residues can be further colored by physico-chemical type. ‘Sequence display’ facilitates
switching between aligned sequences, raw sequences without gaps, and only the aligned inter-
faces, where 3 dots indicate 4 or more left out non-interacting residues.
3.3.1.4 Filter options
Since lots of identical sequences exist among SCOPPI’s over 90 000 domain interactions, non-
redundant sets are provided at various sequence identity levels. A default 90% cut-off leads
to around 15 000 different domain–domain contacts. Non-redundant sets are available via the
‘Redundancy cut-off (%)’ selector. To filter out small interfaces, the change in accessible surface
area ∆ASA was calculated and an interface size cut-off selector for 600, 1400 and 2000 Å2 is
provided.
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Figure 3.5: SCOPPI - A typical query result.
3.3.1.5 Browsing SCOPPI using the Gene Ontology
It is possible to retrieve all available structural interactions related to a Gene Ontology term.
A recursive algorithm traversed the Gene-Ontology and generated static HTML-pages that
provide a list of associated SCOP families and PDB entries. The mapping of GO terms to PDB
was retrieved from GOA, whereas the mapping of GO terms to SCOP families was retrieved
indirectly from InterPro. The browsing is done using a top-down approach, entering at one of
the top levels of Gene ontology: molecular function, cellular compartment or cellular process.
The GO browsing is shown in Figure 3.8. After navigating to a certain GO-term, the associated
PDB entry or SCOP family can be displayed in the main window.
3.3.2 Examples
SCOPPI provides a multiple sequence alignment of domains and their interacting residues within
a family. The multiple alignment of these interaction interfaces in combination with the clus-
tering and classification of binding sites is a unique feature of SCOPPI. The following examples
will illustrate how this feature can provide interesting insight into various fields.
An elaboration of these examples along with meaningful screen-shots is presented online at
SCOPPI’s help page. In the following, IDs such as 1kim refer to PDB structures [Berman et al.,
2000], and a.48.1.1 to SCOP families [Murzin et al., 1995].
3.3.2.1 Binding site similarity: How do viruses mimic interfaces
Chemokines play a key role in leukocyte recruitment and migration. A query for the term
‘chemokine’ in SCOPPI finds, among others, the Interleukin-8 like chemokines family (d.9.1.1).
Following the family link in the results lists all interactions of chemokine family members with
other domains: SCOPPI shows that IL-8 like chemokine domains can associate with domains
of the same family, forming homodimers, or that they can associate with members of the viral
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Figure 3.6: SCOPPI - screen-shots of domain-domain interfaces displaying atomic detail.
chemokine binding protein M3 family (b.116.1.1). Further coloring by face type using the color
selector reveals that the viral protein binds to the same face type of the chemokine that is
used for homo-dimerization. SCOPPI also displays this information in the ‘Face type Family 1’
column. Alexander et al. [2002] report that viral protein M3 indeed employs structural mimicry
to sequestrate chemokines. Section 4.5 describes the detection of these cases in a systematic
manner.
3.3.2.2 Binding site diversity: Where do cytokines bind to their receptors?
Some families’ members display a considerable variety of face types when interacting with mem-
bers of another family. Querying SCOPPI for the Long-chain cytokines (a.26.1.1) reveals such
an example. Domains of this family appear as part of human cytokines, human growth hor-
mone and prolactin. When interacting with their receptors, the ligand’s cytokine domain binds
to the fibronectin type III domain of the receptor. SCOPPI reports that there are 10 differ-
ent interface types for this interaction (‘Face type Family 1’ column on the right). To confirm
this, 3D interactions of several examples are superimposed structurally aligning the cytokine
domain (Fig. 3.12). The cytokine domains are shown in black, with the associated fibronectin
domains in various colors. There are clearly numerous different interaction sites (face types) on
the cytokine domain surface.
3.3.2.3 Binding site conservation: How well conserved is the trypsin pocket?
Consider trypsin-like serine proteases that are found in the family of eukaryotic proteases
(b.47.1.2). The active site of these enzymes is formed by a catalytic triad of three residues:
histidine, aspartic acid and serine (in sequential order). Due to the obvious importance of these
three residues, we expect them to be conserved throughout all members of the serine protease
family. To verify this, the user may enter b.47.1.2 in SCOPPI, apply a redundancy level of
50% for a better overview and select ‘Conservation’ from the color selector. The conservation
percentage is simply calculated by counting the number of residues of the same type in that
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Figure 3.7: Conservation displayed in the SCOPPI web frontend.
Figure 3.8: Browsing SCOPPI using the Gene Ontology. The GO-browser is invoked (elevated
window), and from there: molecular function → motor activity → microtubule motor activity.
Note that structurally very different families can be found in this GO-category, all of which are
listed at a single glance in the GO-browser. Choosing “Myosin s1 fragment, N-terminal region”
brings up the according alignment with interface residues highlighted.
column divided by all residues in that column. Residues with a value above 90% will display
in red, those with a value below 10% in purple. A color legend pop-up is available through a
hyperlink next to the selectors. For the serine proteases, SCOPPI reveals a highly conserved
region AAHC with the catalytic histidine residue. Asp (D) is also well conserved (DIxLxxL
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motif). Serine (S) is found inside a conserved GDSGGP motif. It is striking, however, that the
serine is not fully conserved – between 10% and 20% of the family members are missing the
serine at this position. Closer examination reveals that in these cases serine had been subject
to site-directed mutagenesis studies and was changed to alanine.
Figure 3.9: Conservation of the catalytic triad in trypsins.
3.3.2.4 Binding site orientation: Gene fusion
The interface type classification of SCOPPI defines groups of pairs of domains that associate in
the same geometric orientation (i. e. clusters of domain pairs with the same interface type). In
addition, SCOPPI provides the information if two interacting domains reside on the same or on
separate polypeptide chains (i. e. if the interaction type is intra or inter). If two domain pairs
interact in the same orientation, but the interaction type is intra in one and inter in the other
case, the reason behind this observation might be a gene fusion event.
Such an example is found among domains of the c.1.2.1 family (Histidine biosynthesis en-
zymes) interacting with domains of family c.23.16.1 (Class I glutamine amidotransferases).
SCOPPI’s face type column on the right informs that there are inter and intra cases displaying
the same two face types. The matching face types can also be identified just by looking at the
highlighted interacting residues of the aligned sequences.
Taking two PDB files of the listed cases, 1gpw and 1ox4, and displaying the interacting
domains confirms the above finding at structural level: Both PDB files describe the crystal
structures of Imidazole Glycerolphosphate Synthase, which catalyzes formation of the imidazole
ring in histidine biosynthesis. The functional enzyme consists of a glutamine amidotransferase
domain and a cyclase domain. In T. maritima, a hyperthermophile bacterium, these domains
are located on two separate polypeptide chains, forming a hetero-dimeric protein. In yeast, the
two domains are fused together, as it is common in plants and fungi [Chaudhuri et al., 2003].
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SCOPPI nicely picks up this example by its classification of geometrically distinct interface
types. The comparison of the two interactions is shown in Figure 3.10. In total, 59 of such
examples were identified.
Figure 3.10: Gene fusion event of the SCOP domains c.1.2.1 (Histidine biosynthesis enzymes)
and c.23.16.1 (Class I glutamine amidotransferase) in yeast (PDB id 1ox4, domains shown in red
and pink) with respect to T. maritima (PDB id 1gpw, domains shown in blue and light-blue).
The linker region in yeast is shown in the white rectangle. The alignment, here performed on
c.1.2.1, reveals that the interface type was preserved upon gene fusion.
3.4 Algorithm evaluation
3.4.1 Measurement of interface classification accuracy
The accuracy was measured by comparing a test (T ) and a reference (R) classification on a set
of interfaces. The different interface types are denoted as Ri and Tj respectively. The number of
domain pairs belonging to each interface type is given as |Ri| and |Tj | respectively. Then, each
reference classification (Ri) is mapped to one of the test classification (Tj), which maximizes
|Ri ∩ Tj |, the number of common domain pairs between the two classifications.























The recall measures the ratio of the interfaces of the same type, which correctly grouped
together by the test classification. The precision measures how much the test classification
erroneously merged different types of interfaces into the same group. An ideal classification
would result in recall=1 and precision=1.
3.4.2 Accuracy of classification
(a) Face angle




















































Figure 3.11: ROC diagrams of interface classification by hierarchical clustering using different
linkage methods - single linkage (red empty rectangle), average linkage (green empty triangle)
and complete linkage (blue cross). The recall and the precision by IFT clustering method (filled
rectangle) and by hybrid method (filled circle) are shown together for comparison. a) Face angle
(DA) based classification b) Face overlap distance (DO) based classification.
The classification accuracy is tested using 416 manually classified interfaces between 28
family-family pairs (Table A.1 in Appendix A.2). To make the test challenging and rigorous,
the family pairs are chosen from family pairs having highly diverse binding orientations and the
interfaces were made non-redundant. On average, the family pairs in the benchmark show 5.4
distinct binding orientations or interface types. The benchmark set was made non-redundant
by collating the domain pairs of similar interface patterns (DIFT < 0.3) for both faces.
A series of hierarchical clustering conditions are tested using the face angle (DA) ranging
from 0 to 60 degrees by 5 degree interval and face overlap distances (DO) ranging from 1 to
100% by 5% interval as cut-offs. The recall and the precision is calculated for each interface
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type. In Figure 3.11, the ROC diagrams show the precision and the recall in different clustering
conditions. The classification by face overlap consistently shows better accuracy than the face
angle method. In comparison with the IFT clustering method [Kim and Ison, 2005], the face
overlap method shows nearly 10% better recall at the same precision (Figure 3.11(b)), while the
face angle method shows the lowest accuracy (Figure 3.11(a)). Face overlap and IFT clustering
use a set of atoms or residues, while the face angle method uses only a single point to represent a
face. Accordingly, the face angle method loses the information about shape or volume when the
distance is measured. The observed accuracy reflects the order of how well the face definition
represents the three dimensional shape of each face (overlap > IFT > angle).
The face overlap distance, DO = 40% as cut-off using average linkage is chosen as clustering
condition, which shows 91% recall and 92% precision. In the hybrid procedure, the faces with
DIFT < 0.1 are merged as stage I clusters to remove redundancy. The chosen cut-off is set as
the stage II clustering condition. The hybrid procedure shows 83% recall and 95% precision,
showing a significant improvement from 78% and 90% by IFT clustering alone (Table 3.1). It
suggests that the hybrid procedure achieves an accuracy close to the purely structure-based
method with far less computation. As the classification error tends to be positively correlated
with the diversity of interfaces in a family pair, the estimated accuracy is expected to be close
to the lower bound [Kim and Ison, 2005].
(a) (b)
Figure 3.12: Diverse modes of binding orientations between interacting families. The domains
of one family are superposed at the center. Some binding orientations are omitted for a clear
view. (a) long-chain cytokines (center, a.26.1.1) and fibronectin type III (peripheral, b.1.2.1).
(b)extended AAA-ATPase domain (center, c.37.1.20) and DNA polymerase III clamp loader
subunits, C-terminal domain (peripheral, a.80.1.1)
3.5 Results
3.5.1 Interface Diversity
As some families interact in highly diverse orientations (Figure 3.12), knowing the number of
different interaction modes between two families is critical to model protein complexes using
known structures. The extent of multiple interface development is checked between the family
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Figure 3.13: The number of different interface types between a pair of families.
pairs in our data set. The result shows that there are 1.2 - 2.2 different types of interfaces
per family-family pair depending on interaction category (Table 3.2). About 60% of the family
pairs associate in a unique orientation and the remaining 40% show multiple types of interfaces
(Figure 3.13). In inter-molecular interfaces, multiple interfaces in homodimers (46%) are about
two times more frequent than hetero-dimers (24%). It is expected by frequent occurrence of
homo-oligomeric proteins or complexes in PQS that any oligomer of three or more components
should form multiple interface types. Interestingly, 17% of the intra-type family pairs are shown
to have multiple interfaces although they mostly appear in the same N to C sequence order. The
diversity of binding orientations in intra-type family pairs is caused generally by the structural
flexibility at the linker region between the two domains.
The annual growth of interface diversity is checked along with the number of multi-domain
structures, families and family pairs (Figure 3.14). Multi-domain structures grew rapidly after
1990s geared by structural genomics program and the technical advance of X-ray crystallography.
Nearly 90% of the interface types became available only within the last 10 years and 50% within
the last five years. It suggests that many of the past interface analyses, the scoring systems for
docking and the prediction methods for binding sites were based on a small fraction of interface
types currently available. The number of interfaces grew fast until recently, suggesting that
there still remain many types of unknown interfaces to be discovered as prospected by Aloy and
Russell [2004]. In comparison with the previous work [Kim and Ison, 2005], it shows about 40%
increase of domain interfaces in 14 months between the two SCOP versions (1.65 and 1.69).
The number of distinct family pairs and interface types also increased at a similar rate. It is
notable that the ratio of hetero-inter among the total interface types increased by 13% from
the previous 16.8% to 19.0%, while the portion of homo-intra dropped by 19% from 5.5% to
73
CHAPTER 3. CLASSIFICATION OF DOMAIN INTERFACES


















Figure 3.14: The growth of structures, SCOP family, family pairs and interface types
4.5%. This trend suggests that structures of multi-chain complexes have grown more rapidly
than single-chain or homo-oligomeric ones.
3.5.2 Hub proteins have many faces
Currently, much research is devoted to study protein interaction network as a whole and hub
proteins in particular [Aragues et al., 2007, Kim et al., 2006a]. Hub proteins are a set of
proteins highly connected to many other proteins in a network. SCOPPI can shed light onto
the relationship between the number of partners (NPartner) and the number of faces of a family
(NFace). The number of partners, NPartner and faces, NFace show a positive correlation of
0.66. Most families with multiple partners have multiple face types. The number of face types
is generally similar to or higher than the number of partner families, showing a lower triangular
pattern in Figure 3.15. In general, a family develops one or more distinct faces for each partner
as in the G-proteins family (c.37.1.8) having 43 faces for 47 partner families. In one extreme, the
multiple faces are a result of developing multiple interaction modes between two families as in
long-chain cytokines (a.26.1.1), which has 12 faces for two partner families (Figure 3.12(a)). On
the other end, a family uses an equivalent surface for multiple partners as in the PUA domain
family (b.122.1.1) with only two face types for five different partner families [Kim et al., 2006b].
Besides the highly connected families in our classification, we consider known hub proteins
identified by other experimental methods and try to relate the number of partners to the number
of faces. Dunker and colleagues suggest protein disorder as a mechanism for hub proteins to








Total domain pairs 3562 13665 17227 43939 11690 55629 72856
NR90 domain pairs 511 1689 2200 6313 1567 7880 10080
Superfamily pairs 147 565 712 966 693 1659 2081
Family pairs 189 672 861 1613 783 2396 2934
















Interface type 256 830 1086 3612 1090 4702 5727
Interfaces/family pair 1.4 1.2 1.3 2.2 1.4 2.0 2.0
Table 3.2: Summary of the interface classification. Overall, 40% of the family interactions
associate in multiple orientations.
hub proteins into three classes according to the ratio of disordered regions, which are indicated
here as: (mostly) disordered, intermediate and (mostly) ordered (Table 3.3). We check if the 14
hub proteins tend to have many faces in our classification after assigning SCOP domains using
PSI-BLAST. A single SCOP domain is assigned for six hub proteins and two SCOP domains for
other two proteins. The ratio of domain assigned regions varies from 8% to 100% of the total
length of each protein. The remaining six hubs were not assigned any SCOP domains, which
are all disordered or intermediate class, reflecting the difficulty of crystallization for disordered
proteins. Interestingly, three out of the four ordered hub proteins have significantly more faces
than expected (P < 0.05). 14-3-3’ζ protein is an exception, which has only two faces. However,
14-3-3’ζ protein is likely to have more faces because there are also only two partner families of
14-3-3’ζ itself and N-acetyl transferase family. In the intermediate class, the estrogen receptor
α has 20 faces but 18 of them are for homo-dimeric interactions. In the two other intermediate
and one disordered proteins, the assigned SCOP domains have a comparable number of faces
as the number of partner families. That is, 8 faces for 7 partner families in the RING finger
domain (g.44.1.1) of BRCA1, 3 faces for 3 partners in p53 (b.2.5.2) and 6 faces for 4 partners
in the serine/threonine phosphatase domain (d.159.1.3) of clacineurin subunit A.
Our result shows that the three ordered hub proteins (cdk2, actin, calmodulin) develop
significantly higher number of faces than expected. In the remaining five proteins, seven SCOP
families are assigned and five of them have nearly one face per partner. Obviously, current
structural data do not contain all the interactions of hub proteins. However, the face diversity
of the eight hub proteins strongly suggests that hub proteins tend to use distinct surface regions
for different partners.
In the course of evolution, hub proteins may duplicate, differentiate and develop novel func-
tions with a different set of interaction partners. Such a family needs to continuously develop
new interactions and break existing interactions. By having distinct faces, hub proteins may
avoid cross-talk or competition between different interactions and allow modular evolution of
interfaces. From our observation on the eight hub proteins, we postulate that a face may serve
as an independent evolutionary unit to provide a physical basis for complex wiring around hub
proteins in an interaction network.
The multi-faced nature of hub proteins provides an opportunity to dissect the role of each
interaction with diverse partners. Functional genomics approaches such as gene knockout or
RNA interference remove a whole gene, thus eliminating all the connections around. For hub
proteins, this knockout approach is complicated to interpret because many pathways or functions
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Figure 3.15: The relationship between the number of partner families and the number of faces
per family. The data points are jittered slightly to show the points of the same value.
are influenced simultaneously. In contrast, the engineering of each face may specifically interfere
with a certain type of interaction without influencing others. Conversely, the mutations causing
a certain phenotype can be traced among a series of mutants on random positions, leading to the
identification of specific interactions or partners responsible for the phenotype. The design of
novel interfaces has already been achieved successfully for several proteins including calmodulin
and PDZ domain as reviewed by Kortemme and Baker [2004].
3.5.3 Conservation of interface residues
The residues at protein interfaces are considered to be conserved [Valdar and Thornton, 2001,
Elcock and McCammon, 2001], because of the evolutionary constraint to maintain interactions.
The conservation of interfaces is used for the prediction of binding sites [Armon et al., 2001,
Pupko et al., 2002]. However, it is also argued that the interfaces are conserved only marginally
more than the rest of the surface [Grishin and Phillips, 1994, Caffrey et al., 2004]. In studying
interface conservation, homologous sequences are generally added without considering the pos-
sibility of multiple binding orientations or partners, which may complicate the results. Here,
an example of the Ran family in Caffrey and colleague’s analysis [Caffrey et al., 2004] is scruti-
nized. The graph in Figure 3.18, originally Figure 1 from in Caffrey et al. [2004], shows in the
lower left corner those interfaces with low conservation in comparison to the rest of the surface.
The chosen Ran-interface (PDB id 1rrp, chains A and B) is an outstanding example, where
the reason for poor conservation of the interface was not clear but the existence of additional
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Figure 3.16: The number of faces for a 1 domain protein is calculated from the interface classi-
fication. The other distributions for 2, 3, 4 domain proteins are derived from that of 1 domain
protein. For single domain proteins, we observe that more than 30% of the domain families
display only one face, whereas the protein kinase catalytic subunit family (d.144.1.7) shows the
most face diversity of 51 face types. As the number of domains in a protein increases, the
distribution shifts towards a higher face average, since its domain faces add up. The average
number of faces for a 1, 2, 3, 4 domain protein is 3.2, 6.4, 9.6, 12.8, respectively.
mosome Condensation (RCC1) domain is found in SCOPPI. Figure 3.19 clearly shows that the
interface of Ran family with Ran-binding domain is poorly conserved (Figure 3.19(a),3.19(b)),
while the interface with RCC1 shows strong conservation (Figure 3.19(c),3.19(d)) as well as
the GTP binding pocket. The additional interface with RCC1 domain was not included in the
analysis although the authors suggested a correct hypothesis and the data was already available
in PDB (1i2m). It suggests that our comprehensive classification may be useful in other kinds
of interface studies.
3.5.4 Ancient interfaces are dominated by symmetric homodimers
How did different interface types evolve and how many of them are common among species or
lineage-specific? The question of the evolutionary history and the taxonomic distribution of
interfaces is highly interesting but non-trivial to answer due to the bias and the low coverage
of structures available. Gene duplication and differentiation are an important mechanism to
develop more complex protein functions in higher organisms. The direction of interface evolution
tends to be from symmetric to asymmetric homodimers and hetero-dimers [Ben-Shem et al.,
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Figure 3.17: The taxonomic distribution of family pairs in PQS across the three kingdoms
of life—Archea, Bacteria and Eukaryotes. Note that only 75 family pairs exist in all three
kingdoms.
2004]. Here, a preliminary analysis is performed on the taxonomic distribution of interactions
and interfaces in the three major kingdoms of life – archea, bacteria and eukaryotes [Kim et al.,
2006b].
In terms of family pairs, archea have the most overlap with other kingdoms probably because
archea are the most primitive form of life (Figure S5). There are 75 family pairs which have
member domain pairs from all the kingdoms. For a statistical interpretation, 23 family pairs
are selected out of the common 75 family pairs, each having a taxonomic diversity of 10 or more
species. These core 23 family pairs consist of 127 inter- and 10 intra-type interfaces originating
from 160 species.
It is assumed that an interface type is ancient if it is common to all three kingdoms. The
taxonomic distribution of the 127 inter-type interfaces is shown in Figure 3.20. Interestingly, the
common or ancient 20 interfaces all belong to symmetric homodimers with only two exceptions
(one hetero and one asymmetric homo). Asymmetric homo- and hetero- types are enriched in
lineage-specific category though not as strongly as in the ancient category. This observation
supports the trend of interface evolution from symmetric to asymmetric or hetero. In contrast
to ancient types, the identification of lineage-specific types is always ambiguous because the
structures may simply not be available across multiple kingdoms. Here, 90 of the 127 interfaces
are found lineage-specific to a single kingdom. However, only five of these are estimated signifi-
cantly lineage-specific (P < 0.01), which are four symmetric and one asymmetric homo- types.
The significance (P ) is calculated as the probability of sampling N times only the species of
the single kingdom out of the total species found in the corresponding family pair, where N
is the number of member domain pairs of the interface type. In the 10 intra-type interfaces,
there are 1 symmetric, 2 asymmetric and 5 hetero types, where 5 hetero-types are ancient (data
not shown). None of the lineage-specific interfaces are significant because of the small size of
data. Overall, this analysis supports the hypothesis that ancient interactions are symmetric
homodimers, see also [Kim et al., 2006b].
3.5.5 Database of domain interfaces
The classification of domain interfaces is available on-line as part of the SCOPPI database
[Winter et al., 2006b] at http://www.scoppi.org. Here, the presence of at least 5 distinct
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Figure 3.18: Comparison of interface conservation with exposed non-interface conservation
(Original Figure from [Caffrey et al., 2004, Figure 1]). The average conservation was calcu-
lated for all interface residues and divided by the average conservation for all residues that were
solvent exposed, but not part of the interface residues, using multiple sequence alignments of
close homologs or diverse homologs. A value of 1 or greater indicates that the protein interface
is more conserved than the rest of the surface. Each data point represents one chain of a protein-
protein complex, in which hetero-dimers are red, homodimers are blue, and transient complexes
are green. The red circle indicates a Ran protein with a particularly variable interface, both
with respect to close and diverse homologs.
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(a) Front: Ran and RBP (b) Back: Ran and RBP
(c) Front: Ran and RCC1 (d) Back: Ran and RCC1
Figure 3.19: The conservation of residues on the surface of Ran GTPase. The conservation
score is derived from Consurf-HSSP and is color coded with blue being most variable and red
most conserved [Pupko et al., 2002]. (a) and (b): Front and back of the less conserved interfaces
between Ran GTPase and Ran-binding protein (RBP, grey) in 1rrp. (c) and (d): Front and
back of the same Ran GTPase interacting with Regulator of Chromosome Condensation (RCC1,
grey) protein in 1i2m. The highly conserved, prominent bulge protrudes the cleft between the
homodimer of RCC1 proteins. The GTP binding pocket of Ran GTPase is also well conserved.
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Figure 3.20: The distribution of 127 interfaces and their categories from 23 family pairs common
to all three kingdoms and having 10 or more species diversity. The category of the interfaces
are divided as Homo and Hetero. Symmetric homodimers associate using the faces of the same
type and asymmetric homodimers associate using the faces of different types. The 20 common
or ancient interfaces are mostly symmetric homodimeric.
residue-residue contacts within 5Å rather than a minimal ∆ASA size was used as inclusion
criterion for an interface [Dafas et al., 2004]. While this may result in small and non-specific
interfaces, we leave it to the user to choose from the comprehensive data set and allow filtering
according to ∆ASA.
SCOPPI can be queried for a SCOP family, superfamily, one or several PDB identifiers or
a keyword. Various interface characteristics such as number, type and position of interacting
amino acids, conservation, interface size and permanent or transient nature of the interaction
are provided. In addition, screen-shots are available for every interface and its participating
domains.
3.5.6 Conclusion
Multi-domain structures are rapidly increasing since the 1990s. We classify virtually all the
domain interfaces found in the known structures, resulting in nearly 6000 distinct interface
types. Purely structure based classification achieves the best accuracy of 91% recall and 92%
precision, but requires enormous computation. Our hybrid procedure achieves a similar accuracy
of 83% recall and 95% precision, while saving the amount of computation a hundred fold. The
representative set of interfaces is available at various degree of redundancy cut-off (50% - 100%).
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The interfaces are shown to be highly diverse even between homologous pairs of proteins. In
our analysis, nearly 40% of families associate in multiple orientations. Some family pairs form
extremely diverse interfaces as shown in cytokines/fibronectins pair and AAA-ATPase/DNA
polymerase III clamp loader subunits pair (Figure 3.12). The result suggests that a careful
consideration of alternative interfaces will be necessary in modelling tertiary or quaternary
structures using known interfaces. In terms of computational complexity, the advantage of using
interface classification over combinatorial docking parallels homology modelling over ab initio
prediction of protein folding. Assuming three candidate docking solutions, 3(20−1) ≈ 1.2 × 109
conformations need to be explored for modelling complexes of 20 subunits by combinatorial
docking. With interface classification, only 3(20−1)×0.4 ≈ 4200 conformations are to be explored
assuming 40% of the family pairs have, on average, three types of interfaces. Although the
known interfaces represent only a small fraction in nature, interface modelling is expected to
play a critical role in combination with other experimental and computational methods [Aloy
and Russell, 2006].
Our analysis sheds light onto diverse aspects of interface geometry and evolution:
• Promiscuous interactions: Hub proteins are shown to interact with various partners using
many distinct faces, suggesting face as a module for flexible wiring around hub proteins.
In general, the number of partners and faces correlates.
• Gene fusion: To our knowledge, we provide the first comprehensive screen for the gene
fusion cases of known structure and check their interaction geometry. About two third of
gene fusions are shown to conserve their binding orientation. In at least one third of the
cases, fusion or fission resulted in different geometry. The natural gene fusions cases may
provide a good clue in designing chimeric proteins for research, industry or medicine.
• Interface conservation: The apparently poor conservation of interfaces e.g. in Ran domain
family is due to the diversity of interactions and partners, suggesting any evolutionary
interpretation can be affected similarly such as co-evolution [Kim et al., 2004] or binding
site analysis [Lichtarge et al., 1996, Korkin et al., 2005].
• Ancient interfaces: The ancient interfaces common to archea, bacteria and eukaryotes are
shown to be mostly symmetric homodimers. This suggests that asymmetric and hetero
interactions evolved from these symmetric homodimers.
The above detailed results have larger implications: A protein domain is currently regarded
as a basic unit of protein structure and function [Murzin et al., 1995, Holm and Sander, 1994,
Orengo et al., 1997]. Our results, suggest that faces are equally important unit especially
important when considering interactions and evolution. The diversity of interface types are
rapidly increasing by selecting structure targets with much less bias than before [Xie and Bourne,
2005]. Although it is a daunting task to determine the structures of all the representative
interfaces in nature [Aloy and Russell, 2004, 2006], we observe that more than 90% of the
current 6000 interface types became available only in the last ten years and expect even more
interfaces to accumulate for the next ten years (Figure 3.14). The predictions on interfaces and
docking algorithms are expected to improve as such using a larger and unbiased set of interfaces.
Efforts will continue to understand the physical basis on the organization of interaction network
and its evolution [Pawson and Nash, 2003].
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Convergent evolution has been investigated on the level of cultures, organisms, morphology,
physiology, behavior and on molecular level [Eisthen and Nishikawa, 2002, Pace, 2001]. It
describes the process where cultures, organisms or molecules that do not descend from the
same root, independently evolve similar traits or properties. The necessity to adapt to similar
environments constitutes the selective pressure that enforces the convergence.
On molecular level, convergent evolution occurs in unrelated sequences due to mutations
which lead to adaptive changes in the gene product. Divergent evolution is observed far more
frequently in genetic sequences and is a central paradigm in the theoretical fundament for remote
homology detection. The question of common ancestry between two genes with limited sequence
identity within the twilight zone (that is 20-35%, Rost [1999]) is tightly coupled to the question,
whether homologous genes diverged or non-homologous genes converged.
Convergent evolution can be classified into functional, mechanistic and structural conver-
gence [Doolittle, 1994]. Functional convergence occurs for example in alcohol dehydrogenases
from vertebrates and drosophila. Albeit no structural similarity is observable, the same func-
tion (catalyzing alcohol) is performed. Mechanistic convergence describes the phenomena, when
two enzymatic molecules developed the same atomic mechanism in order to perform the same
function. Lastly, unrelated proteins with very dissimilar sequences can adopt the same folds, a
phenomena that is addressed as structural convergence.
This chapter presents a novel approach to reveal cases of functional and mechanistic conver-
gence. Focus is set on protein interactions, because—as mentioned initially— protein interac-
tions and protein functions strongly correlate. Interestingly, since viruses provide fast evolving
proteomes that are under pressure to adapt to immune response systems, they serve as suitable
case studies.
A straightforward approach to identify cases of convergent evolution is to compare apparently
non-homologous proteins and check if they agree with respect to their function. That is, if
two proteins are considered not to be descendents from the same ancestor yet they are able
to perform the same or a very similar function, it can be a considered a pair of analogous
proteins. Function classification databases and sequence comparison methods exist to identify
these analogies. This direct approach, however, is based on the assumption that functional
classifications for the compared proteins are available.
As a side remark note that the question whether proteins are truly non-homologous or al-
ternatively are the result of a long process of divergent evolution from the same ancestor is very
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intriguing and difficult at times. For a precise distinction between convergent and divergent evo-
lution, more knowledge is required about ancestral versions of the proteins under investigation.
Reconstruction of ancestral sequences from contemporary sequences with parsimony approaches
remains a controversial issue in the field of phylogenetics.
On the other hand, much research has been devoted to the characterization of interaction
interfaces found in complexes with known structure. In this context, the interactions of non-
homologous domains at equivalent binding sites are of particular interest, as they can reveal
convergently evolved interface motifs. Such motifs are an important source of information to
formulate rules for interaction specificity and to design ligands based on the common features
shared among diverse partners.
Much work has concentrated on understanding under what circumstances homologous inter-
actions are conserved (Pazos and Valencia [2001], Aloy et al. [2003], Tsai et al. [1996], Torrance
et al. [2005]). Aloy et al. [2003] did an extensive analysis on the relationship between sequence
similarity and binding orientation and showed the geometry of interaction tends to be conserved
between highly similar pairs.
An alternative approach is to investigate how non-homologous proteins bind at equivalent
surfaces of homologous proteins (Tsai et al. [1996]). Such interactions do not necessarily com-
pete in vivo, but they reveal equivalent interaction sites. In some cases, the interactions may
be truly competitive regulated temporally by chemical modification or regulatory factors and
spatially by compartmentalization. Independent of competitive or non-competitive binding, the
identification of equivalent interfaces is a pointer to convergently evolved motifs. The motifs
help to reveal key features which are necessary for the interaction.
4.1.1 Direct identification of convergent evolution
A well-known example of a convergently evolved motif is the catalytic triad (Ser, His, Asp) found
in both chymotrypsin and subtilisin (see for example Figure 4.10). The local features of the en-
zymes’ catalytic sites are conserved in other enzymes (Torrance et al. [2005]). Chymotrypsin and
subtilisin do not share any sequential or structural similarity. Indeed, both belong to different
SCOP classes with chymotrypsin consisting only of beta-sheets and subtilisin of beta-alpha-beta
units. The case of these proteins was discovered by means of structural comparison in the 1970,
at a time when the PDB was of a size easy to survey [Kraut, 1977]. Both chymotrypsin and
subtilisin were classified as serine proteases (3.4.21.1 and 3.4.21.62, in the Enzyme Commis-
sion (EC) numbering system from the ENZYME database, [Bairoch, 2000]). The discovery of
their commonalities, in particular their catalytic triad, was therefore straightforward given their
crystal structures.
Systematic approaches to detect commonalities between non-homologous, but analogous pro-
teins have been devised. Structural data is not the only source of information, as shown by
Galperin et al. [1998]. The authors use the ENZYME database to check if within one EC-class
non-homologous proteins occur. From the 105 identified pairs, 44 had structural information;
34 of these had different folds.
In a similar attempt, Hegyi and Gerstein [1999] integrate SCOP, SwissProt and ENZYME.
The combined database can address the question, which folds encompass proteins with different
enzymatic functions. Vice versa, it is also possible to detect enzymatic functions that can be
found in different SCOP folds. The authors list 13 cases of EC numbers with different folds.
Recently, Gherardini et al. [2007] developed a method that compares structural motifs formed
by catalytic sites. Their algorithm looks for similar catalytic sites from different SCOP super-
families that can be found in the same EC classes. As a result, analogues were found in 26 out




4.1.2 Indirect identification of convergent evolution
This section describes a technique that does not directly compare non-homologous proteins in
order to detect cases of convergent evolution. Reconsider the chymotrypsin-subtilisin exam-
ple above. Despite the different architecture, there are various inhibitors, which inhibit both
enzymes and which use the same interface to do so. Thus, despite non-homology of the en-
zymes, equivalent binding sites are used. Since the catalytic triads function in an equivalent
way, subtilisin and chymotrypsin pose an example for mechanistic convergence [Doolittle, 1994].
Consider Figure 4.1. To elucidate such interfaces with convergently evolved motifs, the
known structures in PDB are screened for pairs of interactions A − B and A′ − C where B,C
are from different superfamilies and A,A′ from the same family. If B and C bind to equivalent
sites of A and A′, respectively, B and C are labeled as interfaces with convergently evolved
motifs. To define the equivalence of interfaces, sequence and structure alignments of the shared
domains A and A′ are used. If there is sufficient overlap in the sequence alignment of A and
A′’s interface residues and if the angle between interfaces of B and C after super-imposition
of A and A′ is sufficiently small, B and C bind at equivalent sites. These cases of interactions
A−B and A′ − C are refered to as “ABAC” cases.
In the analysis, SCOP domains (Murzin et al. [1995]) are used. A and A′ are required
to be of the same family, since interfaces are known to be more conserved in both sequence
and structure within a family (Valdar and Thornton [2001]), but not across the families of a
superfamily (Rekha et al. [2005]). B and C are required to be from different superfamilies,
which ensures that they are evolutionary not related.
The method sketched above identifies all pairs of interfaces with convergently evolved motifs.
One application of such a resource is the study of viral proteins, which mimic the interfaces of
native proteins and can thus interfere accordingly. Two such cases are discussed: The M3
protein, which mimics the chemokine homodimer interface and the regulatory factor Nef found
in HIV, which mimics a kinase interface when interacting with SH3.
4.1.3 Overview of this Chapter
This work presents a novel method to identify non-homologous structural domains which bind
at equivalent sites when interacting with a common partner. This method is systematically
applied to all pairs of interactions with known structure and derive a comprehensive database
for these interactions. The method details are presented in Section 4.2.
Of all non-homologous domains, which bind with a common interaction partner, 4.2% use the
same interface of the common interaction partner (excluding immunoglobulins and proteases).
This rises to 16% if immunoglobulin and proteases are included. Section 4.3 provides more
details about the statistics of convergent evolution, for example in which families it has been
detected most frequently.
Two applications of the resulting database are shown: First, structural motifs in enzymes
and its inhibitors are analyzed in Section 4.4. In particular, focus has been set on chymotrypsin
with respect to its structural similarity to subtilisin and with respect to its inhibitor’s similar
recognition sites.
Second, the systematic screening for viral protein interfaces, which can mimic native in-
terfaces and thus interfere is presented in Section 4.5. Therein, several cases of virus protein
mimicry are highlighted: Viral M3 protein interferes with a chemokine dimer interface. The
virus has evolved the motif SVSPLP, which mimics the native SSDTTP motif. A second exam-
ple is the regulatory factor Nef in HIV which can mimic a kinase when interacting with SH3.
Among others the virus has evolved the kinase’s PxxP motif. Further, motif resemblances in
Baculovirus p35 and HIV capsid proteins are elucidated.
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4.2 Methods
The identification of non-homologous domains binding at equivalent sites is illustrated in Figure
4.1: all pairs of interactions A − B and A′ − C are considered, where A and A′ belong to the
same family and B and C to different superfamilies. If B and C bind at equivalent interfaces,
they are screened for shared motifs. To define equivalent binding sites, a two-stage procedure is
used: First, the aligned sequences are scanned for significant interface residue overlap. Second,
the angle and the spatial overlap between the two interfaces are used to further refine the search
for overlapping interfaces.
4.2.1 Sequence comparison of interfaces.
Sequential analysis is based on a non-redundant multiple sequence alignment for each SCOP
family. Each sequence contains information about its interacting residues. For all pairs of
interactions A − B and A′ − C it is checked to what extent the interfaces of A and A′ agree.
Sequential interface overlap is defined in terms of positional agreement of interacting residues.
The sequential overlap can be measured as follows:
Interface sequence overlap ISO counts how many interacting residues are aligned in the
multiple sequence alignment of the family containing A and A′.
Interface sequence overlap ISO+ refines ISO in that only ISO residues with a positive
BLOSUM62 substitution are counted.
As an example consider Figure 4.1b), where 59% of the interacting residues of A and A′
are aligned, i.e. ISO=59%, and where 50% of the aligned interacting residues have a positive
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Figure 4.1: a) Overview: Family A, represented by A, A′ and A′′, interacts with B, C, D from
different superfamilies. B and C bind to the same interface on A, whereas D does not. b) A
partial alignment for the sequences of two Subtilisin-like domains (SCOP id c.41.1.1) including
a consensus line for interface residues. The respective binding partners are CI-2 family of
serine protease inhibitors (d.40.1.1) and Protease propeptides/inhibitors (d.58.3.2). Capital
letters indicate interacting residues. The consensus marks interface residues: identical (#), with
positive (:) and negative (.) BLOSUM62 score. Positions with only one residue participating
in the interface are marked . c) Structural comparison of interactions: two interacting pairs
of domains (A − B and A′ − C) with sequential overlap in the interface of A. d) Structural
alignment of A and A′ yields a (partial) spatial overlap of interfaces.
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a) b)
Figure 4.2: a) The centers of mass are calculated for A/A′, B and C (big spheres, in a similar
shade as their domains), as well as for the interfaces (small spheres). b) The centers of mass
between the interfaces with regard to the shared partner’s center of mass constitute an angle
that reflects the proximity of the interfaces. We will refer to it as interface angle IA. The general
binding partners’ orientation—refered to as domain angle DA—is captured similarly.
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Throughout this work the following representation scheme for ABAC cases will be consis-
tently applied: the shared partners are depicted in red (A) and blue (A′). Their interface
residues are in orange and light-blue, respectively. The different binding partners B and C are
represented as yellow and green cartoon diagrams, respectively. Their interfaces are drawn with
balls and sticks.
4.2.2 Structural comparison of interfaces.
Consider Figure 4.1 and 4.2. For two interactions A − B and A′ − C, the domain A and A′
are structurally aligned using MultiProt (Shatsky et al. [2004]). This is feasible since A and
A′ belong to the same family. This process is based on the assumption that all members of a
SCOP family are evolutionary related and hence, share structural features. The solution of the
structural alignment is provided as a rotation matrix and a translation vector that superimposes
A′ on A. The rotation and translation is applied to C as well such that A′ and C remain in
their original constellation to each other.
Next, the centers of mass of the Cα atoms for the domains A,A′, B,C as well as for the
interfaces of B and C are computed. To quantify the overlap on A’s and A′’s interaction sites,
the following measures are computed:
The interface angle IA between the center of mass A(A′) and the centers of the masses of
the interfaces of B and C.
The domain angle DA between the domains is also measured by taking the centers of masses
for A/A′, B and C, as the angle DA gives an information on the spatial arrangement of the
domains in general. Note that IA is rather sensitive, while DA can be large.
The interface atom overlap IAO: the percentage of atoms in B’s interface within k = 3Å of
C’s interface and vice versa are calculated. The PyMOL selection algebra allows to determine
the overlap conveniently. The number of overlap atoms can be normalized with the number of
B’s or C’s interface atoms. The minimum of the two is chosen since an interface being completely
included in another one is considered as maximally similar. The rational behind this definition
is that if a small protein’s interface is contained by another, they are to be considered as binding
to equivalent binding sites. See the sample calculations in Figure 4.3.
The motif match score MMS involves a residue-residue correspondence analysis of domains
B and C on atom level. Correspondences based on pairwise distances between interface atoms
are detected. They fall into 4 categories: C-α atom pairs, C-β atom pairs, remaining side chain
atoms and backbone atoms. Matching residue pairs are discovered by the amount and category
of atom pair matches. The score for each residue pair is simply its BLOSUM score (if positive)
+ the sum of atom pair scores. The latter are between 0 and 1, with 0 for 3Å distance or above
and 1 for exact coordinate matches, linearly interpolated (Equation 4.1). A detailed listing of
















where d is the Euclidian distance of the coordinates of two atoms, k is the distance thresh-
old of atoms within which atoms are considered occupying equivalent locations and O is the
set of possible residue pairs from the two interfaces on domain B and domain C facing do-
main A. Finally, sim is the similarity between two residues, for which the BLOSUM62 matrix
[Henikoff and Henikoff, 1992] is used. BLOSUM matrices are derived from BLOCKS [Henikoff
and Henikoff, 1991] alignments and hence often reflect physico-chemically similar residues. They
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a) b) c)
Figure 4.3: Examples for the calculation of the interface atom overlap. The interface regions
are marked with dotted lines. B’s and C’s interface atoms are symbolized by small circles in
yellow and green, respectively. a) All atoms of B’s interface are in vicinity of C’s interface. The
interface atom overlap is 100%. b) B’s interface contains 15 atoms, C’s interface contains 18
atoms. 6 atoms of C’s interface are in vicinity of B’s interface. The interface atom overlap is
therefore 6/15 = 40%. c) Since all seven of C’s interface atoms are in vicinity of B’s interface
atoms, and C’s interface is smaller than B’s the overlap is 7/7 = 100%.
are conventionally used to score alignments between evolutionary divergent protein sequences.
Substitutions between remote homologues are accounted for. Therefore they are adequate to be
used in the given context of detecting convergent evolution as well.
As an indication of the structural alignment quality, the RMSD between A and A′ as well
as the percentage of aligned residues are checked. For instance, all the examples summarized in
Figure 4.6 have an RMSD less than 1.3Å and more than 90% of residues aligned.
4.2.2.1 Work-flow
1 Compute all domain-domain interaction pairs A-B
2 For all SCOP families Do:
3 Sequence Alignment of all family members
4 For all pairs A-B and A’-C Do
5 If MSA with A,A’ has ISO overlap > 30% Then
6 Structurally align A, A’
7 Compute centers of mass of interfaces
8 Compute interface angle IA
9 Compute interface atom overlap IAO
10 Compute motif match score MMS
11 Add ISO, IA, IAO, MMS to database
12 Sort database by MMS
The work-flow is summarized above as pseudo-code. In step 1, all domain-domain interac-
tions in the Protein Databank, PDB, are considered using the SCOP domain definition. Domain
pairs having at least 5 residue pairs within 5Å are considered as interacting (Park et al. [2001],
Dafas et al. [2004]).
In step 2/3, the domain sequences are aligned using hidden markov models for each SCOP
family in three steps. First, the seed sequences are aligned for each family after generating a
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series of non-redundant (NR) sequences using CD-HIT. The cut-off for removing redundancy
was varied from NR 98% to NR 70% to limit the number of seed sequences practical for mul-
tiple structural alignments. This limitation is needed particularly for large families such as
immunoglobulin, which have more than a thousand member domains. The seed sequences
are aligned by T-Coffee (Notredame et al. [2000]) based on the library of pairwise structural
alignments. As T-Coffee makes the consensus alignments from the pool of pairwise alignment
libraries, the resulting seed alignments are essentially multiple structural alignments. Second,
hidden markov models (HMM) are generated using the seed alignments. The influence of var-
ied NR cut-off gets less critical because sequence weighting is applied in the course of building
HMMs. Finally, all the member domain sequences in each family are aligned using the family-
specific HMM.
Using the multiple sequence alignment described above, the pairwise interface sequence over-
lap ISO is computed (step 4). If the ISO is greater 30%, the structures of A and A′ are aligned
with MultiProt (Shatsky et al. [2004]) in step 5.
The interface angle, interface atom overlap and motif match score in step 6-9 are computed
by scripts using PyMOL functionality (DeLano [2002]). All data characterizing a record of non-
homologous binding is entered into a database (step 10). Finally the database is sorted by the
motif match score (step 11).
4.3 Statistical analysis of ABAC cases
With over 40 000 domain interactions in the PDB, there is a combinatorial explosion of over
800 000 000 pairwise comparisons of domain interactions. Some 12 000 000 of these pairs are
pairs with a common partner. After redundancy reduction, this number reduces dramatically
to 70 000 pairs excluding immunoglobulins/proteases and 360 000 including them. Out of these
pairs, 3 000 (58 000 including immunoglobulins/proteases) have an interface sequence overlap of
greater 30%. That is, 4.2% (16% including immunoglobulins/proteases) of all non-homologous
domains binding to a common partner do so at equivalent sites.
These interactions cover 270 common families, which account for about 15% of the total
1 834 families. Immunoglobulin related families (b.1.1.1, b.1.1.2, b.1.1.4) constitute with 93%
the majority. Some families of regulatory function are frequently found as common partner such
as the P-loop (c.37.1.8), SH3 (b.34.2.1) and Protein kinase-like domain (d.144.1.7). The most
abundant families are shown in Figure 4.5.
More than 63% of interfaces with ISO greater 30% have an interface angle of less than 25◦.
Only 8% have an interface angle of more than 60◦, suggesting the criterion of ISO >30% is
sufficient to filter out most spurious cases where the domains B and C do not bind to equivalent
surfaces on the common family (see Figure 4.6a).
Exceptional cases are Phycocyanin-like phycobilisome proteins (SCOP a.1.1.3, PDB: 1qgw
and 1on7, not shown). They are able to bind non-globular alpha+beta subunits of globular
proteins (SCOP d.184.1.1) or to build homodimers on equivalent binding sites. Despite the
large sequential overlap of interface residues (37%), the interface centers are placed in distant
locations including an angle of 85◦, see Figure 4.4
A large interface sequence overlap ISO generally indicates a small interface angle IA. The
opposite, however, does not hold, as cases with small IA exist despite a small ISO only (see
Figure 4.6b).
The ratio of the overlapping interface residues with positive BLOSUM score (ISO+) is upper-
bounded by ISO and widely distributed nearly over the whole range (0–100%), suggesting the
various degrees of divergence for different partners. The families of the highest overlap (ISO)
and conservation (ISO+) include trypsin (b.47.1.2) and its inhibitors from various superfamilies
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Figure 4.4: Phycoerythrin (PDB 1qgw, blue) differs from other PBP domains (PDB 1on7, red)
mainly in its N-terminal region: the slanted helices employ equivalent residues for interface
formation. The sequence alignment partially accounts for this correspondence. However, the
structural interface features reflect the differences in ligand binding.
(see Figure 4.10). The interface angle generally tends to decrease as the interface sequence
overlap increases. Above 60% of ISO, the two partners associate within 30◦ of angle difference
in most cases. ISO+ and interface angle show similar relationship as ISO and interface angle,
but less correlation. It may be because the angle is only related to the geometry or the position
on the alignments but not to the residue type.
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Family Description Binding to convergent interfaces
b.1.1.2 Immunoglobulin 36.2% (39494/108902)
b.1.1.1 Immunoglobulin 7.8% (13236/168669)
b.47.1.2 Trypsin-like serine proteases 19.0% (1523/8004)
c.37.1.8 P-loop 11.5% (749/6496)
b.1.1.4 Immunoglobulin0 9.6% (371/3840)
b.1.2.1 Fibronectin type III 7.0% (363/5182)
d.19.1.1 MHC antigen-recognition d. 2.2% (221/9886)
g.3.11.1 EGF/Laminin 17.1% (166/966)
b.34.2.1 SH3-domain 20.1% (110/546)
d.15.4.2 2Fe-2S ferredoxin-like 9.8% (70/715)
d.2.1.2 Lysozyme-like 15.1% (57/378)
b.42.2.1 Ricin B-like lectins 21.6% (55/254)
d.144.1.7 Protein kinase-like (PK-like) 4.5% (54/1184)
Figure 4.5: The most frequent families A, which act as shared interaction partners. “Binding to
convergent interfaces” denotes the percentage of cases where B and C bind to A at the same site.
In brackets is the total number of B/C binding at the same site divided by the total number of
B/C binding to A.
95













































Figure 4.6: Statistics of interface overlap parameters. a) The occurrence of all angles. Note that
most angles of all detected interfaces with convergently evolved motifs are below 30◦. b) The
relation between sequential and structural overlap. High interface sequence overlap often gives
a good hint but might not be sufficient. There are also cases of little interface sequence overlap
and small interface angle, due to the here chosen definition of percentage of sequence overlap.
Different top-level SCOP classes are represented by different symbols.
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Next, some examples of convergently evolved motifs are discussed. To start with, a well-
known example of subtilisin and trypsin-like serine proteases is used as a validation of the
presented approach.
4.4 Convergently evolved motifs in enzymes and inhibitors
4.4.1 Shared partners of subtilisin and trypsin like serine proteases
Subtilisin (c.41.1.1) and trypsin-like serine proteases (chymotrypsin, b.47.1.2) have no obvious
similarity with respect to sequence and structure. However, as it is known from Carter and
Wells [1988], their catalytic triads comprise the same residues. While this common motif is
impossible to detect by sequence or structure alignments, it is striking that there are as many as
three inhibitors, which interact with both families: Plant proteinase inhibitors (g.15.1.2), Serine
protease inhibitors (d.40.1.1), and Subtilisin inhibitor (d.84.1.1).
Using the ABAC method with the inhibitors acting as common interaction partner, the
otherwise unalignable structures of subtilisin and chymotrypsin can be superimposed and the
catalytic triads are indeed localized in immediate vicinity. Figure 4.7 illustrates this aspect. The
structural alignment of the serine protease inhibitors yields an RMSD of 0.48Å. A high MMS
value is achieved (107.10). The list of matching residue pairs in the faces B −A and C −A are
given in Table 4.9. Amongst the top ranked residue pairs are the overlaid residues of the catalytic
triad: His57-His64, except aspartate (Asp32 in subtilisin and Asp102 in trypsin, these are in
both cases not part of the interface according to the 5 Å distance rule). Furthermore, many
other residues have atoms in topologically equivalent positions. These often stem from unrelated
amino acids, yet the overall shape is similar. The surface properties of the two evolutionary
unrelated proteins can be investigated, in particular, the electrostatic surfaces compare well, see
Figure 4.8.
Figure 4.7: Trypsin (green) and subtilisin (yellow) overlaid by means of their common inhibitors
(not shown): plant proteinase inhibitor (left) and serine protease inhibitors (right). The cat-
alytic residues Aspartate, Histidine, and Serine are displayed in red, light-pink and pink colors,
respectively. A striking match with respect to their physical location becomes apparent from
the overlay procedure. These are easily detected through an interface comparison. The results
of the automatized MMS calculation are presented in Table 4.9.
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Figure 4.8: Electrostatic similarity of binding sites of trypsin and subtilisin (to the left and
right, from PDB ids 1acb and 1lw6, respectively). Both bind to the CI-2 family of serine
protease inhibitors - SCOP identifier d.40.1.1, (leech protein proteinase inhibitor eglin c and
barley subtilisin-chymotrypsin inhibitor-2A). They have 95.6% interface atoms in equivalent
positions. Negative charge in trypsin and subtilisin is depicted in red, positive charge in blue.
Most of the active center and its surroundings is negatively charged. Also notice the apparent
shape similarity of trypsin and subtilisin. The electrostatic surfaces were calculated by solving
the nonlinear Poisson-Boltzmann equation using APBS. The permittivity (dielectric protein
constant) is set to 2.0 Fm , the temperature is 310 K, grid size is 1 Å. The CHARMM force field
is used to determine the partial charges automatically with PDB2PQR [Dolinsky et al., 2004].
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Residue Pair Atom Matches BLOSUM Score Avg.-Distance
Trypsin - Subtilisin
His57-His64 b b b S S S S S S 8 14.99 1.09
Gly193-Gly219 b b b S 6 9.02 1.19
Trp172-Tyr104 b b S S S S S S S 2 8.16 1.32
Gly216-Gly127 b b S 6 8.16 1.38
Ser195-Ser221 b b S S 4 6.64 1.68
Ser214-Ser125 b b b S 4 6.37 1.58
Trp215-Leu126 b b S S S S S S S -2 5.44 1.52
Phe41-Tyr217 S S S 3 5.10 1.43
Tyr146-Glu156 b S S S S S -2 4.25 1.41
Ile99-Leu96 b S S 2 3.99 1.51
His40-Asn218 b S S S S 1 3.44 1.54
Lys175-Gln103 S S S S 1 3.43 1.17
Cys42-Tyr217 b b b S S -2 2.91 1.75
Asp194-Thr220 S S S -1 2.80 1.32
Leu143-Phe189 b b b S S 0 2.50 1.75
Ile99-Asp32 b b S -3 2.25 0.75
Ser217-Gly128 b S S 0 2.31 1.27
Ser190-Ala152 S 1 1.98 1.53
Ser190-Ala153 b 1 2.07 1.40
Trp215-Ile107 S S S -3 1.87 1.13
Cys191-Gly154 b b S -3 1.53 1.85
Lys175-Ile107 b b b -3 1.59 2.05
Phe41-Asn218 b b b S -3 1.66 1.76
Met192-Asn155 b S S -2 1.41 1.95
Asp194-Met222 b b -3 1.20 1.20
Ser190-Gly154 b b 0 1.03 1.45
Ser214-Asp32 S S 0 1.01 1.49
Total Score (MMS) 107.10
Figure 4.9: Pairs of equivalent residues (Trypsin-Subtilisin), a visualization of the actual atoms
that led to the detaction of the residue pair, the residue based match score and the average dis-
tance of the matching atoms. Top ranked is His57-his64that is anchored in equivalent backbone
positions but also shares a large amount of side chain atoms. In row 5, the second catalytic triad
match is listed: Ser 195-Ser221. Many other residues contribute to a similar shape of trypsin
and subtilisin, yielding a large overall MMS.
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The example of convergent evolution between subtilisin and trypsin is well-known [Doolittle,
1994] and serves as a positive control, i.e. proof of concept for the suggested method. Note
that no a priori knowledge, such as structural templates for catalytic sites (as in Torrance et al.
[2005]) is employed.
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4.4.2 Local structure conservation in chymotrypsin’s binding partners
The screen shows that a large number of chymotrypsin’s inhibitors belong to such diverse su-
perfamilies as ecotin (b.16.1), STI-like (b.42.1) and ovomucoid PCI1-like inhibitor (g.15.1). A
common feature is the binding to a pocket adjacent to trypsin’s catalytic triad, (commonly
refered to as S1 pocket), see Figure 4.10. This keyhole binds to side chains from loop regions
with high but local structural similarity. The structural conservation of the regions around the
S1 pocket ascends towards the keyhole-filling residue. A sequence motif derived from the struc-
turally aligned residues can serve as a template to search for chymotrypsin binding sites. The
non-homologous inhibitors share very little sequence similarity. Yet the structural alignment
enables the detection of sequence patterns, see Figure 4.11.
Figure 4.10: Many non-homologous chymotrypsin inhibitors bind at the S1 pocket featuring a
residue with a long side chain, typically preceded by a threonine or proline.
To the best of our knowledge, homology between ecotin and PMP has not been considered.
The sequence similarity between them is not recognizable with standard search tools such as
BLAST [Altschul et al., 1990]. Yet the binding motif between structures are similar, both on
sequential and structural level. Figure 4.13 pinpoints the sequential similarity: the trypsin
inhibitor PMP-D2 (PDB 1gl0) exposes a stretch of residues that is either identical or physic-
ochemically similar to the binding sequence of Ecotin (PDB 1n8o), both have the consensus:
A polar residue (Serin/Cystein), a threonine, a hydrophobic residue (Leucin/Methionine), a
Methionine, a small amino acid (Alanine/Glycine) and a Cystein. It is interesting to note that
the twenty structural homologs of Ecotin (identified by HSSP) all agree to this consensus, see
Figure 4.13[a)].
101
CHAPTER 4. CONVERGENTLY EVOLVED MOTIFS
Figure 4.11: Different profiles for trypsin inhibition. Sequence logos are constructed from the
inhibitors PDB entries 1AVW/B, 1CGI/I, 1EZU/A and 1K9O/I. The colors reflect the physico-
chemical properties. Sequential data is used from the HSSP database that associates to the
structures sequences from proteins that are assumed to be of very similar structure (structural
homologs). No general sequence pattern is derivable, however, each sequence stretch gives rise
to a motif descriptor.
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Residue Pair Atom Matches BLOSUM Score Avg.-Distance
Ecotin - PMP
Cys87-Cys32 b b b S S S 9 15.35 0.62
Asn51-Asn15 b b b S S S S S 6 13.26 0.82
Thr83-Thr28 b b b S S S S 5 12.51 0.50
Met85-Met30 b b b S S S S S 5 12.29 0.81
Met84-Leu29 b b b S S S S S 2 9.69 0.69
Pro80-Trp25 b b b S S S -4 5.86 0.80
Pro88-Gln33 b b b S S S -1 5.29 1.02
Leu52-Thr16 b b b S S S -1 5.01 1.12
Ser82-Cys27 b b b S S -1 4.85 0.92
Ala86-Gly31 b b b S 0 4.01 0.59
Arg54-Thr18 b S S S S S -1 3.91 1.53
Leu55-Cys19 b b b S S -1 2.72 1.83
Ser78-Thr22 b S 1 2.17 1.24
Asp49-Gln12 b b b S 0 2.01 1.49
Ser78-Val24 b b S -2 1.64 2.02
His53-Gln12 S S S 0 1.73 1.27
Val81-Gly26 S S -3 1.53 1.47
Val81-Cys27 b b S -1 1.34 1.66
Ser79-Val24 b S -2 1.15 1.85
Total Score (MMS) 106.32
Figure 4.12: Topologically equivalent residues between Ecotin and PMP trypsin inhibitor. A
large overall score is achieved because a large amount of atoms are matched. Many residues
pairs are similar in their physicachemical properties.
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Figure 4.13: The chymotrypsin binding motif of PMP
Figure 4.14: Chymotrypsin has been crystallized in complex both with ecotin and PMP (yellow
and green, respectively, PDB ids 1n8o and 1gl0, respectively). The strong similarity of PMP




In order to evade host cells, viruses have evolved elegant mechanisms. Apoptosis pathways,
signal transduction and immune response pathways are usually effected by invading viruses.
Large DNA viruses are capable of encoding homologues of the host system. The genetic
sequences for these genes (often chemokines and cytokines) originally stem from a host organism
but were captured and integrated into the viral genome [Alcami, 2003]. In the context of the
conducted analysis of convergently evolved motifs, it shows that similar invasive effects are
achieved by non-homologous genes.
Viruses are remarkable due to an accelerated mutational process. For example, the human
immunodeficiency virus (HIV) is capable of proliferating up to 9 million times a day in a single
infected patient [Enquist et al., 2003]. Additionally, many viruses have an altered genome repair
system, such that mutations are less likely to be repaired. In HIV many mutations may occur
during the reverse transcription from RNA to DNA, since this is a very error-prone process.
These two aspects—high mutability and high replication rate—equip a tribe of evading HIV
viruses with an enormous adaptability and they are the reason for the frequently observed drug
resistance. Given this high rate of mutability, it is reasonable to assume that functional motifs
in viral proteins have evolved independently. Indeed, the screen of convergently evolved motifs
included a large set of cases that included viruses. Table 4.1 shows a complete list of all 67
ABAC cases that involve viruses. The table is redundancy reduced to one column per family
combination, resulting to 28 family-level ABAC cases. Reducing all ABAC cases to family level
yields 849 instances (excluding all cases involving immunoglobulins), thus virus involved cases
constitute 3.3%.
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Family A Family B Family C Freq. MMS
Caspase-like Baculovirus p35 protein Caspase-like 1 33
Caspase-like Baculovirus p35 protein









Cyclin-like Cyclin-like Protein kinase-like (PK-like) 1 16
Cyclophilin (peptidylprolyl
isomerase)









Ribonuclease H-like 1 18
Interleukin 8-like chemokines
Viral chemokine binding pro-
tein m3
Interleukin 8-like chemokines 7 57
MHC antigen-recognition do-
main











C-type lectin-like 1 2










Protein kinase-like (PK-like) Cyclin-like Protein kinase-like (PK-like) 7 17
Protein kinase-like (PK-like) Cyclin-like SH2 domain 1 8
Ribonuclease H-like
N-terminal Zn binding do-





N-terminal Zn binding do-
main of HIV integrase
Ribonuclease H-like 2 11




SH2 domain 1 14
SH2 domain Protein kinase-like (PK-like) SH2 domain 1 6
SH2 domain SH3-domain SH2 domain 1 7
SH3-domain p53-like transcription factors Regulatory factor Nef 2 42
SH3-domain Regulatory factor Nef Protein kinase-like (PK-like) 8 72
SH3-domain Regulatory factor Nef SH2 domain 2 45




Bowman-Birk inhibitor, BBI 1 39
Trypsin-like serine proteases Trypsin-like serine proteases Bowman-Birk inhibitor, BBI 1 20




Zn-binding domains of AD-
DBP
Domain of early E2A DNA-
binding protein, ADDBP
Zn-binding domains of AD-
DBP
3 67
Table 4.1: Viral mimicry: a complete list of all ABAC cases involving viruses. The
number of ABAC cases for each family combination is given as frequency. As MMS
score, the best MMS score from all these cases is given.
Below, a number of structural examples for viral mimicry are discussed.
4.5.1 Murine herpesvirus mimics chemokine binding
Chemokines are an integral part of the immune response system. More precisely, they play a
key role in leukocyte recruitment and migration. They are present in vertebrates, bacteria and
viruses but in no other invertebrates. The PDB entry 1b3a presents a RANTES chemokine
homodimer (crystallized in complex with AOP) with a resolution of 1.6 Å. Detailed information
about human RANTES’ function has been retrieved. RANTES is involved in a large range
of medical conditions such as atherosclerosis, arthritis, atopic dermatitis, airway inflammatory
disorders, delayed type hypersensitivity reactions, glomerular nephritis, asthma, endometrio-
sis, and cancers. Further, its relation to viral infections (HIV-1) has been recognized, where
RANTES can act as an inhibitor [Cocchi et al., 1995]. According to Skelton et al. [1995], the
dimer is the prevalent form at pH 3.7 in vivo. It is hence reasonable to assume that the dimer-
ized form is not an artefact caused by crystallization. Furthermore, structures of chemokine
oligomerization (SCOP Class Interleukin like 8) have been observed frequently, see Figure 4.15,
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an excerpt from SCOPPI, that shows a multiple sequence alignment from all structures with


































Figure 4.15: Interleukin 8 - like homodimers (Chemokines). An exhaustive list of all interfaces of that type (1-1) is presented using
SCOPPI: 29 instances in 20 different PDB structures of symmetric chemokine homodimer exist as of SCOP release 1.69. The sequence
pattern in SCOPPI reflects a general interface topology: mainly the N-terminal region and some central segments are involved in the
binding site. list of PDB files and the accompanying structural results provide clues about the importance of this oligomerization process.
Note that from the SCOPPI interface type (1-1) it is clear that the complex is symmetric.
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The dimerization of RANTES takes place in the respective N-terminal regions. The oligomer-
ization is important for functional aspects: Baltus et al. [2003] reports that the oligomerization
is required for CC chemokine receptor 1 (CCR1) arrest. Moreover it is known that RANTES
oligomers have an impact on the inflammatory properties according to Appay et al. [1999]. The
authors state that aggregated RANTES, but not disaggregated RANTES, activates human T
cells, monocytes, and neutrophils. The interference to RANTES’ ability to oligomerize is hence
expected to have effects to its functionality.
On the other hand, the PDB structure 1ml0 contains the M3 protein encoded by murine
gamma herpesvirus68 in complex with CC chemokine MCP-1. M3 achieves broad-spectrum
chemokine engagement due to its conformational flexibility [Alexander et al., 2002]. Members of
the M3 adopt a structure consisting of two different beta-sandwich domains of partial topological
similarity to immunoglobulin-like folds. Viral interference with chemokine pathways within inate
or adaptive immune response has been recognized [Alcami, 2003]. To that end, members of
the Herpesviridae and the Poxviridae families encode proteins that modulate the host immune
response, including homologs of cytokines, interferon regulatory factors, chemokines and their
receptors. The structures of MCP-1 and RANTES are readily alignable (RMSD 0.89), both
belonging to the SCOP-family, see Figure 4.16.
Alexander et al. [2002] report that viral protein M3 sequestrates MCP-1 with high affinity due
to conformational flexibility and electrostatic complementation. Figure 4.16 shows an additional
feature of M3: an optimal fitting to the same binding site of the chemokine that is utilized by
chemokines to form homodimers. To achieve this, the virus has evolved the SVSPLP motif
which can play the role of the native motif SSDTTP. The motif is detected by the interface
correspondence identification. Table 4.2 lists details of equivalent atoms and residues in M3 and
RANTES binding their respective chemokine partner.
Note that M3 does not have any known homologues in any other species: PSI-BLAST search
against NCBI’s non-redundant protein sequence database with E-value better than 1 did not
yield hits. It can not be considered as part of the twilight zone as proposed by Rost [1999],
which is defined by a sequence identity range of 20-35%. It is therefore unlikely that the virus
captured this sequence elsewhere and the SVSPLP motif being a result of divergent evolution.
Hence, the structural interface mimicry suggests that the motif is a case of convergent evolution.
The matching residues are those buried deepest into the chemokine. It is further argued
that residues on the shared partners side being involved in binding both ligands are of special
importance. This corresponds to the analysis of chemokine binding capacity to M3 (Alexander
et al. [2002]): The authors report a decrease of M3 binding upon Tyr13 from MCP-1 substitution
with alanine. Figure 4.16b) shows that Tyr13 is indeed in high contact with M3, and so is the
corresponding residue in RANTES (Phe12) with its homodimer partner.
The strongest contribution to the binding free energy of complexes comes from hydrogen
bonds. It is therefore interesting to compare the hydrogen bond patterns of the two complexes.
Figure 4.16c) shows that four central hydrogen bonds are located in equivalent locations. In
both cases they are established by hydrogen acceptors and donors from the backbone. It is
remarkable that these hydrogen bond pairs have their respective acceptors (backbone nitrogen)
and the donors (backbone oxygen) on the same face sides of the interaction.
109
CHAPTER 4. CONVERGENTLY EVOLVED MOTIFS
Residue Pair Atom Matches BLOSUM Score Avg.-Distance
M3 - RANTES
Ser269-Ser4 b b b S S S 4 9.46 0.95
Tyr268-Tyr3 b b b S 7 8.83 1.90
Pro274-Pro9 b b b 7 8.25 2.06
Tyr266-Tyr3 S 7 7.77 0.70
Pro272-Thr7 b b b S S S -1 7.01 0.37
Ser271-Asp6 b b b S S S 0 6.39 0.60
Val270-Ser5 b b b S S S -2 6.07 0.72
Leu273-Thr8 b b b S S S -1 4.89 1.17
Ala275-Cys10 S 0 1.97 1.03
Met276-Cys34 b b S -1 1.07 1.93
Met276-Thr30 S S -1 1.13 1.31
Pro356-Lys33 b S -1 1.20 2.10
Total Score (MMS) 64.03
Table 4.2: Corresponding residues between viral M3 and chemokine MCP-1. The viral motif
Ser269-Pro274 can be extracted from the matches to the chemokine’s N-terminal residues. Note
that Leucine 273 overlays well with Threonine 8. Despite these residues being of different physic-
ochemical nature - reflected by a negative BLOSUM score, these residues play an equivalent role





Figure 4.16: a) Viral protein M3 (yellow) adapting to chemokine (blue), mimicking chemokines
homodimer (green). The backbone of M3 between Ser269 to Pro274 (motif SVSPLP) resem-
bles Ser4 to Pro9 (motif SSDTTP) in chemokine. b) Tyrosin13 from MCP-1 chemokine in
strong contact with M3 (yellow), shown by dotted yellow lines. Mutagenesis experiments em-
phasize the residue’s importance in M3 binding. The corresponding residue in RANTES, Phe12,
overlays well with Tyr13 (not shown). The figure suggests, that Phe12/Tyr13 would strongly
interact with its homodimer (green dotted lines) and hence would be important for the homo-
dimerization process. c) Conservation of hydrogen bonds. The image shows four out of seven
hydrogen bonds that form between the RANTES dimer (red/green, bonds as green dotted lines)
and the M3 - MCP-1 complex (yellow/blue, yellow bonds), respectively. The involved hydrogen
donors and acceptors are depicted as small spheres. The four hydrogen bond pairs are labeled
(1.-4.).
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Figure 4.17: The viral negative factor Nef and a protein kinase-like aligned via their shared part-
ner SH3. Corresponding residues are labelled. For example Pro72/Pro250 and Pro75/Pro253
match.
4.5.2 Nef mimicry of SH3 binding
Regulatory factor Nef (d.102.1.1, PDB: 1efn D) and Protein-Kinase like (PKL) (d.144.1.7, 2chk
B) exhibit similarities in their way of binding SH3. As shown in Figure 4.17 and Table 4.3, several
residues are in relative proximity in Nef/PKL: Arg71/Lys241, Pro72/Pro250, Gln73/Gln251,
Pro75/Pro253 (PxxP motif), Phe90/His289, which are part of a hydrophobic pocket. Note that
all residue pairs are of similar/equal physico-chemical properties. The SH3 domain is known
to bind Nef through the PxxP motif. However, as recently reported in Choi and Smithgall




Residue Pair Atom Matches BLOSUM Score Avg.-Distance
Nef - kinase
Pro72-Pro250 b b b S S S S 7 12.67 1.11
Arg71-Lys249 b b b S S S S 2 8.95 0.68
Pro75-Pro253 b S 7 7.82 1.77
Gln73-Gln251 b b b S 5 7.41 1.80
Tyr120-Trp254 b S S 2 3.10 2.18
Tyr120-Glu255 S S S S S -2 2.91 1.25
Phe90-His289 S S S S -1 2.15 1.38
Arg77-Trp254 b S S S S -3 2.19 1.68
Thr117-Lys252 S S S -1 1.89 1.11
Trp113-His289 S S S -2 1.97 1.03
Gln118-Pro253 b b S -1 1.83 1.17
Val74-Pro253 b S S -2 1.07 1.93
Total Score (MMS) 53.96
Table 4.3: Automatically detected topological residue correspondences. The PxxP motif from
the kinase subunit normally found in association with SH3 domains is also present in the viral
Nef sequence. In particular, Nef’s Pro72 overlays with all atoms of Pro250 from the kinase.
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Residue Pair Atom Matches BLOSUM Score Avg.-Distance
P35-IAP
Asp84-Asp148 b b S S S 6 10.40 1.11
Ser252-Asn234 b b b S S 1 3.62 1.88
Ser83-Ile149 S S -2 2.74 0.95
Ser253-Asn234 b b b 1 2.28 2.04
Val3-Leu140 b b 1 2.36 0.95
Met86-Val146 b S 1 2.02 1.47
Val3-Leu141 b 1 1.96 2.04
Gln85-Val147 S S -2 1.96 1.53
Cys2-Arg142 b b -3 1.52 1.48
Asp84-Val147 b S -3 1.22 1.17
Thr250-Tyr154 S S -2 1.26 1.11
Cys2-Tyr139 b S -2 1.28 1.08
Val3-Ala137 S S 0 1.13 1.30
Total Score 33.75
Table 4.4: Residue correspondences between Baculovirus p35 protein and inhibitor of apoptosis
(IAP)
4.5.3 Baculovirus p35 protein resembles apoptosis inhibitor motif
Apoptosis, the programmed cell death, is a natural form of protection in order to cope with viral
invasion. The caspase enzyme plays a central role in triggering apoptosis. The viral p35 protein
is known to be an effective broad-spectrum inhibitor for caspase thus preventing apoptosis. [Xu
et al., 2003]. The caspase recognition sequence and adjacent residues are found to be similar
to residues of inhibitor of apoptosis (IAP) repeat at corresponding positions. Key residues in
this resemblance are revealed by the similarity screen (step 8), shown in Table 4.4: P35’s Asp84
matches IAP’s Asp148 in both position and orientation (C-α, C-β, backbone and side chain
atoms all correspond). Together with their respective sequence neighbors (backbone matches)
they shape a convergently evolved motif. Moreover, caspase offers a second binding site, which
both p35 and IAP make use of (Ser252-Asn234).
4.5.4 HIV-capsid protein and Cyclophilin interfere
HIV capsid protein (HIV-CA) blocks cyclophilins homo-dimerization binding site by forming
a backbone stretch (Gly94-Ile91) that resembles a loop region of cyclophilin (Arg143-Met146).
Together with Val86-Thr88, HIV-CA corresponds to residues in cyclophilin peripheral to the
active site (orange in Figure 4.18). Table 4.5 lists all residue similarities between the capsids
and cyclophilins interface.
4.5.5 Summary of examples
A summary of interfaces with significant commonalities is presented in Table 4.6. The complete
set of non-redundant examples (with respect to SCOP family combinations) is presented in great
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Residue Pair Atom Matches BLOSUM Score Avg.-Distance
HIV-CA - cyclophilin
Gly94-Gly142 b S 6 7.07 1.39
Gln95-Gln148 S S 5 5.82 1.77
Ile91-Met146 b b b S S 1 4.20 1.63
Ala92-Gly145 b b b S 0 2.03 1.48
His120-Thr141 S S S -2 1.90 1.86
Pro93-Arg143 b b S S -2 1.47 1.90
Pro90-Met146 b S S S -2 1.53 1.85
Gly94-Arg143 b b -2 1.52 1.48
Pro85-Tyr120 S S -3 1.41 0.89
His120-Val139 b b S -3 1.18 1.82
Gln95-His147 b S 0 1.05 1.42
Total Score 29.18
Table 4.5: Similarities between the HIV capsid protein binding site and the binding site of
cyclophilin that it uses for homodimerization
detail on the supplementary material web site.
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Figure 4.18: HIV capsid protein interfering with a cyclophilin homodimer. The cyclophilin












A B C ISO Angle Overlap Motif RMSD Motif
(%) IA IAO score (aligned %)
Serine protease Chymotrypsin Subtilisin 75% 10.8◦ 96% 79 0.8 (99%) Catalytic triad H,D,S well aligned
inhibitor (d.40.1.1) (b.47.1.2) (c.41.1.1) Gly193-Gly219, Phe41-Asn218
Leech/Barley Cow amyloliquef. 411 atom correspondences
Chymotrypsin Inhibitors Inhibitors 77% 21.4◦ 97% 110 1.0 (92%) long side chain (often K,R),
(b.47.1.2) (e.g. b.16.1.1) (e.g. g.4.1.1) ± 3 residues,
Cow E.coli Locust high backbone similarity
SH3 Nef P-kinase like 74% 15.5◦ 92% 56 0.8 (98%) PxxP motif in spacial proximity,
(b.34.2.1) (d.102.1.1) (d.144.1.7) Arg71-Lys241, Phe90-His289
Human HIV-1 Human
Caspase Baculovirus Inhibitor of 56% 19.0◦ 80% 37 1.0 (91%) SDQM (83-86) vs IDVV (149-146)
p35 protein apoptosis repeat consecutive backbone match with
(c.17.1.1) (b.28.1.1) (g.52.1.1) positive blosum score,
Human AcMNPV Human Ser253–Asn234.
Cyclophilin Retrovirus Cyclophilin 52% 23.0◦ 52% 22 1.0 (91%) consecutive backbone match:
capsid protein viral Ile91–Gly94 matches
(c.17.1.1) (b.28.1.1) (g.52.1.1) Met146–Arg143
Human/E.coli HIV-1 E.coli
Chemokine M3 viral protein Chemokine 67% 37.1◦ 70% 64 1.3 (91%) Residues 270–274 in M3 (VSPLP)
(d.9.1.1) (b.116.1.1) (d.9.1.1) match chemokine’s residues 4–9
Human Muhv-4 Human (SDTTP)
Table 4.6: Examples of non-homologous domains binding at equivalent sites together with a description of their convergently evolved
motifs.
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4.6 The implementation of the database of convergently
evolved motifs
4.6.1 The front-end web interface
As a result of the above mentioned work-flow, an exhaustive database of all cases of convergently
evolved motifs is compiled. The database is complete with respect to observable ABAC cases in
PDB/SCOP. Step 1-4 reveal 58.000 cases on the basis sequence alignments. Structural data A
web based front-end to the database is online at scoppi.biotec.tu-dresden.de/abac/. This
front-end lists a set of all ABAC cases, which is non-redundant with respect to family level.
Each ABAC instance shows a visualization of the involved molecules after superposition on the
shared partner. The geometric domain associations after alignment of A and ′A is visualized. A
sequence comparison of A and A′ reveals the commonalities of the interfaces on sequence level.
Details about the common partner is given.
4.6.2 The back-end relational database
The back-end of the database is implemented using MySQL tables, an open-source relational
database, on a Linux platform. One table holds the sequential information, that is, the ABAC
identifier, Gene Ontology annotations of the PDB complexes, SCOP identifiers, SCOP classifi-
cation information for domains A, A′, B, and C, and the actual sequence alignment of A and A′
with the identified interface residues and the similarities therein. A second table contains the
results for 58.000 structural comparisons of the two interactions A−B and A′ −C: the RMSD
between A and A′, the number of shared interface atoms of B’s and C’s interfaces and other
geometric measures regarding the distances and angles of the centers of mass. This table was
produced using the PyMOL alignment command. However, visual inspection of the alignments
and the possibility to monitor the structural alignment quality in terms of aligned residue per-
centage during the fully automated database creation have led to a refinement using MultiProt.
This new table contains additionally the aligned residue percentage, but is only produced for
the 4400 ABAC cases that do not involve immunoglobulins.
The implementation was done using the programming language Python on a 20 node cluster
that are equipped with dual core Intel(R) Xeon(TM) 3.06GHz processors. The parallelization
was implemented using the Message Passing Interface (MPI) and its Python interface PyMPI.
4.7 Discussion
4.7.1 Competitive binding
The detection of equivalent binding sites provides clues about cases for competitive binding.
In the ABAC cases the common partner A was not required to be 100% identical on sequence
level. Yet, the fact that B binds to A suggests that B also is capable of binding to to A′, i.e.
the binding partner of C.
Lets assume that B is indeed present in the organism, where the interaction A′ − C takes
place and that further A′, B and C co-localize and co-express. In this case competitive binding
can occur in vivo since B and C compete not only for the same binding partner A′ but also for
the same binding interface on A′. The more similar A and A′ are, the likelier it is that B also
can interact with A′ [Aloy and Russell, 2002, Deane et al., 2002]. In particular, since Homology
modeling of the interaction A′ − B on the template A − B in combination with Molecular
Dynamic simulations and comparative binding free energy calculation can provide further clues
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about the possibility of competitive binding. By analogy, the same argumentation holds for the
competing interactions A−B and A−C The ABAC screen and the SCOPPI database are hence
a rich source for the detection of competitive binding.
4.7.2 Comparison of interfaces: IAO vs iRMSD
.
In order to measure the similarity of interactions, Aloy et al. [2003] developed the interaction
RMSD (iRMSD). Although other domain-domain association tools implement the iRMSD mea-
sure [Jefferson et al., 2007], the following examples will demonstrate, that the iRMSD measure
is sometimes inaccurate in the task of detecting equivalent binding sites: Figure 4.19 presents
two cases, where the iRMSD calculation yields a wrong value, whereas the IAO is precise.
Note that the iRMSD was mainly geared for comparison of two homologous interactions
A−B and A′−B′, since both A and A′ are supposed to be alignable as well as B and B′. Still
the measure poses a simplification that is not justified as in the cases of Figure 4.19.
a) b)
Figure 4.19: Cases, where the iRMSD calculation is insensitive to the actual interface atom
positions. The centers of mass CoMA, CoMB and CoMC are shown as small black circles. The
iRMSD compares orientation and the distance of CoMB and CoMC after aligning domain A.
The smaller this distance, the higher is the similarity between the interactions according to the
iRMSD. a) The iRMSD yields a low similarity despite the interfaces are essentially the same.
CoMB and CoMC are far apart because of the strong influence of the remaining domain-parts,
that are not interacting. The IAO yields the correct result that would classify B and C as
domains that use equivalent binding sites in A. b) The iRMSD yields a high similarity since
CoMB and CoMB are in close vicinity, despite the interfaces are very different.
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4.8 Conclusion
In this work, instances belonging to the same family are extracted that bind to completely
different binding partners through equivalent interfaces. As pointed out by Tsai et al. [1996],
these cases may provide particular insight into biomolecular recognition: the study of most
diverse binding partners and the extraction of their commonalities suggest key principles for
domain-domain binding.
To this end, a set of both sequential and structural criteria was designed to allow for an
exhaustive screen. This method shows that out of all interaction pairs with a common partner
(excluding immunoglobulins and proteases) and two non-homologous domains 4.2% bind at
equivalent sites and feature convergently evolved motifs.
The degree of ligands’ structural conservation varies strongly. Sometimes, pairwise interface
residue correspondences are possible, either when clefts or enzyme pockets allow for very little
degree of freedom (chymotrypsin’s S1 pocket adjacent to its catalytic triad), or in the case of
flat interfaces as illustrated in the example of SH3 interacting with Nef and PKL.
Generally the presented results suggests that the majority of alternative ligands (B and C)
show some local sequence and shape similarity. For the remaining cases it will be interesting
to explore how patches with neither sequential nor structural similarity can mimic each others
surface conditions. It is shown in the example of chymotrypsin’s binding partners, how the
ABAC method generates sequential patterns from local structural alignments. An adequate
statistic representation (such as position specific scoring matrices) will help to predict potential
binding sites.
As the examples—particularly the subtilisin-chymotrypsin comparison—demonstrate, infor-
mation of functional sites can be inferred using the ABAC method. The incorporation of func-
tional site information (for example from the catalytic site atlas (Porter et al. [2004])) will help
to localize functionally important residues. Finally, viral proteins’ mimicry of native interfaces
are detected (see section on chemokines, SH3, caspase and cyclophilin). More examples are
online in the supplementary database: scoppi.biotec.tu-dresden.de/abac/.
All in all, the presented method allows for a first comprehensive overview on how non-




Structural motif descriptors for
sequence-based interaction
prediction
This Chapter provides a solution to problem 3, protein interaction prediction. The main motiva-
tion for such an endeavor is that many protein sequences are still poorly annotated. Functional
characterization of a protein is often improved by the identification of its interaction partners.
Chapter 3 provides a rigorous collection of all identified interfaces in three-dimensional struc-
tures. These interfaces are the basis for the prediction of protein-protein interactions (PPI)
and protein-ligand interactions (PLI). This chapter focusses on the prediction of interactions
on sequence level. To this end, machine learning is used to compile sequential segments that
constitute structural features of an interaction site into one profile Hidden Markov Model de-
scriptor. These descriptors are constructed according to Occam’s Razor: only the relevant parts
for an interaction are considered. The resulting collection of descriptors can be used to screen
sequence databases in order to predict functional sites.
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A library is compiled that comprises profile HMM descriptors for 740 protein-protein and
3000 protein-ligand binding sites in the Protein Data Bank PDB [Berman et al., 2000]. Each
descriptor describes one face. These descriptors, totalling more than 3740, characterize a protein
interface or a ligand binding site on sequence level. Hence, given a query sequence of interest, it
is possible to compare it to each interface descriptor, thus identifying binding sites to possible
interaction partners including ligands. Gene Ontology (GO) [Ashburner et al., 2000] annotations
are linked to each descriptor from the original PDB entries that were used for its construction.
The complete list of profile HMM descriptors adheres to the HMMer2 format and is hence
directly usable with the HMMer package [Eddy, 1998, Finn et al., 2007].
5.1 Background
Exhaustive knowledge about protein interactions is a prerequisite to understanding the molec-
ular machinery of the cell. Despite the availability of comprehensive databases on primary
protein sequence information, a large number of protein interactions are yet unknown. While
comprehensive protein sequence databases are available, the number of known protein-protein
interactions is still small. In addition, experimentally proven protein-protein interactions often
do not reveal the binding sites involved. The implications of the discovery of binding sites are
manifold: the discovery of patterns in amino acid arrangements is of general importance in
the study of protein-protein interactions. Furthermore, docking algorithms benefit greatly from
the correct prediction of binding sites. Finally, interaction prediction is the key to mapping
global interaction networks and signalling pathways, and may help elucidate the functions of
individual proteins. Complementary to experimental techniques are computational approaches
that analyze and predict protein-protein interactions. Sequence-based methods include gene
context conservation [Galperin and Koonin, 2000], synthetic lethality [Tong et al., 2004], phy-
logenetic profiling [Pellegrini et al., 1999, Sun et al., 2005] or co-evolution of gene expression
[Fraser et al., 2004]. Various databases of binding sites and interfaces between proteins and their
domains exist [Keskin et al., 2004, Davis and Sali, 2005, Stein et al., 2005]. An extensive list
of prediction methods can be found in [Aloy and Russell, 2006]. Functional characterization of
novel genes and their proteins remains an important and challenging task. It often is improved
by the identification of novel interaction partners. To systematically detect these, it has been
observed that structural and functional features of proteins like catalytic sites are often well
conserved [Lichtarge and Sowa, 2002]. In contrast, the rest of the surface is often more variable
(see Figure 5.1a), which impedes sequence similarity searches for functionally equivalent or sim-
ilar proteins. Descriptors previously used for conserved domains and interface motifs include
regular expressions, weight matrices, and profile Hidden Markov Models (HMMs). These de-
scriptors involve either sequentially consecutive stretches [Bairoch, 1992, Espadaler et al., 2005,
Li and Li, 2005] or full length domains [Bateman and Haft, 2002]. In particular, HMMs were
successfully employed in many sequence similarity search tools [Bateman and Haft, 2002, Eddy,
1998, Zdobnov and Apweiler, 2001]. As pointed out by Bailey and Gribskov [1998a], the signal-
to-noise ratio in homology searches can be improved by using sets of motifs that characterize a
family. In this study, descriptors are created for all relevant sequence parts of structurally known
protein-protein and protein-ligand binding sites. These binding sites are often well-conserved
[Kim et al., 2006b], but their segmented nature on sequence level has to be taken into account
for sequence similarity searches (Figure 5.1b). In accordance with the terminology introduced
in Chapter 3, an interface between two protein domains is defined to consist of two faces.
As shown in Chapter 3, similar faces can be clustered geometrically into face types, and sim-
ilar interfaces can be clustered into interface types. Many approaches for interaction prediction
and function annotation require structural knowledge about the protein of interest [Koike and
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Figure 5.1: Constructing a set of sequence profiles to represent a conserved structural feature.
Caspase’s active site is highly conserved (PDB id: 1ice). Conservation levels are calculated
using the von-Neumann entropy and displayed in a color gradient from blue (variable) to red
(conserved). Conserved residues in close vicinity of the tetrapeptide inhibitor largely define the
catalytic site environment. Caspase residues within 5Å of the inhibitor are underlined. Segments
are patched and those with low conservation are discarded to avoid insignificant hits. The amino
acid distribution from HSSP data for each site of the remaining segments is added. It is thus
possible to construct HMMs and visualize the profiles as sequence logos [Crooks et al., 2004].
Takagi, 2004, Bradford and Westhead, 2005, Torrance et al., 2005], see Table 2.10. By waiving
this requirement, interaction prediction is applicable to a much wider range of sequences but
becomes a substantially harder problem. It has been addressed previously (see for example
[Ofran and Rost, 2003a, Obenauer and Yaffe, 2004]). Most notably, Li and Li [2005] discovered
stable and significant interface motifs and represented them with regular expressions, while Es-
padaler et al. [2005] proved the usefulness of HMMs for this endeavor. Both approaches use
single structural templates as seeds for generalization with further sequences, coming from ei-
ther similarity search or random generation. However, several structures for a particular kind of
domain-domain interaction are available, each providing new insights into the sequential vari-
ability of the actual interacting residues. Novel to the presented method is the incorporation
of as many structures as possible for each binding site descriptor. The benefits are intriguing
as protein-protein interactions from complex structures are considered to be the most reliable
source of interaction data.
5.2 Construction of protein-protein interaction descrip-
tors
Based on the family level of the Structural Classification of Proteins, SCOP [Murzin et al.,
1995], we can extract and classify all domain-domain interactions found in the PDB. This
classification is available in the SCOPPI database [Winter et al., 2006b]. As pointed out by Kim
and colleagues, even homologous domain pairs can associate in geometrically different ways by
employing different sets of residues to form interfaces [Kim and Ison, 2005, Kim et al., 2006b].
Consequently, the corresponding interface profiles would differ substantially and combining the
information about interacting residues to a profile would be meaningless. However, often a
number of domain-domain interactions expose striking similarities and it is desirable to collect
all instances of one interface type for the calculation of the respective interface profile. We
therefore compose descriptors for all interface types in SCOPPI by combining all instances of
that interface type. When data for interface types is sparse, we utilize sequence data provided
by HSSP [Schneider et al., 1997]. Often several sequentially remote segments contribute to a
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binding site. To accommodate for this phenomenon, we adopt the multiple-motif approach from
PRINTS [Scordis et al., 1999], MAST [Bailey and Gribskov, 1998a] and Meta-MEME [Grundy
et al., 1997] to represent binding sites as a collection of small HMMs for one local binding motif.
Thus we describe only the important sequence parts that form a structural feature.
5.2.1 Work-flow
The work-flow can be summarized with the following pseudo-code:
0. For all interface types:
1. Extract all non-redundant instances of an interface type from SCOPPI
2. Obtain a MSA and identify interacting residues
3. Identify segments in the MSA predominantly comprising interacting residues
4. Include residues that are between selected sequence neighbors
5. Optionally add sequences identified as structural homologous by HSSP
6. Generate HMMs for each segment
7. Combine HMMs into one descriptor connected by insert states that reflect the
linker regions between segments
8. Add descriptors (one for each face) to library
9. The library can now be used to predict faces and interfaces.
Figure 5.2 shows the work-flow as a flow chart diagram. The method uses protein structural
data that describes a binding site to generate Hidden Markov Models. The primary data source
is SCOPPI, from where all instances of an interface type are retrieved (step a). Multiple sequence
alignments with residue interaction information are also stored in SCOPPI. The second step in
the work-flow deals with the identification of interfacing segments. First, interface columns are
defined by columns with more than 50% interface residues. Interface segments are defined by
including interface flanking columns. Steps c) and d) encode the identified interface segments in
to one Hidden Markov Model. Sections 5.2.4, 5.2.5 and 5.2.6 explain steps b)-d) in gory detail.
Steps a)-d) are implemented such that they can be run in parallel using the Message Passing
Interface (MPI) on a 20 node Linux cluster. Details of the parallelization are provided in Section
5.2.7. Finally, the HMMs are then compare to sequences from SwissProt and uncharacterized
sequences (step f).
5.2.2 Data sources for the generation of PPI descriptors
For PPI descriptors, data is taken from the SCOPPI database [Winter et al., 2006b] (see Chap-
ter 3). Despite the fact that homodimers account for a large set of interface types, we omit
them because it is often unclear whether a homodimer interface is genuine or an artifact from
crystallization. An interface in SCOPPI consists of two faces. Similar faces are clustered into
face types, and similar interfaces are clustered into interface types [Kim et al., 2006b]. For the
generation of descriptors, a non-redundant set of domain sequences is used for every interface
type at 98% sequence identity.
5.2.3 Identification of a consensus of interface residues
SCOPPI provides a multiple sequence alignment constructed with MUSCLE [Edgar, 2004] for
domains of the same SCOP [Murzin et al., 1995] family. Figure 5.3 shows such an alignment
for one face type. Interacting residues are depicted in uppercase. The residues in each column
of the multiple sequence alignment do not always agree on interface membership. Columns
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Figure 5.2: Work flow. a) All instances for interactions between family A and family B with
identical geometric interface classification are retrieved from SCOPPI. Interface residues are
indicated in the accompanying multiple sequence alignments. b) Interface columns are identified
as well as columns with predominantly interface scaffolding residues. c) HMMs are constructed
for each interface segment d) HMMs are merged by insert states with high self-loop probabilities
as to model the non-interacting linker region e) The collection of all merged HMMs constitutes
the descriptor library. f) Sequence searches against SwissProt and uncharacterized sequences
with all descriptors were done using HMMer’s hmmsearch.
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are therefore marked as interface columns if the number of interacting residue at that position
exceed a certain threshold. This threshold is set to 50%.
The complexity of the identification of interface columns is proportional to the length of the
multiple sequence alignment O(k×n), where n is the length of the multiple sequence alignment















































Figure 5.3: A sample alignment for RuBisCo N-terminal domain. Interacting segments are highlighted in corresponding colors in the
alignment as well as in the structure. Interface segment definition is illustrated by the three lines below the alignment. Finally, the
10 fold von Neumann entropy is printed. The structure of the complex is shown below the sequence alignment in surface and ribbon
representations
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Figure 5.4: Number of segments in descriptors. a) Number of segments in PPI descriptors.
Most descriptors consist of several segments, where an interface consisting of three segments is
most commonly observed. b) Ligand binding sites more frequently consist of just one binding
segment. Note that the segment statistics is performed on the redundant set of ligand binding
sites.
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5.2.4 Identification of interface segments and sequence information
enrichment using HSSP
5.2.4.1 Flanking and padding of interface segments
Flanking is the process of identifying a number of columns that are adjacent to interface columns
as defined in Section 5.2.3. Padding is the process of including columns into an interface segment
if the left and right neighbor columns are interface interface columns. The rational behind these
extensions is to include the structural scaffold of a set of dispersed interacting amino acids. For
example, helical interfaces generally consist of several non-consecutive residues that are facing
the binding partner. Note that these residues are not free to mutate arbitrarily as they often
underly atom packing constraints in the protein interior. They would also have a disrupting
effect on the interface if they mutated to helix breaking residues. Therefore, these bridging
residues are considered important and included in the interface segments.
Interface columns are extended by first adding f adjacent columns (flanking) and then bridg-
ing “gaps” of non-interacting residues of length p (padding). The parameters f and p are subject
to fine tuning and were set to 1 in the cross validation process. The results are segments of
continuous interface columns. The algorithms for flanking and padding have a complexity of
O(k× f × i) and O(k× p× i) where i is the number of interface segments. Given that the num-
ber i ≤ n and f and p are constants, the computational effort to calculate the total interface
segment columns is O(n).
Figure 5.5: Helical interfaces: a helix from Arfaptin is in contact with the G-Protein Rac1 (PDB
1i4l), the interacting residues are shown in light-blue. Note that single residues not facing Rac1
are not considered interface residues by default (see the definition discussed in Section 2.2).
A few residues between interacting residues are included in interface segments by the flanking
and padding algorithms, such that a continuous stretch of the helix is considered as interface
segment.
5.2.4.2 Sequence information enrichment using HSSP
In order to cope with the problem that for some interface types only few instances are known, it
is necessary to retrieve further sequences. Espadaler et al. [2005] calculates artificial sequences
by introducing random permutations. Li and Li [2005] use the initial structural template and
sequence similarity searches to obtain further samples. Here, the HSSP, a database of pro-
tein structure-sequence alignments is utilized. Sequence information for each PDB entry can
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be added from identified structural homologs stored in the corresponding entry of the HSSP
database. Such an entry contains
1. the primary sequence of the protein of known structure, along with the derived secondary
structure and solvent accessibility;
2. a collection of aligned sequences extracted from SwissProt/Trembl deemed structurally
homologous to this protein (using the MaxHom algorithm);
3. sequence variability for each position;
4. occupancy, that is, the number of sequences that span this position.
For the generation of profiles it is sufficient to extract the amino acid frequencies at each
position. Ideally the alignment information could be extracted from a HSSP file for the sake of
further refinement, such as further sequence retrieval, sequence weighting or sequence filtering.
Unfortunately, HSSP is provided in an irregular text format, and no plans to remedy this cir-
cumstance (that is, provide xml format) have been uttered (Elmar Krieger, maintainer of HSSP,
personal communication). Therefore parsing the alignment has been skipped. The relevant part
for the amino acid frequencies is exemplified with an excerpt from HSSP entry 2bek:
## SEQUENCE PROFILE AND ENTROPY
SeqNo PDBNo V L I M F W Y G A P S T C H R K Q E N D NOCC
1 5 A 0 0 0 0 0 0 0 0 0 0 0 0 0 26 15 34 5 16 3 0 61
2 6 A 10 22 2 32 0 0 0 2 6 9 0 7 2 0 5 0 1 1 3 0 105
3 7 A 0 2 0 0 0 0 0 0 0 0 0 1 0 2 40 43 10 0 0 0 226
4 8 A 36 3 32 0 0 0 0 0 2 0 0 9 0 0 14 1 2 0 0 0 242
5 9 A 14 11 58 1 8 3 1 0 0 0 0 0 0 0 2 1 0 0 0 0 301
6 10 A 6 1 2 1 0 0 0 4 53 0 18 12 4 0 0 0 0 0 0 0 310
7 11 A 39 10 36 6 7 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 322
8 12 A 10 6 4 1 7 0 1 2 50 0 5 6 7 0 0 0 0 0 1 0 319
9 13 A 0 0 0 1 0 0 1 1 0 0 5 1 0 1 0 0 0 0 89 0 324
10 14 A 1 2 1 1 7 0 0 5 2 0 1 3 0 2 0 0 73 1 1 0 325
11 15 A 0 0 0 0 0 0 0 0 2 0 1 0 0 0 0 96 0 0 1 0 364
12 16 A 0 0 0 0 0 0 0 99 0 0 0 0 0 0 0 0 0 0 0 0 365
...
The first two columns identify the sequence and the PDB residue/chain, respectively, followed
by the 20 amino acid frequencies (in percent), the occupancy and some statistics (omitted).
Mapping of the PDB residues to the sequences from SCOPPI has been done using the relational
SCOP database. HSSP omits the additional letters for PDB residues that contain insertion
codes. These residues have been mapped by first matching the order of the HSSP file and the
SCOP sequence and second by validating that the amino acid letter matches. All identified
interface segment residues are this way enriched with corresponding amino acid frequencies.
5.2.5 Generation of Profile Hidden Markov Models
Hidden Markov models have been briefly introduced in Chapter Background. It is important
to note that Hidden Markov Models provide probability calculations that are well-founded in
probability theory. A Hidden Markov Model is a graph, where nodes represent states Ti and
edges between state Ti and Tj represent the transition probabilities P (i, j) All probabilities are
between 0 and 1 and all outgoing transition probabilities sum up to 1, that is




P (i, j) = 1 (5.2)
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Figure 5.6: Path probabilities in profile Hidden Markov Models. State transitions are assumed
to be independent due to Markov Property. The probability for a path is then simply the
product of all its constituent state transitions.
Hence a HMM is a fully probabilistic model and Bayesian reasoning can be applied. Note that
Hidden Markov Models are based on the Markov property: the probabilities P (πi−1, πi) are
assumed to be independent. Figure 5.6 demonstrates the calculation of a sample path through a
Hidden Markov Model. Because of the Markov property, the path probability is given by simply




P (πi−1, πi) (5.3)
HMMs are constructed for each part of the multiple sequence alignment, that have been
identified as interface segments as described in Section 5.2.4. The training algorithm, HMMer’s
hmmbuild, calculates all probabilities for the state transitions and emissions.
HMMer uses a maximum a posteriori architecture algorithm, that is guaranteed to find the
model architecture with the highest posterior probability for the multiple sequence alignment.
The algorithm is implemented using dynamic programming, with a complexity of O(n2) accord-
ing to Durbin et al. [1998].
5.2.6 Parsing and merging of Hidden Markov Models
For every interface segment, a Hidden Markov Model (HMM) is generated with the HMMer
software [Finn et al., 2007]. Segment HMMs are merged into one HMM by linking them with
insert states. The resulting HMM serves as face type descriptor for a protein-protein interactions.
The linking of HMMs is adopted from Meta-MEME [Grundy et al., 1997], with the difference
that insert and delete states remain unchanged in this work. Note that the preservation of insert
and delete states leads to an increased tolerance when querying the model against a sequence.
Consequently a larger amount of false positives is produced. However, it could be observed that
large amount of interface columns contained gaps. This necessitates the insert and delete states
that can accommodate for sequences with larger or smaller interfaces.
The probability for a self loop in the segment linking insert states is set to l/(l + 1), where
l is the average length of the linker region between two interacting segments. According to
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Figure 5.7: Merging profile Hidden Markov Models. In red are shown the new and modified
transitions. The insert state in plays the role of modeling the linker region between interface
segments.
[Grundy et al., 1997] this probability has been chosen so to maximize the likelihood that a gap
of a certain linker region is emitted.
Likewise, the probability to change into the insert state at the last match state of the first
motif is set to a high probability (again l/(l + 1)). Note that the spacing lengths l differs for
different sequences. Therefore, the average length of the linker regions is calculated for l. The
outgoing state transition probabilities from respectively An and in to B1 are set to 1/(l + 1).
The resulting model is a valid Hidden Markov Model that adheres to Equation 5.1 and 5.2. In
Figure 5.7 all modified probabilities are shown.
Note that HMMer2 does not implement the classical architecture of profile Hidden Markov
Models as defined by Krogh et al. [1994], shown in Figures 5.6 and 5.7. Instead, the Plan7
architecture is provided that differs in two ways. For each node, only 7 state transitions are
allowed as opposed to originally 9 by omitting the transitions from insert to the subsequent delete
state and vice versa. Additionally, Plan7 includes initial and final states B and E, respectively.
State B has outgoing state transitions to all match states and from all match states there are
state transitions to E, as shown in Figure 5.8. This architecture allows for local alignments both
with respect to the query sequence as well as with respect to the HMM. Note that a classical
profile Hidden Markov Model can be emulated by setting the probabilities from B to the match
states other than the first to 0, likewise with the according probabilities to E.
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D1 D2 D3 D4
Figure 1: The Plan7 architecture. Squares indicate match states (modeling consensus positions in the
alignment). Diamonds indicate insert states (modeling insertions relative to consensus) and special ran-
dom sequence emitting states. Circles indicate delete states (modeling deletions relative to consensus) and
special begin/end states. Arrows indicate state transitions.
4 How HMMER builds profile HMMs from alignments
This section walks you through the steps of building a model from a multiple sequence alignment, in gory
detail. You have a fair amount of control over many of these steps, using options to thehmmbuild program.
We’ll start with a description of the “Plan 7” profile HMM architecture used by HMMER, and the
philosophy behind it. It differs in small but important ways from the original Krogh/Haussler architecture.
Specifically, Plan 7 is a fully probabilistic model of both local and global profile alignment.
The Plan 7 profile HMM architecture
HMMER uses a profile HMM architecture called Plan 7. This is somewhat more complex than the original
profile HMM architecture introduced by Krogh, Haussler, and coworkers (Krogh et al., 1994).
The heart of a profile HMM is a linear set of match (M) states, one per consensus column in the multiple
alignment. Each M state emits (aligns to) a single residue, with a probability score that is determined by the
frequency that residues have been observed in the corresponding column of the multiple alignment. Each
match state therefore carries a vector of 20 probabilities, for scoring the 20 amino acids.
Some analysis approaches, including BLOCKS (Henikoff and Henikoff, 1994b), are essentially equiv-
alent to a profile HMM composed only of M states. These methods are calledweight matricesor position-
specific score matrices(PSSMs); they look forungappedalignments to a consensus.
A profile HMM is capable of modeling gapped alignments, e.g. including insertions and deletions,
which lets the software describe a complete conserved domain (rather than just a small ungapped motif).
Insertions and deletions are modeled using (surprise!) insertion (I) states and deletion (D) states. Each
match state has an I and a D state associated with it. HMMER calls a group of three states (M/D/I) at the
same consensus position in the alignment a “node”.
These states are interconnected with arrows calledstate transition probabilities. The transitions are
31
Figure 5.8: Plan7 Hidden Markov Models. The dotted transitions as well as the states B, E,
and J are specific to Plan7. They allow for local alignments with respect to both query sequence
and profile Hidden Markov Model. Yet they are capable of encoding a slightly simplified form of
classical profile Hidden Markov Models as proposed by Krogh and Hauser [Krogh et al., 1994].
Source: HMMer user guide at http://hmmer.janelia.org.
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5.2.6.1 Implementation of a Parser and Merger of HMMer2 Hidden Markov Mod-
els
In order to combine two or more Hidden Markov Models it is necessary to illuminate the se-
mantics of the profile Hidden Markov Model encoding in HMMer2 format. Figure 5.9 shows a
sample HMM.
The parser gets as input a list of i HMMs in HMMer2 format together with a list of i − 1
averaged linker lengths. It then reads the first HMM to the last state while leaving all parsed
lines unmodified. The insert emissions and state transitions of the last state are modified:
instead of the mainly zero probabilities (see for example line 67 and 68 in Figure 5.9) the new
state transition probabilities are set as a function of the length of the first linker region, as
discussed above. The model-end signal // is omitted and the states of the second till i − 1th
model are appended with the final states modified accordingly. The final state of the ith model
is left unmodified
Finally, the merged HMM is calibrated using HMMer’s calibration tool hmmcalibrate with
5000 random sequences. This provides the parameters for an extreme value distribution and is
the base for E-value and p-value estimation during sequence searches. The resulting HMMs are
directly usable with HMMer’s hmmsearch tool which provides sound E-value calculation.
5.2.7 Parallelization of PPI descriptor generation
The task of generating n PPI descriptors (step a)-d) in Figure 5.2) can be divided into n
independent subtasks. A distributor module, implemented as a subclass of the general MPI-
timeout distributor (see Appendix A.1), retrieves all interface types. Each subtask is given the
SCOP identifiers of the interacting family pair as well as the interface type identifiers.
5.3 Construction of protein-ligand interaction descriptors
The prediction of protein ligand interactions is of paramount importance for the function pre-
diction of that protein. Proteins interact with each other, but to get a complete picture of the
metabolic pathways of a cell, protein-ligand interactions need to be considered. Furthermore,
as large protein complexes are often difficult to crystallize, knowledge about protein-protein
interactions can be drawn from the more abundant protein-peptide interactions. The descriptor
construction method can be extended to these cases in particular and to PLI in general. We
construct HMM profiles for faces that bind to small molecules and peptides. To this end we
scanned PDB for most frequently occurring co-crystallized ligands. We identify the residues
surrounding the ligand including possible cofactors. A profile is solely built from one structural
template and aligned sequences utilizing HSSP [Schneider et al., 1997].
5.3.1 Work-flow
Due to the current lack of a comprehensive classification for geometrical associations of protein-
ligand interactions, PLI descriptors are generated from single structural templates:
0. For each structure in the PDB containing a protein and a ligand:
1. Select a ligand
2. Iteratively expand the selection to include surrounding
cofactors
3. Identify the residues surrounding the ligand selection within
4.5 Angstrom
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08: COM hmmbuild -F --amino d.92.1.7_h.4.2.1___03_02_00_L.hmm d.92.1.7_h.4.2.1___03_02_00_L.aln
09: NSEQ 100
10: DATE Tue Aug 15 16:24:28 2006
11: CKSUM 5049
12: XT -8455 -4 -1000 -1000 -8455 -4 -8455 -4
13: NULT -4 -8455
14: NULE 595 -1558 85 338 -294 453 -1158 197 249 (...)
15: HMM A C D E F G H I K (...)
16: m->m m->i m->d i->m i->i d->m d->d b->m m->e
17: -585 * -1585
18: 1 -1877 -1407 -2790 -2669 3303 -2750 341 -953 -2333 (...)
19: - -149 -500 233 43 -381 399 106 -626 210 (...)
20: - -33 -6045 -7087 -894 -1115 -701 -1378 -585 *
21: 2 -312 -1789 1140 1089 -2060 -972 137 -1817 649 (...)
22: - -149 -500 233 43 -381 399 106 -626 210 (...)
23: - -33 -6045 -7087 -894 -1115 -701 -1378 * *
24: 3 -573 -2191 1920 1364 -2428 -923 -14 -2235 68 (...)
25: - -149 -500 233 43 -381 399 106 -626 210 (...)
26: - -33 -6045 -7087 -894 -1115 -701 -1378 * *
27: (...)
63: 16 -132 -1452 435 766 -1738 -190 227 -1451 596 (...)
64: - -149 -500 233 43 -381 399 106 -626 210 (...)
65: - -33 -6045 -7087 -894 -1115 -701 -1378 * *
66: 17 54 -1215 11 1127 -1433 19 229 -457 945 (...)
67: - * * * * * * * * * (...)
68: - * * * * * * * * 0
69: //
Figure 5.9: A HMM of a single interface segment with 17 match states as produced with
HMMer’s hmmbuild. The actual encoding of the probabilities starts at line 15 with opcode HMM.
Note that probabilities are encoded with a logarithmic function, see the HMMer user guide,
http://hmmer.janelia.org. For each column of the multiple sequence alignment, three lines
are provided: The first line assigns emission probabilities of the match state (in line 18, 21, 24
etc.). The second line assigns emission probabilities of the insert state (in line 19, 22, 25 etc.).
The third line assigns state transitions according to line 16, where m abbreviates match state,
i insert state, d delete state, b begin state and e. The latter two states are specific to Plan7
models. Note that the last state transitions in column b->m and m->e are set to 0 (*) to emulate
classical profile HMMs. Long lines are abbreviated for simplicity by (...). Line 69 marks the
end of a Hidden Markov Model.
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4. If this yields at least three well conserved residues:
5. Include direct well conserved sequence neighbours
6. Include residues that are between selected sequence
neighbors
7. Add sequences identified as structural homologous by HSSP
8. Generate HMMs for each segment
9. Combine HMMs into one descriptor connected by inserting
states that reflect the linker regions between segments
10. Add descriptors (one for each ligand) to library
11. The library can now be used to predict ligand binding sites.
Protein-ligand interface identification is implemented with the selection algebra provided by
PyMOL (steps 1-5).
Most of the following steps are equal or similar to the work steps described in the PPI
descriptor work-flow. Step 6 is similar to the flanking procedure in protein-protein interfaces.
The argumentation provided in Section 5.2.4 also applies here. Step 7 (HSSP enrichment)
corresponds to step 5 in the PPI descriptor work-flow, with the sole difference that for PLI
descriptors this step is obligatory. Steps 8 and 9 correspond to the work-flow steps 6 and 7
of PPI descriptors, respectively. Therefore, the concepts for the generation of profile Hidden
Markov Models for PPI descriptors (in Section 5.2.5) and the merging of interface segments (in
Section 5.2.6) are equally valid for protein ligand descriptors.
Conservation of residues is calculated by using the von-Neumann-Entropy in combination
with the substitution matrix BLOSUM62. We evaluate the descriptors’ accuracy in terms of
standard precision and recall, where precision is defined as TP/(TP+FP) and recall is defined
as TP/(TP+FN). TP, FP, and FN denote the numbers of true positives, false positives and false
negatives, respectively.
5.4 Evaluation
In order to assess the significance of HMM scores, a number of comparisons to shuffled databases
were conducted. Figure 5.11 demonstrates the expressive power of low E-values achieved with
interface type HMMs against SwissProt vs. shuffled SwissProt. Random hits generally only
occur with E-values above 1, while hits in SwissProt below 1 can be considered significant.
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Figure 5.10: Assessing accuracy and significance of ATP-binding descriptors. Precision-recall
curve for ATP-binding descriptors derived from protein structures with bound ATP or ADP
tested against SwissProt, shown as curve with red circles. Each circled point corresponds to
a different E-value cutoff. The PROSITE patterns for ”ATP-binding” and ”ADP-binding” are
included as well (green crosses). Overall, PROSITE achieves a recall of 31% with a precision of
62% (blue cross). For all E-values, the generated descriptors perform better than PROSITE.
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Figure 5.11: Assessing accuracy and significance of ATP-binding descriptors. Distribution of
E-values for the ATP-binding descriptors. To assess the significance of hits, the descriptors
were tested both against SwissProt (black line) and a shuffled SwissProt version (red line). The
cumulative number of hits below a certain E-value threshold is shown. Below an E-value of 1
(dotted vertical line), 53,000 hits are found in SwissProt whereas only 1,200 hits are found in
the shuffled SwissProt. The graph below shows a magnification of the lower right corner.
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Hits Precision Recall Threshold TP FP New
2873 96.59 7.55 1.00E-10 2775 98 771
3113 96.5 8.17 1.00E-09 3004 109 814
3459 96.18 9.05 1.00E-08 3327 132 854
3943 96.25 10.32 1.00E-07 3795 148 899
4488 95.9 11.7 1.00E-06 4304 184 929
5114 93.86 13.05 1.00E-05 4800 314 955
5773 92.74 14.56 0.0001 5354 419 982
6477 91.71 16.15 0.001 5940 537 1012
7477 91.53 18.61 0.01 6844 633 1053
8749 91.45 21.76 0.1 8001 748 1115
10349 89.43 25.17 1 9255 1094 1249
14165 78.86 30.38 10 11171 2994 1499
27926 53.67 40.76 100 14988 12938 2440
93261 25.85 65.56 1000 24109 69152 6397
Table 5.1: Matches for ATP- and ADP-binding descriptors with various E-value thresholds. A
benchmark set containing 205.000 known ATP-binding or not ATP-binding SwissProt entries
was used to measure the precision and recall of 306 ADP/ATP binding descriptors. Hits were
counted at various E-value cutoffs. Number of True Positives (TP), False Positives (FP) and
number of those True Positives not found automatically by any Prosite-pattern (New) were
determined.
5.4.1 Assessing the performance of PLI descriptors
Benchmarking HMMer E-values Expectation values provided by the HMMer software are
a means for assessing the significance of HMM hits. As demonstrated by Li and Li [2005], the
statistical evaluation to randomness can be used to establish a Z-score to distinguish significant
from random hits. Here, we use comparisons to shuffled databases to gain further information
about the significance: by calculating the ratio of best E-values of hits from shuffled and not
shuffled sequence databases. For database shuffling, we generated a random permutation for
every single sequence in the database. In the sequel, we demonstrate the use of shuffled databases
for one particular ligand - adenosine triphosphate (ATP).
Case study: ATP-binding sites. Ligand-binding descriptors are evaluated for the case of
ATP. It is assumed that all proteins that bind ATP also bind ADP, adenosine-diphosphate,
which is the end-product when ATP loses one of its phosphate groups located at the end of the
molecule. The conversion of ATP and ADP plays a critical role in supplying energy for many
processes of the cell. The assumption helps to compose a larger set of descriptors for the same
bindings site, since molecules are often easier to crystallize in their inactive state, that is, in
ADP-bound state.
The descriptors for ADP-binding and ATP-binding were run against 205,000 SwissProt-
annotated sequences and could extract 10,349 hits whereof 9,255 were true positives and 1,094
false positives. Given that 36,774 sequences were annotated as ATP-binding, this amounts to
25.2 % recall and a precision of 89.4%. PROSITE’s P-loop motif recognizes 24.87% but in
contrast produces 6792 false positives (precision: 57.4%). Figure 5.12 shows an overview of
these numbers. The precision-recall curve (Figure 5.10) for the descriptors was generated from
true/false positive rates at different E-value thresholds (Table 5.1).
Scores for regular expressions from PROSITE are generally below this curve. PROSITE
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improves on this by adding highly specific full length sequence profiles (matrices) with high
precision but very low recall. Note that these matrices have been compiled manually. Moreover
domain matching matrices from PROSITE loose the ability to pinpoint the exact binding motif.
Patterns and profiles from PROSITE were extracted in a systematic way: all PROSITE doc-
umentations (PDOC entries) were text-mined for ATP/ADP-binding, the according PROSITE
entries were extracted. Those PROSITE entries with very low recall and precision were removed.
A particular ATP binding site descriptor, that complements existing PROSITE patterns is de-
scribed in detail in Section 5.4.2.
Figures 5.16 a) - d) illustrate the use of E-value ratios of unshuffled vs. shuffled sequence
databases. In case of the ATP-binding descriptors searched against SwissProt, the comparison
of the two E-value distributions (shuffled/not shuffled) allows the identification of a significance
threshold (Figure 5.11). Note that small motifs like for example the poly-proline (PxxP) motif
occur frequently in sequence where only 5% are functional. Nevertheless, hits of small motifs
are helpful to identify candidate sets that should undergo manual post-processing.
Figure 5.12: Validation of PLI-descriptors. Prediction of sequences annotated with the Swis-
sProt keyword “ATP-binding” (or ATP/ADP as part of the catalytic activity) using PROSITE
patterns and multiple motif descriptors with hits below E-value 1: while both methods detect




5.4.2 A novel P-loop variant indicates ATP binding sites
Figure 5.13: A P-loop motif variant for ATP binding in Bacteria: The ATP binding pocket
of the PDB structure 2bek (chain A) is shown in complex with ATP. The protein is from
Thermus thermophilus and it has not been classified by SCOP. However, Pre-SCOP [Andreeva
et al., 2007] assigns the superfamily “P-loop containing nucleoside triphosphate hydrolases”.
Hydrogen bonds between protein and ligand are shown in yellow. The conserved part of the
pocket is responsible for the ligand binding mainly through hydrogen bonds to the pyrophosphate
group. This part consists of residues that form a sequence motif which is readily detectable in
unannotated sequences. Note that the sequence motif defining patch is the most conserved
surface patch. The rest of the surface, in particular also on backside, shown to the right, is
variable. Motif residues are labeled with three letter code and sequence positions. In brackets
is the numbering relative to the motif, as used in Figure 5.2.
Some descriptors exhibited great similarity to the PROSITE P-loop motif, for example the
descriptor derived from PDB entry 2bek, a chromosome partitioning ATPase (Figures 5.13 and
5.2): the central binding motif conserves Glycine and Lysine that build hydrogen bonds to
ATP’s phosphate tail. The PROSITE pattern only disagrees on its first position (requires Ala-
nine or Glycine, mostly Glutamine found) and does not give any specification to the following
four residues. These however, are found to be well conserved in a wide variety of ATP-binding
homologs. The different variants of the motif in various species are displayed in Figure 5.2.
This way a variation of the P-loop motif has been automatically developed which is more pre-
cise for a range of orthologous chromosome partitioning ATPases that are picked by HSSP in
other species. The selected sequences from HSSP that would be matched by the descriptor are
annotated in SwissProt/Trembl as ATPases involved in chromosome splitting. An alignment
of these sequences is shown in Figure 5.14. It shows that the ATP-binding motif is the single
most conserved block in the HSSP sequences. As for the SwissProt-cross-reference annotations,
Pfam/InterPro detects only a global domain match for cobyrinic acid a,c-diamide synthases
(Pfam PF0165) and nitrogenase II (InterPro IPR000392) families. However, no explicit anno-
tation about the local nucleotide binding motif in the sequence has been made (for example for
SwissProt entry Q8NQL3). No PROSITE pattern matches, although PROSITE attempts to
provide short descriptors (regular expression patterns) for ATP binding sites, as this excerpt
from PROSITE shows (in original SwissProt notation):
ID ATP_GTP_A; PATTERN. PS00017
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DE ATP/GTP-binding site motif A (P-loop).
PA [AG]-x(4)-G-K-[ST].
\\
ID GHMP_KINASES_ATP; PATTERN. PS00627
DE GHMP kinases putative ATP-binding domain.
PA [LIVM]-[PK]-x-[GSTA]-x(0,1)-G-[LM]-[GS]-S-S-[GSA]-[GSTAC].
\\
ID SIGMA54_INTERACT_2; PATTERN. PS00676




ID GLNA_ATP; PATTERN. PS00181
DE Glutamine synthetase putative ATP-binding region signature.
PA K-P-[LIVMFYA]-x(3,5)-[NPAT]-[GA]-[GSTAN]-[GA]-x-H-x(3)-S.
\\
ID SIGMA54_INTERACT_1; PATTERN. PS00675
DE Sigma-54 interaction domain ATP-binding region A signature.
PA [LIVMFY](3)-x-G-[DEQ]-[STE]-G-[STAV]-G-K-x(2)-[LIVMFY].
This list is the manually extracted pattern subset of the extracted PROSITE entries that ex-
plicitly state ATP-binding. Note that some similarities also exist between the P-loop variant
(from 2bek) and PROSITE pattern PS00675, but disagreements in other positions render these
motifs complementary.
Furthermore, 9 HSSP-sequences did not receive any Pfam/InterPro annotation (according
to SwissProt/Trembl) although they carry the described motif:




Haloarcula marismortui 2004 EKGGVGKT
O51962 SojA (Spo0A activation inhibitor). Halobacterium salinarium 1998 QKGGVGKT
Q937Z5 Putative ParA. Mycobacterium avium 2001 TKGGVAKT
Q5NUS2 Putative partitioning protein. Streptomyces albulus 2005 QKGGVGKT
Q93MJ0 ParA. Corynebacterium jeikeium 2001 TKGGVGKT
Q8RN45 ParA. Corynebacterium jeikeium 2002 TKGGVGKT
Q9F770 SOJ-like protein (Fragment). Pseudomonas aeruginosa 2001 TKGGVGKS




Rhodopirellula baltica 2003 LKGGVGKT
These sequences are well suited for homology modeling, as HSSP identified them as structural
homologs to the PDB entry 2bek. The seed alignment provided by the motif increases the
quality of the modeling. Given the motif occurrence and the structural homology, there is
strong evidence, that these proteins are capable of binding ATP at the identified motif position.
The presented motif therefore is a valuable pointer to ATP-binding sites, which —to the best of
my knowledge— can not be detected by any other conventional sequence annotation method.
In order to annotate other sequences that have not been identified by HSSP, the NCBI non-
redundant protein database (NCBI NR) was scanned for the motif. The motif was encoded
as regular expression: M={AG}-K-G-G-x-x-K-[TS]. According to Equation 2.2 and the amino
acid background propensity from the SwissProt database, the profile probability p(M) can be
estimated to 1.766×10−6. The motif M occurs 1031 times, in the NCBI NR database, a volume
of 3.2 × 106 sequences. None of the sequences would have been detected by the PROSITE P-
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loop motif as it disagrees on the first position. Many of the 1031 sequences are labeled as
ATPases and have been annotated by the Conserved domain database (CDD, Marchler-Bauer
et al. [2002]). The CDD contains models from Pfam, SMART and manually created models.
In particular, the CDD models 73297-73302 and 48368 - 48371 recognize variants of the P-
loop motif. These models have been created by a similar method that uses structural evidence
[Panchenko et al., 2004]: PDB entries with ligand binding sites have been aligned with similar
sequences recognized by PSI-BLAST. If the identified binding residues matched, the sequences
were annotated. This way CDD annotated 971 of the 1031 sequences with the ATP-binding
motif. Note that the PSI-BLAST technique produced alignments with conserved core blocks of
length 38-516 residues. Therefore, 60 diverging sequences have been missed out. The remaining
60 sequences contain a binding site only recognized by the provided descriptor. Partially they
have been recognized as ATPases, which shows that the motif matches are likely to be true
positives. The complete list is provided in Appendix A.5.
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2K 3G 4G 5EV 6G 7K 8ST
C
Bacteria Proteobacteria Deltaproteobacteria Bacteria Spirochaetes Spirochaetales
Table 5.2: ATP binding motif derived from PDB id 2bek and HSSP, and various derivatives
in different phylogenetic sub-branches. The descriptor is compared to the the P-loop pattern
(below, PROSITE entry PS00017). A single conflict occurs in the first position, and more specific
detail is given about the second to the fifth residue. It is striking that residues 2-4 (KGG) are
totally conserved, whereas the sixth residue of the P-loop motif, Glycine, occasionally is mutated.
The descriptor correctly detects other ATP binding sites in chromosome partitioning ATPases.
The motif was derived from 366 SwissProt/Trembl sequences provided by the HSSP database.
These were categorized into 27 sub-branches, 10 of which had more than 5 entries. No specific
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Figure 5.14: Structural homologs identified by HSSP for PDB 2bek: the ATP-binding region
(first conserved block between residues40 and 48) is the major similarity between the sequences.
Other conserved parts are shorter and not located on the surface (Figure 5.13). Redundancy
reduction of the 366 HSSP sequences was performed using CD-HIT with a maximum of 70%
sequence identity. MUSCLE was used to align the remaining 189 sequences. The upper part
shows the full alignment of a subset of the sequences; below is an overview fingerprint of all
non-redundant sequences.
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5.4.3 Assessing the performance of PPI descriptors
5.4.3.1 Cross validation with structure data sets
The initial data set comprised 740 interface descriptors of protein-protein interactions, each
having at least three non-redundant instances (not more than 98% sequence identity). In order
to check the ability of face descriptors to recognize faces from structures in the PDB, 2-, 4-
and 8-fold cross validations was performed on interface types with at least 8 non-redundant
instances. This yields a set of 45 interface types, that is, 90 face types. This set was run against
domains from PDB that are classified by SCOP. For 61 face types (67%), a reasonable recall
of 70%-100% was achieved (Table A.3 in Appendix A.4). Face types with low recall often have
small interfaces with short, dispersed segments producing insignificant hits or have low face
conservation. Another source of errors is misalignments of sequences of an interface type.
The recall for interaction prediction by requiring both face types to be present is upper bound
by the minimal recall of both faces. Hence, the average recall for interface detection dropped to
39%. This problem is most eminent for predicting interactions of promiscuous faces. Using the
Structural Classification of Protein-Protein Interactions (SCOPPI [Winter et al., 2006b]), it is
then still possible to provide candidate interaction partners. In particular, for dedicated faces,
that is, those with just one opposite binding face, recognition of one face type suffices.
5.4.3.2 HSSP-enriched vs. non-HSSP-enriched descriptors
In five cases, the recall could be improved by adding homologous sequences from HSSP. HSSP
residue frequencies add sequence diversity to the descriptors. One problem of HSSP enrich-
ment is that HSSP sequences are assigned to a certain structural template according to global
sequence similarity criteria, regardless of the preservation of the binding sites. Consequently,
some sequences for a descriptor are not guaranteed to be capable of the actual interaction that
is to be described. These sequences contaminate the interface descriptors.
5.4.3.3 Total family models vs. short interface segment models
As expected, descriptors that are compiled using complete domains of an interface type often
outperform descriptors composed of interface segments only. The reason is that test set se-
quences often are very similar to training set sequences due to the permissive sequence identity
cut-off of 98%. This means that often not only interfaces but also other parts of the protein
are conserved, in particular core residues (see the detailed analysis in Section 2.5.2). Longer
sequence matches yield smaller E-values. Since the definition of predicted positives is depen-
dent of the threshold for the E-value, family descriptors are more likely to succeed, in particular
in homogeneous families. However, it has been pointed out, that sequence profiles based on
low-diversity alignments perform relatively poorly in database searches [Panchenko and Bryant,
2002]. Also, in heterogeneous families, short sequence descriptors are more successful because
fewer sequences are required to account for the sequence variability. The short descriptors are
more likely to discover binding sites and motifs in remote homologs and analogs. As shown in
Section 5.4.2, the CDD alignments of core conserved blocks with lengths of 38-516 residues are
not sensitive enough to recognize all ATP-binding sites the NCBI NR database, whereas a single
eight-residue descriptor identifies 60 more sequences.
5.4.3.4 Literature protein-protein interaction benchmark
To investigate how well the presented method is suited to detect protein-protein interactions,
it is benchmark against a set of high quality literature-curated interactions. To this end, a
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subset of NetPro is used, an expert curated and annotated database containing 15,000 protein-
protein interactions [Connections, 2005]. These were extracted from PubMed abstracts by a
semi-automated method and then cross-checked by human experts. Using 740 multiple motif
descriptor pairs, the NetPro benchmark set is searched for matches where a descriptor pair
matches two interacting proteins. If the E-value cutoff is maximally relaxed, it is possible to
predict 80% of the literature interactions. At a stricter E-value of 0.001, still 230 interactions
can be validated (see details in Table 2).
5.4.4 Using the descriptors to annotate uncharacterized sequences
A corpus of 32,000 uncharacterized proteins was obtained from the NCBI’s non-redundant pro-
tein sequence database. Face descriptors were run against these sequences and a shuffled version.
The result is shown in Figure 5.16d). A number of hits can be identified in the upper left part
that have significant difference between E-values of log E-values of best hit against original
sequences and against best hit of shuffled sequences. One example is the uncharacterized Fe-S
protein from Yersinia bercovieri (NCBI ZP 00820831). The face descriptor constructed from E.
coli Complex II 2Fe-2S ferredoxin domain (which binds to the N-terminal domain of succinate
dehydrogenase/fumarate reductase flavoprotein) matches this protein with an E-value of 4.4e-
7. In contrast, the same descriptor achieves only 0.057 as best E-value when run against the
shuffled version of the uncharacterized sequence database (Figure 5.17).
This suggests that uncharacterized Fe-S protein could be part of the Complex II of Yersinia
bercovieri interacting with succinate dehydrogenase flavoprotein subunit. The latter was found
to be present in the available Yersinia pestis genome via sequence similarity search. The descrip-
tors for the binding site in Ferredoxin (derived from SCOP family d.15.4.2, 2Fe-2S ferredoxin
domains from multidomain proteins) and for the partner binding site in succinate dehydrogenase
flavoprotein subunit (SCOP family c.3.1.4) are shown in Figure 5.17.
In order to estimate the quality of descriptors, E-value ratios for all descriptors in shuffled
and original databases were analyzed in dependence of descriptor length (Figure 5.16). Not
surprisingly, most descriptors perform well against SwissProt, in particular long descriptors.
Significant hits are rarer in uncharacterized sequences, which had less or no influence in the
generation of descriptors (Figures 5.16 c) and d). Interestingly, the best results were achieved
by short and medium size descriptors. This suggests that long descriptors are less likely to
discover binding behavior in unknown sequences.
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Figure 5.15: PPI descriptors, length vs. recall. a) Data points from Table A.3 are shown, where
recall is plotted against the length. While motifs with low recall are usually short, high recall
sequences are available in all lengths. The conservation (von-Neumann Entropy) of the data
points is reflected by the color. It can be observed that amongst the short motifs with high
recall, there are many highly conserved motifs. The descriptors in the green rectangle are shown





Figure 5.16: Correlation of length and quality of HMM descriptors. ATP-binding descriptors as
well as face type descriptors for protein-protein interactions were run against original and shuffled
versions of SwissProt and uncharacterized NCBI sequences. The length of a profile Hidden
Markov Model descriptor is defined as its number of (match) states. Quality is measured as the
difference between log E-values of best hit against original sequences and shuffled sequences.
For SwissProt, longer descriptors have better quality and therefore produce more significant
hits. For uncharacterized sequences, this does not hold. One explanation could be that these
sequences are depleted of significant matches by similarity searches.
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Figure 5.17: An alignment and descriptor logos for the binding site in Ferredoxin and its coun-
terpart in the succinate dehydrogenase flavoprotein subunit. The logos have been produced




Descriptors for 740 classified types of protein-protein binding sites and for more than 3,000
protein-ligand binding sites are generated. Cross validation reveals that two thirds of the PPI
descriptors are sufficiently conserved and significant enough to be used for binding site recogni-
tion.
Further, the descriptors were used to validate 230 protein-protein interactions that were
extracted from the literature, where the descriptors additionally identify the interface residues.
Finally ligand-binding descriptors for the case of the ligand adenosine triphosphate (ATP) were
tested. From sequences with SwissProt annotation ”ATP-binding”, the ATP-descriptors achieve
a recall of 25% with a precision of 89%, whereas PROSITE’s P-loop motif recognizes an equal
amount of hits at the expense of a much higher number of false positives (precision: 57%). The
method presented here yields 771 hits with a precision of 96% that were not previously picked
up by any PROSITE-pattern. In particular, a novel variant of the P-loop motif was discovered
and its usefulness for sequence annotation was demonstrated.
As a conclusion, it can be stated that the automatically generated descriptors are a useful
complement to known PROSITE/InterPro motifs. They serve to predict protein-protein as well
as protein-ligand interactions along with their binding site residues for proteins where merely
sequence information is available.
5.6 Limitations
For some interface types only few or no structures are available. This implies that protein-protein
interaction descriptors are inaccurately or not at all represented by the descriptor library. On
the other side, a pair of homologous sequences from HSSP does not necessarily preserve the
interaction of the structural template and thus does not belong to a certain interface type.
These sequences “contaminate” the alignments of interface descriptors. It is therefore essen-
tial to assure that recruited sequence pairs not only maintain an interaction but also agree in
interface type, that is, have similar sets of interface residues. A related problem is that of
interaction specificity. An interface descriptor with N and M hits for each face, respectively,
induces N×M candidate interaction pairs. Aytuna et al. [2005] argue analogously for structural
face descriptor pairs and Deane et al. [2002] verify interactions between pairs of yeast proteins
by known paralogous interactions. Although the latter report only 1% false positives, results
should be–as with any computational method–ideally supported by further evidence from ex-
perimental results. The presented technique to construct interface descriptors is inadequate for
short, strongly dispersed or highly variable interfaces (for example loops in immunoglobulins).
However, it is possible to create a descriptor with the presented method that spans over the
surrounding secondary structures, which are often well conserved.
5.7 Applications and future work
5.7.1 Interface annotation of Pfam domains with interface descriptors
Pfam is a widely used database comprising more than 3000 models for protein domains (see
[Sonnhammer et al., 1998] as well as Section 2.3.1 in Chapter Background). The motivation is to
provide interface residue annotations for Pfam models. Single sequences from three-dimensional
structures with identified interacting residues could be used to annotate the Pfam domains.
However, it is desirable to compare Pfam domains to all homologous structures. The rational
is to obtain a maximal confidence in which residues are part of an interface.
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In order to compare Pfam domains and interface type descriptors, it is necessary to perform
profile-profile comparisons, as both the interface descriptors and Pfam domains are represented
as Hidden Markov Models. Profile-profile comparison have been recognized to be a significant
improvement over profile-sequence based methods in a variety of benchmarks [Söding, 2005,
Sadreyev and Grishin, 2003].
The comparison of two (or more) profile Hidden Markov Models necessitates the alignment
of their respective insert-, match- and delete states. A successful implementation for comparing
profile HMMs is HHsearch, developed by Söding [2005]. HHsearch was used to compare the
generated interface descriptors and Pfam domains in an all against all manner ([Tuukkanen
et al.], in preparation).
A preliminary result is shown in Figure 5.18: Note that the sequences of the SCOP EF-hand
family differ strongly in sequence from the EF-hand sequences in Pfam.
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a)
b)
Figure 5.18: Alignment for the Pfam EF-hand domain vs. interface descriptors derived from
SCOPPI a) The alignment visualized with Logomat. b) Full length sequences of the Pfam
domain and the descriptor. Note that only the C-terminal regions bear a significant sequence
similarity signal.
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5.7.2 Guidance of site directed mutagenesis experiments
The match of a descriptor pair allows identification of the putative residues responsible for the
interaction. This information can be used to guide site-directed mutagenesis experiments that
aim at disrupting the interaction: the number of mutations can be reduced from the length of
the sequence to length of the descriptor match.
On the other hand, mutagenesis experiments and peptide libraries can be used to enrich
the sequence based interface descriptors. They provide additional information of the sequence
variability in binding sites. The binding ability of these sequences is experimentally validated,
which is advantageous in contrast to HSSP sequences, as stated in Section 5.6 (Limitations).
Furthermore, the positive and negative examples of site directed mutagenesis experiments serve
as benchmark for testing the descriptor specificity. The lack of specificity in descriptors is
likewise discussed in Section 5.6 (Limitations).
5.7.3 Combining descriptor predictions with
The proposed method for binding site prediction can be applied by itself or in combination
with other methods. A common technique for protein interaction prediction is by identifying
interacting homologues. This concept of so-called interologs is described in Section 2.1.6. The
usage of descriptors can serve here as a refinement: the assumption that the residues responsible
for the interaction are present can be easily confirmed by descriptor matches of the according
families. Since a match provides residue correspondences to the original structures used to create
the descriptor, the match alignment can serve as an initial setup for homology modeling of the
interface region.
5.8 Discussion
5.8.1 PLI descriptors produce matches of higher significance than PPI
descriptors
Protein-protein interfaces are less conserved than protein-ligand interfaces. The phenomenon
was observed by Burgoyne and Jackson [2006]. The authors find that protein-ligand interfaces
were easier to distinguish on protein surfaces A possible explanation is that ligand binding
residues are often buried and hence part of the core that provides stability to the protein. The
need for stability and the possible loss of function combine to an increased selective pressure on
these functional core residues. Hence, these residues are often strongly conserved and according
to Burgoyne and Jackson [2006] detect using pocket finding techniques. Pockets on protein
surfaces are often small enough to accommodate ligands, but protein-protein interactions have
often a more flat architecture (Nooren and Thornton [2003a])
5.8.2 Short interface motifs vs. full length models
To represent the full sequence space of a whole family with a weight matrix or a profile-HMM,
a large number of sequences is required, in particular for families of strong sequence variability.
However, considerably fewer sequences are needed for short, conserved motifs. Modelling only
the interface region leads to a significant parameter reduction in the Hidden Markov Model.
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5.8.3 Search for segmented interfaces using merged vs. individual mod-
els
An alternative approach to handle segments is to find a probabilistic model that allows to com-
bine the results from N individual Hidden markov Models representing N interface sequence
segments. For N models with scores s1 to sN , multiplying p-values together as in PRINTS/Fin-
gerPrintScan [Attwood and Beck, 1994, Scordis et al., 1999] yields the joint probability of model
1 scoring ≥ s1, model 2 scoring ≥ s2 . . . model N scoring ≥ sN , under an assumption that the N
models are statistically independent. This assumption is difficult to establish when the models
are interface segments of the same interface. The combined p-value does not, however, seem
likely to be the p-value of the total sum score S =
∑
si. The distribution of S should still be
an extreme value distribution, but it’s not immediately clear whether one could derive extreme
value distribution parameters for that distribution from knowing the extreme value distribution
parameters for the N individual models (Sean Eddy, personal communication). The merged
HMMs elegantly circumvent this problem by creating from a set of HMMs a single profile Hid-
den Markov Model that are embedded in probability theory.
5.9 Summary
A library of Hidden Markov Model based descriptors is provided that capture important struc-
tural features such as protein interfaces, ligand binding sites and active sites of enzymes. The im-
plications for predicting binding sites and binding partners of proteins are manifold. It provides
insights into the biological processes the matched protein might be involved in. Furthermore the
method can pinpoint interacting residues. It thus bears the potential for functional annotation
and for assisting in discovering new drug targets. Cross validation with the available structural
data for a number of interface types reveals that two thirds of the face descriptors have a recall
between 70% and 100%. Interaction prediction by recognizing both faces is intrinsically harder
than just one-sided binding site detection. The cross validation results reflect this fact, as the
recall for predicted interactions drops to 39%. To demonstrate the biological significance of
the descriptors, the descriptors are compared to NetPro, a protein-protein interaction database
with literature evidence. This way, the predicted interactions could be validated and moreover
insights about the critical interacting residues were provided. A benchmark for ATP-binding
site detection was created. From a database of SwissProt annotated sequences, the descriptors
successfully recognized 30% while producing much less false positives than PROSITE’s regular
expression for the P-loop motif. Finally, an example for a significant hit for a binding site in an
uncharacterized protein from Yersinia bercovieri is presented, which suggests a possible function
as Complex II (succinate dehydrogenase) subunit for this protein.
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Summary of results and future
work
This chapter highlights the solutions to the open problems listed in Chapter 1. It emphasizes
the scientific contributions to Bioinformatics.
6.1 Open problem 1 revisited
Open problem 1: classification
The goal is to generate a classification of domain-domain interactions from all available
multi-domain complexes with structural information. The domain-domain interactions
are not only to be distinguished by their constituting domains’ families but also by
their geometric associations, leading to interface types. For each interface type the
interacting residues shall be identified and visualized in structure and sequence. The
algorithm should trade-off between classification accuracy and computational expense.
Chapter 3 describes the creation of a unique database, SCOPPI, that allows the study of
all structural interface types between protein domains, a novel aspect in contrast to existing
protein-protein interaction databases (listed in Table 2.3). For the first time it is now possible to
see, how many and which geometric associations are known for each family-family interaction.
Open problem 1 was solved using a fast and precise algorithm: a two-stage hierarchical
clustering algorithm on the complete set of all extractable domain-domain interactions available
from multi-domain entries in structural databases. The algorithm is quadratic with respect
to family interactions, moreover each interaction comparison is time consuming. To keep the
task computationally manageable, a sequence based interface tag (IFT) clustering was devised.
As Figure 3.11 shows, the performance loss in terms of recall and precision is marginal, while
the computation time reduced from estimated 3000 CPU days to 32 CPU days. The accuracy
of the classification has been evaluated with respect to a manually created benchmark set:
the performance improves previous work [Kim and Ison, 2005]: In comparison with the IFT
clustering method [Kim and Ison, 2005], the face overlap method shows nearly 10% better recall
at the same precision or 5% on both terms, depending on the chosen clustering thresholds.
Various scenarios that provide new insights to biological problems prove the usefulness of
SCOPPI:
Alternative binding modes. Domain-domain interactions are not always employing similar
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interfaces. As discussed in Chapter 3, 40% of domain-domain interactions can have alter-
native geometric associations. Being aware of the interface diversity of domains can guide
macromolecular complex assembly.
Hub proteins. A selection of 14 diverse hub proteins were investigated. They were found to
have many faces regardless of their degree of disorder.
Conservation of interface residues. In order to investigate the conservation of interface
residues in comparison to the remaining surface, it is important to know of all bind-
ing sites. Here a database is generated that provides information for all known binding
sites of a protein family
Ancient interfaces are dominated by homodimers. A case study showed that family-family
interactions found in all three kingdoms of life were enriched in homodimers.
Versatility of binding sites. A single binding site can be able to bind to a single partner or
to various different partners. SCOPPI can be queried for this aspect.
Wide range of visualization possibilities. A web-frontend provides various visualizations
and filters, that help to explore general principles of family-family interactions.
A web-frontend to query the database of domain interfaces was implemented. It allows
various visualizations and filters of interactions.
6.2 Open problem 2 revisited
Open problem 2 - Convergently evolved motifs: The objective is to discover
binding sites that exist in non-homologous proteins that are able to bind to the same
or equivalent interfaces of homologous proteins. The idea is to identify all cases that
are discoverable from the complexes that are deposited in the PDB. Similarities, that
is, convergences between the interfaces of the non-homologous proteins can then be
studied on residue and atom level. For viral proteins that mimic interfaces in their
hosts, the crucial residues responsible for the mimicry shell be identified.
A solution to problem 2 is presented in Chapter 4. Therein, a novel method, termed ABAC,
is developed to identify non-homologous structural domains which bind at equivalent sites when
interacting with a common partner. This method is systematically applied to all pairs of
interactions with known structure and derive a comprehensive database for these interactions.
New statistical insights about the phenomenon of convergent evolution could be gained: of all
non-homologous domains, which bind with a common interaction partner, 4.2% use the same
interface of the common interaction partner (excluding immunoglobulins and proteases). This
rises to 16% if immunoglobulin and proteases are included.
Two applications of the ABAC-database are demonstrated: first, the systematic screening
for all viral protein interfaces, which can mimic native interfaces and thus interfere; and second,
structural motifs in enzymes and its inhibitors.
Several cases of virus protein mimicry are highlighted: viral M3 protein interferes with a
chemokine dimer interface. The virus has evolved the motif SVSPLP, which mimics the native
SSDTTP motif. A second example is the regulatory factor Nef in HIV which can mimic a kinase
when interacting with the SH3 domain. Among others the virus has evolved the kinase’s PxxP
motif. Further, motif resemblances in Baculovirus p35 and HIV capsid proteins are elucidated.
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Finally, chymotrypsin is subject to scrutiny with respect to its structural similarity to subtilisin
and with respect to its inhibitor’s similar recognition sites.
An algorithm that detects residue correspondences and a score for interface similarity has
been implemented. The detailed lists of residues and atoms in equivalent positions are presented
for the above-mentioned examples.
6.3 Open problem 3 revisited
Open problem 3 - Protein interaction prediction
Given an interface type classification that is derived from domain-domain interactions
(problem 1), sequence motifs are to be constructed from conserved interface regions
in order to predict interactions. A representation is to be found that accounts for
the dispersion of interfaces. Further, the representation shall allow for a well-founded
probability score of the matches of the sequences motifs in sequence databases in order
to judge the statistical significance of a hit. The motif descriptors should undergo
validation.
Chapter 5 describes a novel solution to the open problem 3. Protein interactions could
be predicted using a method that combines for the first time several advantages: all known
instances of an interface type are encoded in a single descriptor, thereby handling dispersed
sequence stretches and being able to search for interfaces on sequence level.
The presented solution demonstrates how the classification of interfaces from Chapter 3 can
be used to create motif descriptors. A representation that accounts for the dispersed nature of
interfaces on sequence level is found: namely merged profile Hidden Markov Models, As valid
HMMs, they are well-founded in probability theory and can be used to score the significance
of matches. The developed descriptors were validated using cross validation for each interface
type. Descriptors for 740 classified types of protein-protein binding sites and for more than
3,000 protein-ligand binding sites are generated. Cross validation reveals that two thirds of
the PPI descriptors are sufficiently conserved and significant enough to be used for binding
site recognition. Table 6.1 shows the main novelty of the approach in comparison to examined
existing protein-protein interaction prediction methods: none of the other methods makes use
of training data that was classified into structural interface types.
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between residues)
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Table 6.1: Comparison of protein interaction prediction methods. Abbreviations
used in the table: CV - Cross validation; SVM - Support Vector machines; PSSM -
Position specific scoring matrix; ASA - accessible surface area; AA - amino acids;
RegExp - Regular expressions; VdW - van der Waals.
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Table 6.2 compares the interface descriptors to other motif search approaches. Apart from
the unique source (SCOPPI), the presented work is also distinct in the combination of auto-
mated descriptor creation derived from structures, suited for sequence search and capable of
representing dispersed motifs. PRINTS and Meta-MEME are similar tools but do not draw from
the available three-dimensional structures. The most comparable work is by Espadaler et al.
[2005]. There, also HMMs have been used to represent interface regions. The authors do not
group structural interactions according to interface type. Instead, motifs of interface patches
are derived from every hetero-dimer, using one structural template and artificial, randomized
sequences.
The descriptors were used to validate 230 protein-protein interactions that were extracted
from the literature. The added value to these interactions is the identification of the interface
residues.
Finally, a novel P-loop variant has been identified, that is used to annotate ATP-binding sites
in 60 protein sequences. These sequences were not annotated with respect to the ATP-binding
site before by PROSITE or CDD. They carry variants of ATP-binding motifs, that are highly
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6.4 Future Work
A number of promising continuations starting from this work have been spun off. They are
discussed in more detail below.
6.4.1 Investigation of conservation of interfaces vs. remaining surface
The interface classification alleviates the investigation, whether protein interfaces are more con-
served than the rest of the surface. Using SCOPPI, it is possible for a family to identify all
known binding sites. This precondition for the comparison was violated in previous studies
[Caffrey et al., 2004]. Therein, highly conserved surface patches were considered non-interacting
despite other structures showed that the patch indeed was interacting. Despite the fact that
some binding sites still might be unknown, it is expected that accounting for all known binding
sites will lead to a more precise result. In concert with conservation of interfaces, it is possible
to analyze the co-evolution of interfaces. It is expected that an interface that occurs in many
species, was maintained either because it remained unchanged (conserved) or it changed and
the opposite face compensated for the changes (co-evolution). The intriguing question of how
much an interface co-evolved vs. how much it was conserved can be addressed with SCOPPI.
6.4.2 Macromolecular complex assembly using alternative geometric
associations
Macromolecular complex assembly algorithms benefit from the available information of possible
geometric associations of subunits. Aloy et al. [2004] tackle the problem of complex analysis in a
high-throughput manner for all yeast complexes. The authors do not consider alternative binding
modes. Yet, as the investigation in Chapter 3 shows, 40% of all family-family interactions occur
in more than one way. Additionally, data from a variety of proteomics experiments, including
affinity purification, ultracentrifugation, and immuno-electron microscopy, as used recently by
[Alber et al., 2007a,b], pose constraints to the quaternary structure. Figure 6.1 shows the three
domains of an exonuclease, fitted in a low resolution density map. The binary interactions can
be derived from SCOPPI and assembled by structural alignment.
6.4.3 Data enrichment from mutagenesis experiments
A major limitation of the descriptors is the sparse data available for some interface types. Hidden
Markov Models for the interface segments had to be generated either from few sequences or
from homologous sequences where it was unclear whether the modeled interaction indeed took
place. Text-mined results from interaction disrupting mutagenesis experiments can improve the
quality of interface descriptors: providing additional sequences for interaction types yields a
gain of information of the sequence diversity. Positive examples can be included in the multiple
sequence alignment that is used to construct the descriptor. Moreover, negative examples for an
interaction can be used to re-weight the emission probabilities at match states to better reflect
the observed mutagenesis data.
6.4.4 Identification of interacting residues in Pfam
Finally, interface descriptors can be used to annotate binding sites in Pfam domains. Pfam
domains are represented as profile Hidden Markov Models. Using profile-profile comparison
techniques such as HHsearch [Söding, 2005], it is possible to align Pfam regions to interface
164
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Figure 6.1: Macromolecular complex assembly: exonuclease subunits fitted into an electron-
density map.
descriptors, as shown in 5.18. The identified interacting regions and the binding partners provide
a valuable annotation to the Pfam families.
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Glossary
ABAC An instance that comprises two comparable in-
teractions with domains A−B and A′−C where
A and A′ are homolog, and B and C are non-
homolog, 87
BIND Biomolecular Interaction Network Database,
one of the first protein-protein interaction
databases, ceased, 13
BioGRID A protein-protein interaction database, 12
c.37.1.8 a SCOP identification number, composed of a
letter for the SCOP class and three numbers
separated by dots, 14
CV Cross validation: a concept to estimate the ac-
curacy of a classifier by testing a fraction of the
data, for which the correct class label is known
and that was not used in the training of the
classifier., 33
DIP Database of Interacting Proteins, with data
from experiments, structures and literature, 13
ELISA Enzyme-Linked ImmunoSorbent Assay, a tech-
nique that detects protein-antibody interactions
by affixing a protein to a surface, washing a spe-
cific antibody over the surface. This antibody
is linked to an enzyme which can produce a de-
tectable signal., 10
face a set of interface residues on a single domain
contacting with another domain, 55
GO Gene Ontology, an ontology for gene products,
comprising the molecular function, the role in




heterodimer A complex of two unequal units. In the context
of SCOPPI, the units are domains, that do not
belong to the same SCOP family, 57
HMM Hidden Markov Model, statistical framework
with states and transitions, 25
homodimer A complex of two equal units. In the context of
SCOPPI, the units are domains, that belong to
the same SCOP family, 57
Homology Two proteins are homolog, when they have a
common ancestor, 2
Homology based annotation transfer A protein’s function can often be infered from
the information that homolog proteins have
been annotated with, 7
Homology modeling a technique to predict the three-dimensional
structure of a protein with the use of a homolog
template structure, 2
HPRD Human Protein Reference Database, interac-
tions and other data for 2750 human proteins.,
12
IFT interface tag, a string of 0’s and 1’s associated
to a protein sequence. A 0 indicates a non-
interacting residue, whereas a 1 indicates an in-
teracting residue., 58
IntAct Binary protein-protein interaction database ex-
tracted from publications, 12
inter interaction class: two domains that are placed
on the different protein chains interact with each
other, 57
interface consists of two interacting faces, 55
intra interaction class: two domains that are placed
on the same protein chain interact with each
other, 57
MEME Motif search algorithm, based on expectation
maximization, 42
Metabolic pathway A concerted series of subsequent chemical re-
actions occurring in a cell involving catalyzing
enzymes, 7
MINT Molecular INTeraction database for experimen-
tally verified protein-protein interactions, in-
cluding enzymatic modifications, kinetics and
binding constants, 13
MIPS daabase A database at Munich Information Center
for Protein Sequences, based on whole-genome
analysis, 12
MPI Message passing interface, a communication
protocol for parallel computation, 64
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Glossary
NetPro A manually generated molecular interaction
database, 13
NMR spectroscopy Nuclear Magnetic Resonance, a technique to de-
rive spatial information of atoms in molecules
by exploiting the magnetic properties of certain
nuclei., 10
PDB Protein Databank, a depository of three-
dimensional structures, 2
PDB id 1kim identifiers consisting of a digit followed by three
alphanumeric symbols refer to a complex stored
in the Protein Databank., 2
PLI protein-ligand interaction, 121
PPI protein-protein interaction, 121
profile Hidden Markov Model HMM that represents a sequence profile using
match states that have amino acid emission
probabilities that relate to the amino acid fre-
quencies in the corresponding column of the se-
quence alignment (profile)., 25
PROSITE Hand-collected motif database, where potifs are
represented as regular expressions or frequency
matrices, 42
PSIMAP Protein Structural Interactome map, a protein-
protein interaction database derived from three-
dimensional structures, 14
PSSM Position Specific Scoring Matrices: a statistical
representation of a multiple sequence alignment,
where a matrix provides for each position in a
sequence the probabilities for all amino acids to
occur at that position, 24
Python A versatile open source, object oriented pro-
gramming language developed by Guido van
Rossum www.python.org., 58
SCOP Structural classification of proteins, a hierarchi-
cal database of structural protein domains, 14
SCOPPI Structural classification of Protein-Protein In-
teractions, 15
STRING Search Tool for the Retrieval of Interacting
Genes/Proteins, a database of known and pre-
dicted protein-protein interactions from ge-
nomic context, high-throughput experiments,
co-expression, literature and other databases, 13
SVM Support Vector Machine: a binary classifier
which uses a kernel function to project data into
a higher-dimensional space, where it is separa-
ble by a hyperplane., 33
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Glossary
TAP Tandem affinity purification, a tagged fusion
protein is used to pull out protein complexes,
thus complex membership of proteins can be de-
termined., 10
X-ray crystallograpgy A technique to derive spatial information of
atoms within a crystal in which a beam of X-
rays is scattered from the electrons within the
crystal. The resulting diffraction pattern pro-
vides clues about the electron density, from
which three-dimensional structures can be de-
duced., 10
Y2H Yeast two hybrid, a reporter gene is transcribed,
if its transcription factor can be assembled





A.1 MPItimeoutDistributor - A generic class for Paral-
lelization using the Message Passing Interface (MPI)
and the Python Programming language
In order to distribute subtasks on a number of nodes, a producer-consumer protocoll is imple-
mented. The Message Passing Interface [Skjellum et al., 1994] serves as the base for low level
communication. The MPI module from Scientific Python [Jones et al., 2001–] serves as the
Python interface to MPI. The subtasks are not assumed to be of equal volume. The producer,
residing on the initial node, creates a task list (method taskList). Subtasks are distributed
on demand. A subtask is formulated by a set of parameters. Since parameter objects can
be serialized as strings, (procedure stringify) parameters can be any object. The meth-
ods taskList and perform task are supposed to be overwritten by classes that subclass the
MPItimeoutDistributor. Subclasses have been created for a varity of distribution jobs:
• For the calculation of ABAC and its visualization
• SCOPPI hierarchical clustering of interface types
• Creation of PDB files for individual SCOP domain
• Generation of Interface type descriptors
• Scans of PROSITE patterns against the ADP/ATP benchmark database
See the accompanying CD containing these programs.
1 ## Authors: Christof Winter & Andreas Henschel
2 ## mpirun C mpipython distributeJobs.py #to run on all CPU’s
3 ## rank then gives the process id 0, 1, 2 ...
4 ##
5
6 from Scientific import MPI ##!MPI
7 import sys, os, pickle
8 import time, random
9
10 class MPItimeoutDistributor:
11 def __init__(self, timeout=600, verbose=False, reschedule=True, standalone=False):
12 self.timeout = timeout
13 self.reschedule = reschedule




16 if self.communicator.rank == 0: ##!MPI (but also do when standalone!)
17 print "Timeout set to", self.timeout
18 self.resultList = []
19 self.init()
20 self.jobs = []
21 self.ip = self.machine_name()
22 if verbose:
23 print "working on", self.ip
24 def init(self): pass ## to be overwritten, only executed by root
25 def machine_name(self):
26 return os.popen("/sbin/ifconfig eth0 | grep inet | cut -c21-38").read().split()[0]
27





33 def handleResult(self, result):
34 ## only done by producer!





40 print "running on", self.ip, os.popen("echo $PYTHONPATH").readlines()
41 if self.communicator.rank == 0:
42 ## Producer
43 jobTimes = [(0, 0)] * (self.communicator.size)
44 taskList = [""]*(self.communicator.size - 1) + self.taskList()[::-1]
45
46 while taskList:
47 request, requestingProcess, tag = self.communicator.receiveString()
48 self.handleResult(request)
49 now = time.time()
50 for (jobid, (startTime, job)) in enumerate(jobTimes):
51 if startTime > 0 and now - startTime > self.timeout :
52 print "Warning: TimeOut occured on %s, rescheduling task %s"%(jobid, job)
53 jobTimes[jobid] = (now, job) ## leave the job (maybe kill it?)
54 if self.reschedule: taskList.append(job)
55 task = taskList.pop()
56 if task: jobTimes[requestingProcess] = (time.time(), task)
57 else: jobTimes[requestingProcess] = (-1, task)
58 self.communicator.send(self.stringify(task), requestingProcess, 0)
59 ## Consumer
60 else:
61 unpickledTask = "expecting..."
62 result = None
63 while unpickledTask:
64 result = self.stringify(result)
65 self.communicator.send(result, 0, 42)
66 task, process, tag = self.communicator.receiveString()
67 unpickledTask = self.stringify(task, decode=True)
68 if unpickledTask:
69 result = self.perform_task(unpickledTask)




74 for task in self.taskList():
75 self.perform_task(task)
76





82 def perform_task(self, task):
83 print "Process %s at %15s: attempts task %s " % (self.communicator.rank, self.ip, task)
84 ## simulating workload
85 for i in range(self.communicator.rank*1000*random.randint(2,3)):
86 for j in range(50):




A.2. BENCHMARK SET FOR THE INTERFACE CLASSIFICATION
90 def finish(self):
91 print "Process %s finished, completed %s (%s jobs)" % \









101 mpirun C mpipython <file.py>
102
103 where C is the number of available cpus.
104 file.py is executed C times in parallel!
105 Make use of the rank to execute som initial stuff only once (ie. database creation etc.)
106 See __init__ for an example
107
108 1. Produce a task list, ie. a list with any kind of objects, they serve as parameters for single
109 task procedure calls -> def taskList
110
111 2. perform_task handles a single list element from the task list. Each job might run on a different
112 cluster node.
113
114 3. (OPTIONAL) finish. if some results should be collected from the subprocesses or som general
115 job statistic should be produced, use finish to overwrite.
116
117 """





A.2 Benchmark set for the interface classification
Domain A Domain B Family A Family B Face A Face B PQS File
25005D 42259A b.40.2.1 d.166.1.1 1 1 1xtc.mmol
25006E 42259A b.40.2.1 d.166.1.1 1 2 1xtc.mmol
25007F 42259A b.40.2.1 d.166.1.1 1 3 1xtc.mmol
25008G 42259A b.40.2.1 d.166.1.1 1 4 1xtc.mmol
25009H 42259A b.40.2.1 d.166.1.1 1 5 1xtc.mmol
24910D 42230A b.40.2.1 d.166.1.1 1 4 1lt3.mmol
24911E 42230A b.40.2.1 d.166.1.1 1 3 1lt3.mmol
24912F 42230A b.40.2.1 d.166.1.1 1 2 1lt3.mmol
24913G 42230A b.40.2.1 d.166.1.1 1 1 1lt3.mmol
24914H 42230A b.40.2.1 d.166.1.1 1 5 1lt3.mmol
24905D 42231A b.40.2.1 d.166.1.1 1 4 1lt4.mmol
24906E 42231A b.40.2.1 d.166.1.1 1 3 1lt4.mmol
24907F 42231A b.40.2.1 d.166.1.1 1 2 1lt4.mmol
24908G 42231A b.40.2.1 d.166.1.1 1 1 1lt4.mmol
24909H 42231A b.40.2.1 d.166.1.1 1 5 1lt4.mmol
24965D 42238A b.40.2.1 d.166.1.1 1 5 1tii.mmol
24966E 42238A b.40.2.1 d.166.1.1 1 3 1tii.mmol
25116B1 42253A1 b.40.2.1 d.166.1.1 1 10 1prt 1.mmol
25117C1 42253A1 b.40.2.1 d.166.1.1 1 6 1prt 1.mmol
25129E1 42253A1 b.40.2.1 d.166.1.1 2 8 1prt 1.mmol
25121C1 42255A1 b.40.2.1 d.166.1.1 1 6 1bcp 1.mmol
16833A 22003B a.26.1.1 b.1.2.1 2 1 1a22.mmol
16833A 22004B a.26.1.1 b.1.2.1 3 2 1a22.mmol
87994B 87995C a.26.1.1 b.1.2.1 2 1 1p9m.mmol
87994B 87996C a.26.1.1 b.1.2.1 3 2 1p9m.mmol
16817A 22045B a.26.1.1 b.1.2.1 1 1 1pgr.mmol
16818C 22047D a.26.1.1 b.1.2.1 1 1 1pgr.mmol
16832A 21998C a.26.1.1 b.1.2.1 8 4 1axi.mmol
16835A 22007C a.26.1.1 b.1.2.1 1 1 3hhr.mmol
16838A 22032B a.26.1.1 b.1.2.1 3 2 1bp3.mmol
77351A1 77352B1 a.26.1.1 b.1.2.1 2 1 1kf9 1.mmol
77351A1 77353B1 a.26.1.1 b.1.2.1 3 2 1kf9 1.mmol
77351A1 77354C1 a.26.1.1 b.1.2.1 1 1 1kf9 1.mmol
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Domain A Domain B Family A Family B Face A Face B PQS File
77356D2 77359F2 a.26.1.1 b.1.2.1 1 1 1kf9 2.mmol
16839A 22033B a.26.1.1 b.1.2.1 2 1 1f6f.mmol
16839A 22034B a.26.1.1 b.1.2.1 3 2 1f6f.mmol
16839A 22035C a.26.1.1 b.1.2.1 1 1 1f6f.mmol
16839A 22035D a.26.1.1 b.1.2.1 4 7 1f6f.mmol
16836A 22010C a.26.1.1 b.1.2.1 8 4 1hwh.mmol
87994D 87991A a.26.1.1 b.1.2.1 5 6 1p9m.mmol
87994B 87992A a.26.1.1 b.1.2.1 1 1 1p9m.mmol
59642B 59640A a.26.1.1 b.1.2.1 6 1 1f45.mmol
59642B 59641A a.26.1.1 b.1.2.1 7 2 1f45.mmol
61548C 61545A a.26.1.1 b.1.2.1 5 6 1i1r.mmol
61548B 61546A a.26.1.1 b.1.2.1 1 1 1i1r.mmol
61548B 61547A a.26.1.1 b.1.2.1 9 5 1i1r.mmol
76901B 76900A a.2.11.1 d.44.1.1 1 2 1ix9.mmol
74265B 74264A a.2.11.1 d.44.1.1 2 5 1luv.mmol
74611B1 74610A1 a.2.11.1 d.44.1.1 1 2 1ma1 1.mmol
74617E2 74614C2 a.2.11.1 d.44.1.1 5 4 1ma1 2.mmol
65363C1 65360A1 a.2.11.1 d.44.1.1 5 4 1gn2 1.mmol
85234B 85233A a.2.11.1 d.44.1.1 1 2 1my6.mmol
59467B2 59466A2 a.2.11.1 d.44.1.1 1 2 1en5 2.mmol
15756A 38715A a.2.11.1 d.44.1.1 4 3 1var.mmol
15765D2 38690D2 a.2.11.1 d.44.1.1 4 3 1d5n 2.mmol
74267A 74268C a.2.11.1 d.44.1.1 1 2 1luw.mmol
15738A 38735C a.2.11.1 d.44.1.1 5 4 1sss.mmol
15738A 38736B a.2.11.1 d.44.1.1 1 2 1sss.mmol
15740A1 38737A1 a.2.11.1 d.44.1.1 4 3 1b06 1.mmol
15776A 38701C a.2.11.1 d.44.1.1 5 6 1mng.mmol
15792A 38757C a.2.11.1 d.44.1.1 3 1 1qnn.mmol
15794C 38755A a.2.11.1 d.44.1.1 3 1 1qnn.mmol
70587B 70588B a.2.11.1 d.44.1.1 4 3 1gv3.mmol
15729A 38722A a.2.11.1 d.44.1.1 4 3 3sdp.mmol
15729A 38723B a.2.11.1 d.44.1.1 1 2 3sdp.mmol
15730B 38722A a.2.11.1 d.44.1.1 1 2 3sdp.mmol
59477C1 59478C1 a.2.11.1 d.44.1.1 4 3 1en6 1.mmol
68664X 68665X a.2.11.1 d.44.1.1 4 3 1kkc.mmol
15737A 38734C a.2.11.1 d.44.1.1 1 2 1coj.mmol
15737A 38734D a.2.11.1 d.44.1.1 5 4 1coj.mmol
15770A1 38696B1 a.2.11.1 d.44.1.1 1 2 1i08 1.mmol
16907A1 22055B1 a.26.1.3 b.1.2.1 1 2 1fyh 1.mmol
16907A1 22056B1 a.26.1.3 b.1.2.1 2 1 1fyh 1.mmol
16908A1 22055B1 a.26.1.3 b.1.2.1 3 2 1fyh 1.mmol
16908A1 22056B1 a.26.1.3 b.1.2.1 4 1 1fyh 1.mmol
16909D2 22058E2 a.26.1.3 b.1.2.1 2 1 1fyh 2.mmol
16910D2 22058E2 a.26.1.3 b.1.2.1 4 1 1fyh 2.mmol
74192A 74194C a.26.1.3 b.1.2.1 1 2 1lqs.mmol
74192A 74195C a.26.1.3 b.1.2.1 2 1 1lqs.mmol
74192A 74196D a.26.1.3 b.1.2.1 5 2 1lqs.mmol
74192A 74197D a.26.1.3 b.1.2.1 6 1 1lqs.mmol
62704A 62705B a.26.1.3 b.1.2.1 1 2 1j7v.mmol
62704A 62705R a.26.1.3 b.1.2.1 7 2 1j7v.mmol
62704A 62706B a.26.1.3 b.1.2.1 2 1 1j7v.mmol
62704A 62706R a.26.1.3 b.1.2.1 4 1 1j7v.mmol
16915A 22061C a.26.1.3 b.1.2.1 2 1 1fg9.mmol
16915A 22063D a.26.1.3 b.1.2.1 4 1 1fg9.mmol
16916B 22061C a.26.1.3 b.1.2.1 4 1 1fg9.mmol
16916B 22063D a.26.1.3 b.1.2.1 2 1 1fg9.mmol
87770D 87767B a.60.9.1 d.163.1.1 1 1 1p4e.mmol
64792A 64793A a.60.9.1 d.163.1.1 4 4 1drg.mmol
18108C 42168C a.60.9.1 d.163.1.1 5 5 1flo.mmol
64982A 64983A a.60.9.1 d.163.1.1 4 4 1f44.mmol
18103A 42164F a.60.9.1 d.163.1.1 2 2 5crx.mmol
18096B 42155A a.60.9.1 d.163.1.1 2 2 4crx.mmol
18101A 42162H a.60.9.1 d.163.1.1 2 2 3crx.mmol
84923B 84924B a.60.9.1 d.163.1.1 4 4 1ma7.mmol
84921A 84924F a.60.9.1 d.163.1.1 2 2 1ma7.mmol
78708A 78715D a.60.9.1 d.163.1.1 1 1 1m6x.mmol
87770D 87771D a.60.9.1 d.163.1.1 5 5 1p4e.mmol
87768C 87769C a.60.9.1 d.163.1.1 5 5 1p4e.mmol
87764A 87765A a.60.9.1 d.163.1.1 5 5 1p4e.mmol
18105 42165 a.60.9.1 d.163.1.1 3 3 1a0p.water
84923B 84922A a.60.9.1 d.163.1.1 2 2 1ma7.mmol
72286B 72287B a.60.9.1 d.163.1.1 4 4 1kbu.mmol
18311A 33165F a.69.1.1 c.49.2.1 1 1 1mab.mmol
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18312B 33165D a.69.1.1 c.49.2.1 1 2 1mab.mmol
18312B 33165F a.69.1.1 c.49.2.1 1 3 1mab.mmol
18312B 33165G a.69.1.1 c.49.2.1 1 4 1mab.mmol
18293A 33162G a.69.1.1 c.49.2.1 1 1 1e1q.mmol
18296D 33162G a.69.1.1 c.49.2.1 1 3 1e1q.mmol
18297E 33162G a.69.1.1 c.49.2.1 1 2 1e1q.mmol
18298F 33162G a.69.1.1 c.49.2.1 1 4 1e1q.mmol
18275A 33159G a.69.1.1 c.49.2.1 1 1 1e1r.mmol
18279E 33159G a.69.1.1 c.49.2.1 1 2 1e1r.mmol
18270B 33158G a.69.1.1 c.49.2.1 1 5 1e79.mmol
18272D 33158G a.69.1.1 c.49.2.1 1 3 1e79.mmol
18273E 33158G a.69.1.1 c.49.2.1 1 2 1e79.mmol
18282B 33160G a.69.1.1 c.49.2.1 1 5 1bmf.mmol
18299A 33163G a.69.1.1 c.49.2.1 1 1 1efr.mmol
18291E 33161G a.69.1.1 c.49.2.1 1 2 1nbm.mmol
18292F 33161G a.69.1.1 c.49.2.1 1 4 1nbm.mmol
60738A 60756G a.69.1.1 c.49.2.1 1 1 1h8e.mmol
60747D 60756G a.69.1.1 c.49.2.1 1 3 1h8e.mmol
60750E 60756G a.69.1.1 c.49.2.1 1 2 1h8e.mmol
62659F 62650A a.80.1.1 c.37.1.20 1 1 1iqp.mmol
62659F 62652B a.80.1.1 c.37.1.20 4 1 1iqp.mmol
63251D 63250C a.80.1.1 c.37.1.20 2 2 1jr3.mmol
62649A 62650A a.80.1.1 c.37.1.20 5 3 1iqp.mmol
62649A 62652B a.80.1.1 c.37.1.20 2 2 1iqp.mmol
62653C 62654C a.80.1.1 c.37.1.20 5 3 1iqp.mmol
62653C 62656D a.80.1.1 c.37.1.20 1 1 1iqp.mmol
62655D 62658E a.80.1.1 c.37.1.20 2 2 1iqp.mmol
18450A 32423A a.80.1.1 c.37.1.20 6 3 1a5t.mmol
67097C 67098C a.80.1.1 c.37.1.20 5 3 1jqj.mmol
67097C 67100D a.80.1.1 c.37.1.20 3 4 1jqj.mmol
67099D 67100D a.80.1.1 c.37.1.20 3 3 1jqj.mmol
63245A 63246A a.80.1.1 c.37.1.20 5 3 1jr3.mmol
63245A 63248B a.80.1.1 c.37.1.20 2 3 1jr3.mmol
63247B 63248B a.80.1.1 c.37.1.20 5 3 1jr3.mmol
63247B 63254E a.80.1.1 c.37.1.20 2 2 1jr3.mmol
63249C 63250C a.80.1.1 c.37.1.20 5 3 1jr3.mmol
63253E 63254E a.80.1.1 c.37.1.20 6 3 1jr3.mmol
22427B 23204A b.2.3.2 b.7.2.1 1 1 1pdk.mmol
22415B1 23208A1 b.2.3.2 b.7.2.1 2 2 1qun 1.mmol
22416B1 23208A1 b.2.3.2 b.7.2.1 1 1 1qun 1.mmol
22424D1 23212C1 b.2.3.2 b.7.2.1 1 1 1qun 1.mmol
22411B4 23207C4 b.2.3.2 b.7.2.1 3 3 1qun 4.mmol
22422L4 23208E4 b.2.3.2 b.7.2.1 3 4 1qun 4.mmol
87810B 87809A b.2.3.2 b.7.2.1 1 1 1p5u.mmol
87811C 87809A b.2.3.2 b.7.2.1 2 2 1p5u.mmol
79746B1 79745A1 b.2.3.2 b.7.2.1 1 1 1n0l 1.mmol
79749D2 79748C2 b.2.3.2 b.7.2.1 1 1 1n0l 2.mmol
72541J5 72540I5 b.2.3.2 b.7.2.1 2 2 1kiu 5.mmol
23885A 44918R b.22.1.1 g.24.1.1 1 1 1d0g.mmol
23885A 44919R b.22.1.1 g.24.1.1 2 3 1d0g.mmol
23885A 44921S b.22.1.1 g.24.1.1 3 2 1d0g.mmol
23885A 44922S b.22.1.1 g.24.1.1 4 2 1d0g.mmol
23885A 44923S b.22.1.1 g.24.1.1 5 6 1d0g.mmol
23887D 44924T b.22.1.1 g.24.1.1 1 1 1d0g.mmol
23884B 44915A b.22.1.1 g.24.1.1 1 1 1d4v.mmol
23884B 44916A b.22.1.1 g.24.1.1 2 5 1d4v.mmol
23884B 44917D b.22.1.1 g.24.1.1 5 6 1d4v.mmol
23867A 44912R b.22.1.1 g.24.1.1 1 1 1tnr.mmol
23867A 44913E b.22.1.1 g.24.1.1 4 4 1tnr.mmol
23867A 44913R b.22.1.1 g.24.1.1 2 6 1tnr.mmol
23888D1 44927A1 b.22.1.1 g.24.1.1 1 1 1du3 1.mmol
23888D1 44928A1 b.22.1.1 g.24.1.1 2 5 1du3 1.mmol
23888D1 44932B1 b.22.1.1 g.24.1.1 5 6 1du3 1.mmol
87232A 87233A b.34.2.1 d.93.1.1 4 1 1opk.mmol
24481 40525 b.34.2.1 d.93.1.1 1 5 2abl.water
24505A1 40491A1 b.34.2.1 d.93.1.1 4 1 1ad5 1.mmol
60341A1 60342A1 b.34.2.1 d.93.1.1 4 1 1g83 1.mmol
24498 40490 b.34.2.1 d.93.1.1 4 1 1qcf.water
24512 40437 b.34.2.1 d.93.1.1 4 1 2src.water
24531A 40473A b.34.2.1 d.93.1.1 4 7 1gri.mmol
24532A 40474B b.34.2.1 d.93.1.1 5 5 1gri.mmol
24552A 40421A b.34.2.1 d.93.1.1 4 2 1lck.mmol
24552A 40421G b.34.2.1 d.93.1.1 2 3 1lck.mmol
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24552A 40421I b.34.2.1 d.93.1.1 3 4 1lck.mmol
84749C 84748A b.34.2.1 d.93.1.1 3 2 1m27.mmol
24635A1 33640A1 b.34.7.1 c.55.3.2 1 1 1c0m 1.mmol
24639A 33644A b.34.7.1 c.55.3.2 1 1 1c1a.mmol
24640B 33644A b.34.7.1 c.55.3.2 6 2 1c1a.mmol
24641X 33672A b.34.7.1 c.55.3.2 3 1 1c6v.mmol
24641X 33674C b.34.7.1 c.55.3.2 6 2 1c6v.mmol
24627A 33670A b.34.7.1 c.55.3.2 5 4 1ex4.mmol
24627A 33670C b.34.7.1 c.55.3.2 2 3 1ex4.mmol
24628B 33671E b.34.7.1 c.55.3.2 2 3 1ex4.mmol
25185C 37774C b.40.2.2 d.15.6.1 1 1 1d5m.mmol
78120D 78121D b.40.2.2 d.15.6.1 1 1 1lo5.mmol
25202A 37791A b.40.2.2 d.15.6.1 1 1 1an8.mmol
25174A1 37763A1 b.40.2.2 d.15.6.1 1 1 1ts2 1.mmol
74459A1 74460A1 b.40.2.2 d.15.6.1 1 1 1m4v 1.mmol
25182A2 37771B2 b.40.2.2 d.15.6.1 2 2 1ts4 2.mmol
25216A 37806B b.40.2.2 d.15.6.1 3 3 1b1z.mmol
25216A 37808D b.40.2.2 d.15.6.1 4 4 1b1z.mmol
25217B 37805A b.40.2.2 d.15.6.1 3 3 1b1z.mmol
25218C 37808D b.40.2.2 d.15.6.1 3 3 1b1z.mmol
25219D 37807C b.40.2.2 d.15.6.1 3 3 1b1z.mmol
25198A 37787A b.40.2.2 d.15.6.1 1 1 1enf.mmol
25198A 37787C b.40.2.2 d.15.6.1 5 5 1enf.mmol
70931C 70934D b.40.2.2 d.15.6.1 3 3 1ha5.mmol
25204 37793 b.40.2.2 d.15.6.1 1 1 1et9.water
70067A 70068B b.40.2.2 d.15.6.1 6 6 1ck1.mmol
25199A 37788C b.40.2.2 d.15.6.1 5 5 1ewc.mmol
25213B 37801A b.40.2.2 d.15.6.1 3 3 1fnu.mmol
25213B 37803C b.40.2.2 d.15.6.1 4 4 1fnu.mmol
25222C 37812D b.40.2.2 d.15.6.1 3 3 1fnv.mmol
25224A 37814N b.40.2.2 d.15.6.1 7 7 1fnw.mmol
70929B 70928A b.40.2.2 d.15.6.1 3 3 1ha5.mmol
25686A1 32119A1 b.43.3.1 c.37.1.8 1 1 1d8t 1.mmol
25707 32142 b.43.3.1 c.37.1.8 2 2 1dar.water
25706A 32141A b.43.3.1 c.37.1.8 1 1 1g7c.mmol
25716 32149 b.43.3.1 c.37.1.8 2 2 1g7r.water
25712 32147 b.43.3.1 c.37.1.8 2 2 1g7s.water
25697A1 32132A1 b.43.3.1 c.37.1.8 1 1 1aip 1.mmol
25690A1 32125A1 b.43.3.1 c.37.1.8 2 2 1ttt 1.mmol
25689B 32124P b.43.3.1 c.37.1.8 3 3 1b23.mmol
66982A1 66984A1 b.43.3.1 c.37.1.8 1 1 1jny 1.mmol
66985B2 66987B2 b.43.3.1 c.37.1.8 1 1 1jny 2.mmol
79757A 79758A b.43.3.1 c.37.1.8 2 2 1n0u.mmol
72628A 72630A b.43.3.1 c.37.1.8 2 2 1kjz.mmol
72631A 72633A b.43.3.1 c.37.1.8 2 2 1kk0.mmol
26372A 37729C b.47.1.2 d.15.5.1 1 4 1bml.mmol
26372A 37730C b.47.1.2 d.15.5.1 2 5 1bml.mmol
26372A 37731C b.47.1.2 d.15.5.1 3 3 1bml.mmol
26372A 37734D b.47.1.2 d.15.5.1 7 2 1bml.mmol
26370A 37719C b.47.1.2 d.15.5.1 1 4 1bui.mmol
26371B 37719C b.47.1.2 d.15.5.1 4 3 1bui.mmol
77683A 77684B b.47.1.2 d.15.5.1 5 5 1l4d.mmol
77683A 77684D b.47.1.2 d.15.5.1 6 4 1l4d.mmol
77703A 77704B b.47.1.2 d.15.5.1 5 5 1l4z.mmol
77703A 77704D b.47.1.2 d.15.5.1 7 1 1l4z.mmol
26344C 44237L b.47.1.2 g.3.11.1 1 1 1xka.mmol
26354A 44205B b.47.1.2 g.3.11.1 1 1 1rfn.mmol
26354A 44205C b.47.1.2 g.3.11.1 2 2 1rfn.mmol
62856H 62857L b.47.1.2 g.3.11.1 1 1 1jbu.mmol
26348C 44245L b.47.1.2 g.3.11.1 1 1 1aut.mmol
26296H 44218M b.47.1.2 g.3.11.1 3 4 1dva.mmol
26296H 44219M b.47.1.2 g.3.11.1 7 4 1dva.mmol
26155A1 44304I1 b.47.1.2 g.3.11.1 5 3 1dx5 1.mmol
26295B 44215L b.47.1.2 g.3.11.1 6 2 1qfk.mmol
26338B 44228F b.47.1.2 g.3.11.1 7 5 1c5m.mmol
77178B 77176A b.86.1.2 d.95.2.2 2 4 1jva.mmol
28377B 40580B b.86.1.2 d.95.2.2 5 6 1ef0.mmol
28377B 40579B b.86.1.2 d.95.2.2 4 2 1ef0.mmol
28377B 40577A b.86.1.2 d.95.2.2 2 4 1ef0.mmol
77178B 77180B b.86.1.2 d.95.2.2 5 6 1jva.mmol
77175A 77179B b.86.1.2 d.95.2.2 2 4 1jva.mmol
77175A 77177A b.86.1.2 d.95.2.2 5 6 1jva.mmol
28380 40586 b.86.1.2 d.95.2.2 5 6 1dq3.water
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28380 40585 b.86.1.2 d.95.2.2 4 3 1dq3.water
78275A 78277D b.86.1.2 d.95.2.2 3 5 1lws.mmol
78275A 78277A b.86.1.2 d.95.2.2 5 6 1lws.mmol
78275A 78276A b.86.1.2 d.95.2.2 4 2 1lws.mmol
28375A 40576B b.86.1.2 d.95.2.2 1 1 1dfa.mmol
28375A 40575A b.86.1.2 d.95.2.2 4 2 1dfa.mmol
28378A 40584B b.86.1.2 d.95.2.2 1 1 1vde.mmol
28378A 40582A b.86.1.2 d.95.2.2 5 6 1vde.mmol
28378A 40581A b.86.1.2 d.95.2.2 4 2 1vde.mmol
72586B 72584A b.84.2.1 c.30.1.1 1 1 1kj8.mmol
72583A 72584A b.84.2.1 c.30.1.1 2 2 1kj8.mmol
28241A 31648B b.84.2.1 c.30.1.1 1 1 1b6r.mmol
28241A 31648A b.84.2.1 c.30.1.1 2 2 1b6r.mmol
28234A 31642B b.84.2.1 c.30.1.1 3 3 1dv1.mmol
28234A 31641A b.84.2.1 c.30.1.1 2 2 1dv1.mmol
77561A 77562A b.71.1.1 c.1.8.1 1 1 1kwg.mmol
27721A 28708A b.71.1.1 c.1.8.1 1 1 1hvx.mmol
72960A 72961B b.71.1.1 c.1.8.1 3 3 1ktb.mmol
72960A 72961A b.71.1.1 c.1.8.1 1 1 1ktb.mmol
27785A 28772A b.71.1.1 c.1.8.1 1 1 1eh9.mmol
70088A1 70089A1 b.71.1.1 c.1.8.1 1 1 1ea9 1.mmol
85159A 85160A b.71.1.1 c.1.8.1 1 1 1mwo.mmol
27800A 28787B b.71.1.1 c.1.8.1 2 2 1bg9.mmol
29251A 38895A c.1.11.2 d.54.1.1 1 2 2chr.mmol
29251A 38895E c.1.11.2 d.54.1.1 2 1 2chr.mmol
62882A1 62883A1 c.1.11.2 d.54.1.1 1 4 1jct 1.mmol
62882A1 62883B1 c.1.11.2 d.54.1.1 2 1 1jct 1.mmol
62897A 62902C c.1.11.2 d.54.1.1 2 1 1jdf.mmol
29249A 38893A c.1.11.2 d.54.1.1 1 4 1dtn.mmol
29249A 38893B c.1.11.2 d.54.1.1 3 3 1dtn.mmol
29241A 38885A c.1.11.2 d.54.1.1 1 4 2muc.mmol
29242B 38885C c.1.11.2 d.54.1.1 2 1 2muc.mmol
67031A1 67032A1 c.1.11.2 d.54.1.1 1 4 1jpm 1.mmol
67031A1 67034B1 c.1.11.2 d.54.1.1 2 1 1jpm 1.mmol
29217A 38861C c.1.11.2 d.54.1.1 2 1 1bqg.mmol
68451A 68452A c.1.11.2 d.54.1.1 1 4 1kcz.mmol
68451A 68454B c.1.11.2 d.54.1.1 4 2 1kcz.mmol
68675A 68676A c.1.11.2 d.54.1.1 1 4 1kko.mmol
68675A 68678B c.1.11.2 d.54.1.1 4 2 1kko.mmol
29234 38878 c.1.11.2 d.54.1.1 1 4 1fhu.water
68457B 68456A c.1.11.2 d.54.1.1 4 2 1kd0.mmol
28638A 38540A c.1.5.1 d.37.1.1 2 1 1zfj.mmol
28638A 38541A c.1.5.1 d.37.1.1 1 2 1zfj.mmol
28641A2 38538A2 c.1.5.1 d.37.1.1 2 1 1b3o 2.mmol
63241A1 63243A1 c.1.5.1 d.37.1.1 1 2 1jr1 1.mmol
68719A 68720A c.10.2.3 d.58.7.2 1 1 1koh.mmol
68721B 68723C c.10.2.3 d.58.7.2 2 2 1koh.mmol
68722C 68723C c.10.2.3 d.58.7.2 1 1 1koh.mmol
68726A4 68727A4 c.10.2.3 d.58.7.2 1 1 1koo 4.mmol
68728B5 68730C5 c.10.2.3 d.58.7.2 2 2 1koo 5.mmol
30869A1 39213A1 c.10.2.3 d.58.7.2 3 6 1fo1 1.mmol
30871A 39214A c.10.2.3 d.58.7.2 1 1 1ft8.mmol
30871A 39216E c.10.2.3 d.58.7.2 2 3 1ft8.mmol
30874D 39214A c.10.2.3 d.58.7.2 4 2 1ft8.mmol
30874D 39215C c.10.2.3 d.58.7.2 5 7 1ft8.mmol
30874D 39216E c.10.2.3 d.58.7.2 6 4 1ft8.mmol
68721B 68720A c.10.2.3 d.58.7.2 5 7 1koh.mmol
68724D 68723C c.10.2.3 d.58.7.2 5 7 1koh.mmol
68728B5 68727A5 c.10.2.3 d.58.7.2 6 4 1koo 5.mmol
59515B 59514A c.2.1.7 c.58.1.1 1 1 1euz.mmol
59517C 59514A c.2.1.7 c.58.1.1 2 2 1euz.mmol
59521E 59516B c.2.1.7 c.58.1.1 3 3 1euz.mmol
86060E1 86053A1 c.2.1.7 c.58.1.1 3 3 1nqt 1.mmol
86062F1 86053A1 c.2.1.7 c.58.1.1 1 1 1nqt 1.mmol
86058D1 86055B1 c.2.1.7 c.58.1.1 3 3 1nqt 1.mmol
86062F1 86057C1 c.2.1.7 c.58.1.1 3 3 1nqt 1.mmol
86072K2 86065G2 c.2.1.7 c.58.1.1 3 3 1nqt 2.mmol
30268A 33916A c.2.1.7 c.58.1.1 4 6 1leh.mmol
30268A 33916E c.2.1.7 c.58.1.1 1 5 1leh.mmol
30268A 33917F c.2.1.7 c.58.1.1 1 4 1leh.mmol
30222A 33870A c.2.1.7 c.58.1.1 4 6 1aup.mmol
30222A 33870C c.2.1.7 c.58.1.1 1 1 1aup.mmol
30222A 33870E c.2.1.7 c.58.1.1 3 3 1aup.mmol
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30222F 33870B c.2.1.7 c.58.1.1 3 3 1aup.mmol
30232A 33880A c.2.1.7 c.58.1.1 4 6 1b26.mmol
30232A 33882C c.2.1.7 c.58.1.1 1 1 1b26.mmol
30238A 33888C c.2.1.7 c.58.1.1 1 1 2tmg.mmol
30241D 33891F c.2.1.7 c.58.1.1 1 1 2tmg.mmol
30223A 33873E c.2.1.7 c.58.1.1 3 3 1gtm.mmol
30217A 33865A c.2.1.7 c.58.1.1 4 6 1bgv.mmol
30217A 33865B c.2.1.7 c.58.1.1 2 2 1bgv.mmol
30274A 33922A c.2.1.7 c.58.1.1 4 6 1bw9.mmol
86052A1 86053A1 c.2.1.7 c.58.1.1 4 6 1nqt 1.mmol
30250A 33901D c.2.1.7 c.58.1.1 3 3 1hwx.mmol
30250A 33903F c.2.1.7 c.58.1.1 1 1 1hwx.mmol
30258C 33907D c.2.1.7 c.58.1.1 1 1 1hwz.mmol
60708F1 60707E1 c.3.1.5 d.87.1.1 1 1 1h6v 1.mmol
60702D3 60701C3 c.3.1.5 d.87.1.1 1 1 1h6v 3.mmol
30449A 40156A c.3.1.5 d.87.1.1 2 2 1xan.mmol
30449A 40156B c.3.1.5 d.87.1.1 1 1 1xan.mmol
30450A 40156A c.3.1.5 d.87.1.1 1 3 1xan.mmol
30565 40204 c.3.1.5 d.87.1.1 2 2 1d7y.water
30566 40204 c.3.1.5 d.87.1.1 1 3 1d7y.water
30569A 40206A c.3.1.5 d.87.1.1 2 2 1lpf.mmol
30569A 40207B c.3.1.5 d.87.1.1 1 1 1lpf.mmol
30581A 40212A c.3.1.5 d.87.1.1 2 2 1ojt.mmol
87464B 87462A c.31.1.3 c.36.1.5 1 1 1ovm.mmol
87467C 87462A c.31.1.3 c.36.1.5 2 3 1ovm.mmol
78955B1 78953A1 c.31.1.3 c.36.1.5 1 1 1mcz 1.mmol
78961D1 78953A1 c.31.1.3 c.36.1.5 4 3 1mcz 1.mmol
79737B 79735A c.31.1.3 c.36.1.5 1 1 1n0h.mmol
31741A 31785A c.31.1.3 c.36.1.5 3 2 1zpd.mmol
31741A 31787B c.31.1.3 c.36.1.5 1 1 1zpd.mmol
31741A 31791F c.31.1.3 c.36.1.5 2 3 1zpd.mmol
87461A 87462A c.31.1.3 c.36.1.5 3 2 1ovm.mmol
31733A 31797A c.31.1.3 c.36.1.5 3 2 1pow.mmol
31733A 31797C c.31.1.3 c.36.1.5 1 1 1pow.mmol
31733A 31799B c.31.1.3 c.36.1.5 4 3 1pow.mmol
78952A1 78953A1 c.31.1.3 c.36.1.5 3 2 1mcz 1.mmol
31737A 31777A c.31.1.3 c.36.1.5 3 2 1pvd.mmol
67224A 67225A c.31.1.3 c.36.1.5 3 2 1jsc.mmol
31739A 31783B c.31.1.3 c.36.1.5 1 1 1qpb.mmol
79734A 79735A c.31.1.3 c.36.1.5 3 2 1n0h.mmol
32247E 35613A c.37.1.10 c.92.2.3 5 5 1g20.mmol
32247E 35614B c.37.1.10 c.92.2.3 4 4 1g20.mmol
32248F 35613A c.37.1.10 c.92.2.3 4 4 1g20.mmol
32248F 35614B c.37.1.10 c.92.2.3 5 5 1g20.mmol
32265E 35621A c.37.1.10 c.92.2.3 1 1 1g21.mmol
32265E 35624D c.37.1.10 c.92.2.3 2 2 1g21.mmol
32266F 35624D c.37.1.10 c.92.2.3 3 3 1g21.mmol
32268H 35624D c.37.1.10 c.92.2.3 5 5 1g21.mmol
78446F1 78442B1 c.37.1.10 c.92.2.3 6 6 1m1y 1.mmol
78448H1 78443C1 c.37.1.10 c.92.2.3 7 7 1m1y 1.mmol
78454N2 78449I2 c.37.1.10 c.92.2.3 7 7 1m1y 2.mmol
78456P2 78451K2 c.37.1.10 c.92.2.3 7 7 1m1y 2.mmol
78456P2 78452L2 c.37.1.10 c.92.2.3 6 6 1m1y 2.mmol
86948A1 86951C1 c.37.1.20 d.153.1.4 1 1 1ofh 1.mmol
86948A1 86951F1 c.37.1.20 d.153.1.4 2 2 1ofh 1.mmol
86948A1 86951G1 c.37.1.20 d.153.1.4 3 3 1ofh 1.mmol
86950A2 86952F2 c.37.1.20 d.153.1.4 2 2 1ofh 2.mmol
32453C 41994I c.37.1.20 d.153.1.4 3 3 1g3i.mmol
32458T 41998M c.37.1.20 d.153.1.4 1 1 1g3i.mmol
73246X 73235M c.37.1.20 d.153.1.4 2 2 1kyi.mmol
33206A 40755A c.51.1.1 d.104.1.1 1 1 1fyf.mmol
60270A1 60271A1 c.51.1.1 d.104.1.1 1 1 1g5h 1.mmol
60270A1 60273B1 c.51.1.1 d.104.1.1 3 2 1g5h 1.mmol
60272B1 60273B1 c.51.1.1 d.104.1.1 1 1 1g5h 1.mmol
60274C2 60277D2 c.51.1.1 d.104.1.1 3 2 1g5h 2.mmol
60276D2 60277D2 c.51.1.1 d.104.1.1 1 1 1g5h 2.mmol
60278A1 60279A1 c.51.1.1 d.104.1.1 1 1 1g5i 1.mmol
33188A1 40737A1 c.51.1.1 d.104.1.1 2 4 1adj 1.mmol
33188A1 40738B1 c.51.1.1 d.104.1.1 3 2 1adj 1.mmol
33200A 40749A c.51.1.1 d.104.1.1 1 1 1ggm.mmol
33200A 40750B c.51.1.1 d.104.1.1 3 2 1ggm.mmol
33186A 40735A c.51.1.1 d.104.1.1 2 4 1qe0.mmol
33186A 40736B c.51.1.1 d.104.1.1 3 2 1qe0.mmol
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Domain A Domain B Family A Family B Face A Face B PQS File
60598A 60599A c.51.1.1 d.104.1.1 1 1 1h4q.mmol
60610A1 60614B1 c.51.1.1 d.104.1.1 4 3 1h4t 1.mmol
85755A 85757A c.51.1.1 d.104.1.1 1 1 1nj1.mmol
33174A1 40724B1 c.51.1.1 d.104.1.1 3 2 1kmm 1.mmol
33175B1 40723A1 c.51.1.1 d.104.1.1 3 2 1kmm 1.mmol
33175B1 40724B1 c.51.1.1 d.104.1.1 2 4 1kmm 1.mmol
33183B1 40732B1 c.51.1.1 d.104.1.1 2 4 1kmn 1.mmol
33178A1 40727A1 c.51.1.1 d.104.1.1 2 4 1htt 1.mmol
60280B1 60279A1 c.51.1.1 d.104.1.1 3 2 1g5i 1.mmol
76878C 76874A d.225.1.1 d.58.44.1 1 1 1iwg.mmol
76879A 76874A d.225.1.1 d.58.44.1 2 1 1iwg.mmol
76879C 76874A d.225.1.1 d.58.44.1 3 2 1iwg.mmol
76878A 76875A d.225.1.1 d.58.44.1 4 3 1iwg.mmol
76879A 76875A d.225.1.1 d.58.44.1 5 2 1iwg.mmol
76878C 76876A d.225.1.1 d.58.44.1 5 1 1iwg.mmol
76879A 76877A d.225.1.1 d.58.44.1 4 3 1iwg.mmol
87576A 87572A d.225.1.1 d.58.44.1 5 2 1oy9.mmol
87576A 87574A d.225.1.1 d.58.44.1 4 3 1oy9.mmol
Table A.1: The benchmark classification of domain interfaces using SCOP 1.69.
Domain A, B: SCOP sunid + PQS chain id + (an optional number for multiple
domains in a single chain); Family A, B: the family id by SCOP; Face A, B: the
manually classified type of face; PQS File: the names of PQS coordinate files from
ftp://ftp.ebi.ac.uk/pub/databases/msd/pqs/macmol
A.3 All detected ABAC cases on family level
In the sequel, a list of all detected ABAC cases is provided. The instances are non-redundant on
family level, that is, only one instance for each family constellation is provided. The provided
representatitive is the one with the maximal motif match score (MMS).
Family A Family B Family C Freq. Score
Trypsin-like serine proteases Serpins Leech antihemostatic proteins 15 202
Trypsin-like serine proteases Plant inhibitors of proteinases
and amylases
BPTI-like 102 200
Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors Plant inhibitors of proteinases
and amylases
42 192
Trypsin-like serine proteases Serpins BPTI-like 37 190
Trypsin-like serine proteases Bowman-Birk inhibitor, BBI Plant inhibitors of proteinases
and amylases
14 187
Trypsin-like serine proteases STI-like Plant inhibitors of proteinases
and amylases
7 184
Trypsin-like serine proteases STI-like BPTI-like 14 184
(Trans)glycosidases Concanavalin A-like lectins/glu-
canases
Plant inhibitors of proteinases
and amylases
2 182
Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors BPTI-like 92 180
Trypsin-like serine proteases Bowman-Birk inhibitor, BBI BPTI-like 28 180
Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors Bowman-Birk inhibitor, BBI 12 178
Trypsin-like serine proteases STI-like Leech antihemostatic proteins 6 173
Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors Leech antihemostatic proteins 37 171
Trypsin-like serine proteases Leech antihemostatic proteins Plant inhibitors of proteinases
and amylases
42 171
Trypsin-like serine proteases Ecotin, trypsin inhibitor BPTI-like 47 169





Trypsin-like serine proteases Serpins Ovomucoid/PCI-1 like inhibitors 16 167
(Trans)glycosidases Bifunctional inhibitor/lipid-





Trypsin-like serine proteases Ecotin, trypsin inhibitor Serpins 9 166
Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors PMP inhibitors 12 166
Trypsin-like serine proteases STI-like Ovomucoid/PCI-1 like inhibitors 6 165
Trypsin-like serine proteases Serine proterase inhibitors Plant inhibitors of proteinases
and amylases
7 165
Trypsin-like serine proteases Leech antihemostatic proteins BPTI-like 87 164
Trypsin-like serine proteases Bowman-Birk inhibitor, BBI Leech antihemostatic proteins 12 162
Trypsin-like serine proteases STI-like Bowman-Birk inhibitor, BBI 2 161
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
Ovomucoid/PCI-1 like inhibitors 6 157
Trypsin-like serine proteases Ecotin, trypsin inhibitor Ovomucoid/PCI-1 like inhibitors 19 155
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GEF domain of SopE toxin DBL homology domain (DH-
domain)
5 155
Trypsin-like serine proteases Ecotin, trypsin inhibitor Bowman-Birk inhibitor, BBI 7 153
Trypsin-like serine proteases Ecotin, trypsin inhibitor Leech antihemostatic proteins 18 150
Trypsin-like serine proteases Serpins Plant inhibitors of proteinases
and amylases
21 150
Trypsin-like serine proteases Ecotin, trypsin inhibitor STI-like 3 149
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
PMP inhibitors 2 148
(Trans)glycosidases Bifunctional inhibitor/lipid-
transfer protein/seed storage 2S
albumin
Plant inhibitors of proteinases
and amylases
1 147
Subtilisin-like CI-2 family of serine protease
inhibitors
Subtilisin inhibitor 7 147
WD40-repeat PH domain-like Thioredoxin-like 3 145
Trypsin-like serine proteases Elafin-like Plant inhibitors of proteinases
and amylases
7 144
WD40-repeat P-loop containing nucleoside
triphosphate hydrolases
Thioredoxin-like 6 141
Trypsin-like serine proteases Serpins Bowman-Birk inhibitor, BBI 6 140
Subtilisin-like CI-2 family of serine protease
inhibitors
Ovomucoid/PCI-1 like inhibitors 7 140
Trypsin-like serine proteases STI-like Serpins 3 139
Trypsin-like serine proteases Serine proterase inhibitors Elafin-like 1 137
Subtilisin-like CI-2 family of serine protease
inhibitors





beta and beta-prime subunits
of DNA dependent RNA-
polymerase
2 133
Subtilisin-like Protease propeptides/inhibitors Subtilisin inhibitor 2 130
WD40-repeat PH domain-like P-loop containing nucleoside
triphosphate hydrolases
2 120
Caspase-like Caspase-like Inhibitor of apoptosis (IAP)
repeat
12 120
Trypsin-like serine proteases Cystine-knot cytokines BPTI-like 14 118
Subtilisin-like Protease propeptides/inhibitors Ovomucoid/PCI-1 like inhibitors 2 117





Families 57/38 glycoside trans-
ferase middle domain
Galactose mutarotase-like Glycoside hydrolase/deacetylase 2 115
Cysteine proteinases Cystatin/monellin Thyroglobulin type-1 domain 6 115
Trypsin-like serine proteases Bowman-Birk inhibitor, BBI PMP inhibitors 4 113
Trypsin-like serine proteases Plant inhibitors of proteinases
and amylases
PMP inhibitors 14 113
Subtilisin-like Subtilisin inhibitor Ovomucoid/PCI-1 like inhibitors 1 113
Trypsin-like serine proteases Cystine-knot cytokines Leech antihemostatic proteins 6 112
Trypsin-like serine proteases Trypsin-like serine proteases Protease propeptides/inhibitors 8 111
Trypsin-like serine proteases PMP inhibitors BPTI-like 30 111
Trypsin-like serine proteases Ecotin, trypsin inhibitor PMP inhibitors 8 109
P-loop containing nucleoside
triphosphate hydrolases
GTPase activation domain, GAP Ras GEF 8 109
Trypsin-like serine proteases Ecotin, trypsin inhibitor CI-2 family of serine protease
inhibitors
3 104
Trypsin-like serine proteases STI-like Cystine-knot cytokines 1 104
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
Bowman-Birk inhibitor, BBI 2 104
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
Leech antihemostatic proteins 6 104
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
Plant inhibitors of proteinases
and amylases
7 104
Trypsin-like serine proteases Serpins PMP inhibitors 6 104
Trypsin-like serine proteases Leech antihemostatic proteins PMP inhibitors 12 104
Trypsin-like serine proteases Trypsin-like serine proteases Serpins 9 102
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
BPTI-like 14 102
Globin-like Globin-like Non-globular alpha+beta sub-




PGBD-like TIMP-like 6 101
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(Trans)glycosidases Bifunctional inhibitor/lipid-





Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors Cystine-knot cytokines 6 98
Trypsin-like serine proteases Cystine-knot cytokines Plant inhibitors of proteinases
and amylases
7 98






Trypsin-like serine proteases STI-like PMP inhibitors 2 96
Trypsin-like serine proteases STI-like CI-2 family of serine protease
inhibitors
1 95
EF-hand EF-hand Adenylylcyclase toxin (the
edema factor)
1 94
Trypsin-like serine proteases Cystine-knot cytokines Bowman-Birk inhibitor, BBI 2 93
Carbamoyl phosphate syn-
thetase, large subunit connection
domain
Carbamoyl phosphate syn-







Bacterial GAP domain DBL homology domain (DH-
domain)
10 92





Snake toxin-like alpha/beta-Hydrolases Snake toxin-like 14 91
Trypsin-like serine proteases Ecotin, trypsin inhibitor Cystine-knot cytokines 3 90
Trypsin-like serine proteases Protease propeptides/inhibitors Serine proterase inhibitors 1 89
Trypsin-like serine proteases Serpins Cystine-knot cytokines 3 88
Glycoside hydrolase/deacetylase Families 57/38 glycoside trans-
ferase middle domain
Galactose mutarotase-like 1 88
Trypsin-like serine proteases L domain-like Serpins 1 87
Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors Serine proterase inhibitors 6 87
(Trans)glycosidases alpha-Amylase inhibitor ten-
damistat
Plant inhibitors of proteinases
and amylases
1 87
Trypsin-like serine proteases Ecotin, trypsin inhibitor Serine proterase inhibitors 3 86
Trypsin-like serine proteases Protease propeptides/inhibitors Elafin-like 1 86
P-loop containing nucleoside
triphosphate hydrolases
GEF domain of SopE toxin Bacterial GAP domain 2 86
Ribonuclease H-like Ribonuclease H-like DNA/RNA polymerases 16 86
Trypsin-like serine proteases Protease propeptides/inhibitors Plant inhibitors of proteinases
and amylases
7 85
Trypsin-like serine proteases Serine proterase inhibitors PMP inhibitors 2 85
Actin-like ATPase domain Actin-like ATPase domain Actin depolymerizing proteins 6 85
N-terminal domains of the minor
coat protein g3p
N-terminal domains of the minor
coat protein g3p








Trypsin-like serine proteases Serine proterase inhibitors Bowman-Birk inhibitor, BBI 2 82
Serpins Trypsin-like serine proteases Serpins 3 82
Trypsin-like serine proteases Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors 40 80
Trypsin-like serine proteases Serine proterase inhibitors BPTI-like 14 80
Trypsin-like serine proteases Trypsin-like serine proteases P-loop containing nucleoside
triphosphate hydrolases
1 80
CI-2 family of serine protease
inhibitors
Trypsin-like serine proteases Subtilisin-like 7 80







GTPase activation domain, GAP GEF domain of SopE toxin 4 79
P-loop containing nucleoside
triphosphate hydrolases
GTPase activation domain, GAP Bacterial GAP domain 8 79
Bifunctional inhibitor/lipid-
transfer protein/seed storage 2S
albumin
Bifunctional inhibitor/lipid-
transfer protein/seed storage 2S
albumin
(Trans)glycosidases 1 78
Trypsin-like serine proteases L domain-like Leech antihemostatic proteins 3 78
Cytochrome c Cytochrome c C-terminal (heme d1) domain of
cytochrome cd1-nitrite reductase
2 77
Trypsin-like serine proteases Serine proterase inhibitors Leech antihemostatic proteins 6 77
P-loop containing nucleoside
triphosphate hydrolases
RCC1/BLIP-II RNI-like 1 77
Leech antihemostatic proteins Trypsin-like serine proteases Leech antihemostatic proteins 6 77
Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors Elafin-like 6 76
Acid proteases Proteinase A inhibitor IA3 Pepsin inhibitor-3 3 76
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
Serine proterase inhibitors 1 75
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GTPase activation domain, GAP DBL homology domain (DH-
domain)
20 74
Zn-dependent exopeptidases Protease propeptides/inhibitors Carboxypeptidase inhibitor 3 74
Trypsin-like serine proteases Trypsin-like serine proteases BPTI-like 74 73
Trypsin-like serine proteases Trypsin-like serine proteases Plant inhibitors of proteinases
and amylases
29 73
Trypsin-like serine proteases Trypsin-like serine proteases PMP inhibitors 9 73
P-loop containing nucleoside
triphosphate hydrolases
Ras GEF GEF domain of SopE toxin 2 73
Ribosomal protein S8 Ribosomal protein S5 domain
2-like
Ribosomal protein S8 1 73
SH3-domain Regulatory factor Nef Protein kinase-like (PK-like) 8 72
Trypsin-like serine proteases Ecotin, trypsin inhibitor Elafin-like 3 72
Trypsin-like serine proteases Elafin-like PMP inhibitors 2 72
P-loop containing nucleoside
triphosphate hydrolases
GEF domain of SopE toxin P-loop containing nucleoside
triphosphate hydrolases
3 72
Ubiquitin-like Ubiquitin-like Cysteine proteinases 5 72
Trypsin-like serine proteases STI-like Serine proterase inhibitors 1 71
P-loop containing nucleoside
triphosphate hydrolases
GTPase activation domain, GAP Ubiquitin-like 8 71
P-loop containing nucleoside
triphosphate hydrolases
Ras GEF DBL homology domain (DH-
domain)
10 71
Trypsin-like serine proteases Bowman-Birk inhibitor, BBI Elafin-like 2 70
Trypsin-like serine proteases Trypsin-like serine proteases Serine proterase inhibitors 3 69
Trypsin-like serine proteases Serpins Serine proterase inhibitors 2 69
EF-hand EF-hand P-loop containing nucleoside
triphosphate hydrolases
12 68
Trypsin-like serine proteases Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
7 68
Trypsin-like serine proteases Cystine-knot cytokines Serine proterase inhibitors 1 68
Trypsin-like serine proteases Elafin-like Leech antihemostatic proteins 6 68




Cytochrome c FAD/NAD(P)-binding domain 1 68
P-loop containing nucleoside
triphosphate hydrolases







FMN-linked oxidoreductases PRTase-like 2 67
Zn-binding domains of ADDBP Domain of early E2A DNA-
binding protein, ADDBP
Zn-binding domains of ADDBP 3 67
Trypsin-like serine proteases Protease propeptides/inhibitors Bowman-Birk inhibitor, BBI 2 66
Actin-like ATPase domain Serum albumin-like Actin depolymerizing proteins 30 66
Trypsin-like serine proteases Ecotin, trypsin inhibitor Trypsin-like serine proteases 7 65
Trypsin-like serine proteases Lipocalins L domain-like 1 65




Protein kinase-like (PK-like) 1 65
Cell cycle regulatory proteins Protein kinase-like (PK-like) Cell cycle regulatory proteins 1 65
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
Cystine-knot cytokines 1 64
Trypsin-like serine proteases Cystine-knot cytokines PMP inhibitors 2 64
Thioredoxin-like FAD/NAD(P)-binding domain DNA/RNA polymerases 1 64
Trypsin-like serine proteases STI-like Elafin-like 1 63
Glycosyl hydrolase domain Glycosyl hydrolase domain (Trans)glycosidases 8 63
Carbamoyl phosphate syn-
thetase, small subunit N-
terminal domain
Carbamoyl phosphate syn-





Trypsin-like serine proteases Trypsin-like serine proteases Bowman-Birk inhibitor, BBI 9 62











Ras GEF Bacterial GAP domain 4 61
P-loop containing nucleoside
triphosphate hydrolases
Ras GEF Ubiquitin-like 3 61





oxidase subunit VIIIb (aka IX)
1 61
Trypsin-like serine proteases Lipocalins BPTI-like 2 60
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Trypsin-like serine proteases L domain-like BPTI-like 2 60
Trypsin-like serine proteases Protease propeptides/inhibitors BPTI-like 16 60
Trypsin-like serine proteases Ovomucoid/PCI-1 like inhibitors EGF/Laminin 8 60
Trypsin-like serine proteases EGF/Laminin BPTI-like 8 60
P-loop containing nucleoside
triphosphate hydrolases
GTPase activation domain, GAP RNI-like 4 60
P-loop containing nucleoside
triphosphate hydrolases
Ras GEF RNI-like 2 60
Cystine-knot cytokines Cystine-knot cytokines Snake toxin-like 5 60
RNA polymerase subunit RPB10 Insert subdomain of RNA poly-
merase alpha subunit
beta and beta-prime subunits
of DNA dependent RNA-
polymerase
2 60
Ovomucoid/PCI-1 like inhibitors Trypsin-like serine proteases Subtilisin-like 1 60
Trypsin-like serine proteases Ecotin, trypsin inhibitor Protease propeptides/inhibitors 4 59








Bacterial GAP domain P-loop containing nucleoside
triphosphate hydrolases
8 58
Actin-like ATPase domain Actin-like ATPase domain Profilin (actin-binding protein) 2 58
Ubiquinone-binding protein QP-
C of cytochrome bc1 complex
(Ubiquinol-cytochrome c reduc-
tase)





Trypsin-like serine proteases STI-like Trypsin-like serine proteases 2 57
Trypsin-like serine proteases Trypsin-like serine proteases Cystine-knot cytokines 5 57
Trypsin-like serine proteases L domain-like EGF/Laminin 2 57
CheY-like CheY-like Sporulation responce regulatory
protein Spo0B
2 57
Interleukin 8-like chemokines Viral chemokine binding protein
m3
Interleukin 8-like chemokines 7 57







Trypsin-like serine proteases Trypsin-like serine proteases Leech antihemostatic proteins 25 56
Trypsin-like serine proteases Trypsin-like serine proteases Elafin-like 3 56
Trypsin-like serine proteases Protease propeptides/inhibitors Ovomucoid/PCI-1 like inhibitors 6 56
Actin depolymerizing proteins Actin-like ATPase domain Actin depolymerizing proteins 38 56
Molybdemum cofactor-binding
domain





Trypsin-like serine proteases STI-like Protease propeptides/inhibitors 1 55
Trypsin-like serine proteases Lipocalins EGF/Laminin 4 55
L domain-like L domain-like vWA-like 1 55
P-loop containing nucleoside
triphosphate hydrolases
RNI-like NTF2-like 1 55
UBC-like Ubiquitin-protein ligase E3a,
Hect catalytic domain (E6ap)
RING/U-box 1 55
Ubiquinone-binding protein QP-
C of cytochrome bc1 complex
(Ubiquinol-cytochrome c reduc-
tase)











Prokaryotic type KH domain
(KH-domain type II)
Ribosomal protein S10 1 55
EF-hand EF-hand Small-conductance potassium
channel
1 54
TIMP-like TIMP-like Metalloproteases (”zincins”),
catalytic domain
2 54
Trypsin-like serine proteases Protease propeptides/inhibitors PMP inhibitors 2 54
Trypsin-like serine proteases Cystine-knot cytokines Elafin-like 1 54

















FAD-binding domain 1 54
ISP domain Transmembrane di-heme cy-
tochromes




Protein kinase-like (PK-like) SH3-domain Protein kinase-like (PK-like) 11 53













Bacterial GAP domain RNI-like 2 52
Actin-like ATPase domain Serum albumin-like Profilin (actin-binding protein) 1 52
N-terminal nucleophile aminohy-
drolases (Ntn hydrolases)
Alpha subunit of glutamate
synthase, C-terminal domain
PRTase-like 4 52
Second domain of FERM Second domain of FERM Moesin tail domain 1 51
EF-hand P-loop containing nucleoside
triphosphate hydrolases
Metallo-dependent phosphatases 14 51










PRTase-like SIS domain 2 51
Trypsin-like serine proteases CI-2 family of serine protease
inhibitors
Protease propeptides/inhibitors 1 50
Trypsin-like serine proteases Protease propeptides/inhibitors Leech antihemostatic proteins 6 50
P-loop containing nucleoside
triphosphate hydrolases
GTPase activation domain, GAP P-loop containing nucleoside
triphosphate hydrolases
9 50
Actin-like ATPase domain Actin depolymerizing proteins Profilin (actin-binding protein) 2 50
Protein kinase-like (PK-like) (Phosphotyrosine protein) phos-
phatases II






FKBP-like EF-hand Protein kinase-like (PK-like) 1 49
SH2 domain (Phosphotyrosine protein) phos-
phatases II
SH2 domain 4 49
Iron-sulfur subunit (ISP)
of cytochrome bc1 complex
(Ubiquinol-cytochrome c re-
ductase), transmembrane region
LuxS/MPP-like metallohydrolase Ubiquinone-binding protein QP-






Photosystem I subunit PsaD Subunit III of photosystem I
reaction centre, PsaF
1 49
EGF/Laminin Diphtheria toxin, C-terminal
domain
L domain-like 1 49
SH3-domain SH3-domain Regulatory factor Nef 6 48
Trypsin-like serine proteases Protease propeptides/inhibitors Serpins 2 48
Trypsin-like serine proteases EGF/Laminin Leech antihemostatic proteins 2 48
RNA-binding domain, RBD L domain-like RNA-binding domain, RBD 2 48
ISP domain Formate dehydrogenase/DMSO
reductase, domains 1-3




Acid proteases Acid proteases Pepsin inhibitor-3 3 47
C-type lectin-like C-type lectin-like GLA-domain 4 47
4Fe-4S ferredoxins Formate dehydrogenase/DMSO
reductase, domains 1-3
2Fe-2S ferredoxin-like 2 47




thetase, small subunit N-
terminal domain
ADC synthase 3 46
P-loop containing nucleoside
triphosphate hydrolases





Ricin B-like lectins Ribosome inactivating proteins
(RIP)
6 46




DNA repair protein MutS, do-
main II
2 45
CO dehydrogenase ISP C-
domain like
FAD-binding domain 2Fe-2S ferredoxin-like 4 45
SH3-domain Regulatory factor Nef SH2 domain 2 45
SH3-domain Protein kinase-like (PK-like) SH2 domain 10 45
Ricin B-like lectins Ricin B-like lectins Ribosome inactivating proteins
(RIP)
55 45
Trypsin-like serine proteases Trypsin-like serine proteases EGF/Laminin 46 45





ARM repeat FYVE/PHD zinc finger 1 45




of cytochrome bc1 complex
(Ubiquinol-cytochrome c re-
ductase), transmembrane region
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Iron-sulfur subunit (ISP)
of cytochrome bc1 complex
(Ubiquinol-cytochrome c re-
ductase), transmembrane region
















SH3-domain p53-like transcription factors Protein kinase-like (PK-like) 4 44
SH3-domain SH3-domain Protein kinase-like (PK-like) 16 44
Caspase-like Baculovirus p35 protein Inhibitor of apoptosis (IAP)
repeat
1 44
Cytochrome c oxidase subunit
I-like
Cytochrome c oxidase subunit
II-like, transmembrane region
Bacterial ba3 type cytochrome c
oxidase subunit IIa
2 44
Serum albumin-like Serum albumin-like Actin-like ATPase domain 1 43





2Fe-2S ferredoxin-like CO dehydrogenase ISP C-
domain like
FAD-binding domain 6 43
LuxS/MPP-like metallohydrolase Iron-sulfur subunit (ISP)















cofactor of HNF1 (DCoH)
2 43
Cytochrome c Transmembrane di-heme cy-
tochromes





C-terminal effector domain of
the bipartite response regulators
C-terminal effector domain of
the bipartite response regulators
CheY-like 4 42
SH3-domain p53-like transcription factors Regulatory factor Nef 2 42
Trypsin-like serine proteases Trypsin-like serine proteases Kringle-like 9 42
















Ras GEF NTF2-like 2 42
P-loop containing nucleoside
triphosphate hydrolases
GEF domain of SopE toxin RNI-like 1 42
Ubiquitin-like Second domain of FERM PH domain-like 10 42
Guanido kinase N-terminal do-
main





PDZ domain-like PDZ domain-like P-loop containing nucleoside
triphosphate hydrolases
1 41
Trypsin-like serine proteases Staphylokinase/streptokinase BPTI-like 2 41
Duplicated hybrid motif Duplicated hybrid motif Actin-like ATPase domain 1 41
MHC antigen-recognition do-
main
Bacterial enterotoxins MHC antigen-recognition do-
main
5 41
Sulfite reductase, domains 1 and
3
Sulfite reductase hemoprotein
(SiRHP), domains 2 and 4




C of cytochrome bc1 complex
(Ubiquinol-cytochrome c reduc-
tase)
LuxS/MPP-like metallohydrolase Iron-sulfur subunit (ISP)




EF-hand Metallo-dependent phosphatases Adenylylcyclase toxin (the
edema factor)
2 40
CO dehydrogenase ISP C-
domain like





Hemocyanin, N-terminal domain C-terminal domain of mollusc
hemocyanin
2 40
Thioredoxin-like FAD/NAD(P)-binding domain Thioredoxin-like 2 40
Periplasmic binding protein-like
II
Homeodomain-like ”Winged helix” DNA-binding
domain
1 40
S13-like H2TH domain ATPase domain of HSP90 chap-
erone/DNA topoisomerase
II/histidine kinase
Ribosomal protein S5 domain
2-like
1 39





C-terminal domain of transcrip-
tional repressors
1 39
Bacterial enterotoxins Bacterial enterotoxins ADP-ribosylation 11 39
Trypsin-like serine proteases Protease propeptides/inhibitors Cystine-knot cytokines 1 39
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Trypsin-like serine proteases P-loop containing nucleoside
triphosphate hydrolases
Bowman-Birk inhibitor, BBI 1 39
P-loop containing nucleoside
triphosphate hydrolases
GEF domain of SopE toxin Ubiquitin-like 4 39
P-loop containing nucleoside
triphosphate hydrolases
DBL homology domain (DH-
domain)
Ubiquitin-like 19 39
POZ domain Cullin repeat RNI-like 1 39
Sigma3 and sigma4 domains of
RNA polymerase sigma factors
Sigma2 domain of RNA poly-
merase sigma factors
beta and beta-prime subunits
of DNA dependent RNA-
polymerase
2 38
Ribosomal protein L14 Ribosomal protein L14 Glucocorticoid receptor-like
(DNA-binding domain)
1 38
Translation proteins Translation proteins eEF-1beta-like 1 38
POZ domain Cullin repeat Skp1 dimerisation domain-like 2 38
4Fe-4S ferredoxins Thiamin diphosphate-binding
fold (THDP-binding)
Fe-only hydrogenase 1 38
Ribosomal protein S6 Ribosomal protein S18 Ribosomal protein S6 2 38




Subunit X (nonheme 7 kDa pro-




Cyclin-like Cyclin-like TATA-box binding protein-like 10 37
P-loop containing nucleoside
triphosphate hydrolases
GTPase activation domain, GAP RCC1/BLIP-II 3 37
P-loop containing nucleoside
triphosphate hydrolases
DBL homology domain (DH-
domain)
RNI-like 5 37





4Fe-4S ferredoxins 2 37
SH3-domain p53-like transcription factors SH3-domain 2 36
SH3-domain p53-like transcription factors SH2 domain 1 36
Bacterial enterotoxins Bacterial enterotoxins C-type lectin-like 1 36







Metallo-dependent phosphatases 1 36








C of cytochrome bc1 complex
(Ubiquinol-cytochrome c reduc-
tase)




BPTI-like Trypsin-like serine proteases BPTI-like 7 36
Epsilon subunit of mitochondrial
F1F0-ATP synthase
Epsilon subunit of F1F0-ATP
synthase C-terminal domain





GEF domain of SopE toxin NTF2-like 1 35
P-loop containing nucleoside
triphosphate hydrolases





DBL homology domain (DH-
domain)
NTF2-like 5 35













F-box domain F-box domain RNI-like 2 34
Cytochrome c Cytochrome c Heme-dependent peroxidases 11 34
Cytochrome c Cytochrome c Quinohemoprotein amine de-










p53-like transcription factors SH3-domain BRCT domain 1 34












SH2 domain 1 34
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ATP synthase (F1-ATPase),
gamma subunit
Epsilon subunit of F1F0-ATP
synthase C-terminal domain
C-terminal domain of alpha









C of cytochrome bc1 complex
(Ubiquinol-cytochrome c reduc-
tase)
LuxS/MPP-like metallohydrolase Transmembrane di-heme cy-
tochromes
2 34
Cytochrome c oxidase subunit
III-like
Bacterial aa3 type cytochrome c
oxidase subunit IV
Rubredoxin-like 1 34
Kringle-like Hairpin loop containing domain-
like
GLA-domain 1 34
Second domain of FERM PH domain-like Ubiquitin-like 15 33
Cyclin-like Cyclin-like Protein kinase-like (PK-like) 7 33
Caspase-like Baculovirus p35 protein Caspase-like 1 33
P-loop containing nucleoside
triphosphate hydrolases
GAT domain FYVE/PHD zinc finger 1 33
P-loop containing nucleoside
triphosphate hydrolases
DBL homology domain (DH-
domain)



























C of cytochrome bc1 complex
(Ubiquinol-cytochrome c reduc-
tase)




EGF/Laminin EGF/Laminin GLA-domain 8 33











Bacterial GAP domain Ubiquitin-like 6 32
2Fe-2S ferredoxin-like alpha-helical ferredoxin CO dehydrogenase ISP C-
domain like
15 32
EF-G/eEF-2 domains III and V Ribosomal protein S5 domain
2-like
EF-G/eEF-2 domains III and V 3 32

























SH3-domain SH3-domain SH2 domain 35 31
P-loop containing nucleoside
triphosphate hydrolases





Elongation factor Ts (EF-Ts),
dimerisation domain
2 31
Ubiquitin-like UBA-like Ubiquitin-like 2 31
EGF/Laminin L domain-like EGF/Laminin 3 31
Homeodomain-like Homeodomain-like Periplasmic binding protein-like
II
3 30
C-terminal domain of alpha
and beta subunits of F1 ATP
synthase
C-terminal domain of alpha





Translation proteins Translation proteins P-loop containing nucleoside
triphosphate hydrolases
1 30






EGF/Laminin Trypsin-like serine proteases L domain-like 11 30
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DNA helicase RuvA subunit,
C-terminal domain
Nucleic acid-binding proteins P-loop containing nucleoside
triphosphate hydrolases
2 29







Bacterial enterotoxins Bacterial enterotoxins MHC antigen-recognition do-
main
5 29
L domain-like L domain-like RNA-binding domain, RBD 1 29
P-loop containing nucleoside
triphosphate hydrolases
Ras GEF ARM repeat 1 29
P-loop containing nucleoside
triphosphate hydrolases





DBL homology domain (DH-
domain)
eEF-1beta-like 5 29
Metallo-dependent phosphatases Cyclophilin (peptidylprolyl iso-
merase)
FKBP-like 1 29
LuxS/MPP-like metallohydrolase Iron-sulfur subunit (ISP)
of cytochrome bc1 complex
(Ubiquinol-cytochrome c re-
ductase), transmembrane region
Subunit X (nonheme 7 kDa pro-














Riboflavin synthase domain-like Globin-like 2Fe-2S ferredoxin-like 8 28
Cyclophilin (peptidylprolyl iso-
merase)







Ras GEF P-loop containing nucleoside
triphosphate hydrolases
3 28
Kringle-like Kringle-like GLA-domain 2 28






p53-like transcription factors p53-like transcription factors BRCT domain 1 27
Cyclophilin (peptidylprolyl iso-
merase)
TPR-like Cyclophilin (peptidylprolyl iso-
merase)
1 27
Tricorn protease domain 2 PDZ domain-like Tricorn protease domain 2 1 27










LuxS/MPP-like metallohydrolase Ubiquinone-binding protein QP-




14 kDa protein of cytochrome
bc1 complex (Ubiquinol-
cytochrome c reductase)









Trypsin-like serine proteases Trypsin-like serine proteases Complement control mod-
ule/SCR domain
9 26





DNA repair protein MutS, do-
main III





Ras GEF eEF-1beta-like 2 26
TATA-box binding protein-like Cyclin-like TATA-box binding protein-like 2 26
Protein kinase-like (PK-like) (Phosphotyrosine protein) phos-
phatases II










Hemopexin-like domain Kringle-like 4 26
Subunit X (nonheme 7 kDa pro-
tein) of cytochrome bc1 complex
(Ubiquinol-cytochrome c reduc-
tase)
LuxS/MPP-like metallohydrolase Iron-sulfur subunit (ISP)




EGF/Laminin Spermadhesin, CUB domain EGF/Laminin 19 26
DNA polymerase III clamp




DNA clamp 2 25
Translation proteins P-loop containing nucleoside
triphosphate hydrolases
eEF-1beta-like 1 25
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RNA-binding domain, RBD ARM repeat RNA-binding domain, RBD 5 25
SH2 domain p53-like transcription factors SH3-domain 2 25
Insulin-like Insulin-like Growth factor receptor domain 7 25































thetase, large subunit connection
domain
PreATP-grasp domain 1 24
EGF/Laminin Trypsin-like serine proteases Low density lipoprotein (LDL)
receptor YWTD domain
14 24
RING/U-box UBC-like RING/U-box 1 24
SAM/Pointed domain ARM repeat SAM/Pointed domain 1 23
SH3-domain SH3-domain Ankyrin repeat 6 23
Nucleic acid-binding proteins Translation proteins SH3-like
domain
Zn-binding ribosomal proteins 1 23





Ras GEF TPR-like 1 23
P-loop containing nucleoside
triphosphate hydrolases
GEF domain of SopE toxin eEF-1beta-like 1 23
P-loop containing nucleoside
triphosphate hydrolases
GEF domain of SopE toxin FYVE/PHD zinc finger 1 23
P-loop containing nucleoside
triphosphate hydrolases
Helical domain of Sec23/24 SNARE-like 1 23
ADP-ribosylation ADP-ribosylation Metalloproteases (”zincins”),
catalytic domain
8 23
C-type lectin-like C-type lectin-like EGF/Laminin 7 23














Cytochrome c Subunit X (nonheme 7 kDa pro-









of cytochrome bc1 complex
(Ubiquinol-cytochrome c re-
ductase), transmembrane region




TNF receptor-like TNF-like TNF receptor-like 10 23
Plant inhibitors of proteinases
and amylases
Trypsin-like serine proteases (Trans)glycosidases 7 23







cofactor of HNF1 (DCoH)
6 22
Trypsin-like serine proteases Trypsin-like serine proteases Lipocalins 8 22
Trypsin-like serine proteases Trypsin-like serine proteases Staphylokinase/streptokinase 15 22
PH domain-like Regulator of G-protein sig-
nalling, RGS
PH domain-like 2 22
P-loop containing nucleoside
triphosphate hydrolases

















CO dehydrogenase ISP C-
domain like
2Fe-2S ferredoxin-like 8 22
SH2 domain EF-hand SH3-domain 1 22
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SH2 domain SH3-domain (Phosphotyrosine protein) phos-
phatases II
1 22
Cytochrome c Cytochrome c Bacterial photosystem II reac-
tion centre, L and M subunits
6 21
Cytochrome c Heme-dependent peroxidases Bacterial photosystem II reac-




HMG-box Homeodomain-like 1 21
DNA helicase RuvA subunit,
C-terminal domain
RuvA domain 2-like P-loop containing nucleoside
triphosphate hydrolases
1 21
Helical domain of Sec23/24 P-loop containing nucleoside
triphosphate hydrolases
vWA-like 1 21
Trypsin-like serine proteases Staphylokinase/streptokinase PMP inhibitors 1 21





GTPase activation domain, GAP Transducin (alpha subunit),
insertion domain
9 21
Ribonuclease H-like N-terminal Zn binding domain of
HIV integrase
DNA-binding domain of retrovi-
ral integrase
1 21
GAF domain-like ”Winged helix” DNA-binding
domain
GAF domain-like 1 21
N-terminal nucleophile aminohy-
drolases (Ntn hydrolases)













mains 2 and 5
Ribosomal protein S5 domain
2-like
1 20
SH3-domain Ankyrin repeat SH2 domain 2 20
Trypsin-like serine proteases Zn-dependent exopeptidases Elafin-like 1 20
C2 domain (Calcium/lipid-
binding domain, CaLB)
ARM repeat PLC-like phosphodiesterases 5 20
CheY-like C-terminal effector domain of












Protein kinase-like (PK-like) Protein kinase-like (PK-like) Ankyrin repeat 4 20
SH2 domain p53-like transcription factors SH2 domain 2 20
Ubiquinone-binding protein QP-










A.4 Cross validation results for protein-protein interac-
tion descriptors
90 interface types were selected acording to the criteria described in Section 5.4.3. The row colors
reflect the performance of the interface descriptor where red indicates optimal cross validation
(100% recall) and shades of red indicate less optimal recall values.
Family 1 Family 2 Face 1 Face 2 Side Recall Entropy Descriptor
length
a.2.11.1 d.44.1.1 7 3 Left 100 0.3 43
a.2.11.1 d.44.1.1 7 3 Right 98.83 0.29 52
a.2.11.1 d.44.1.1 8 1 Left 94.41 0.29 19
a.2.11.1 d.44.1.1 8 1 Right 100 0.27 16
a.27.1.1 c.26.1.1 3 15 Left 75 0.4 39
a.27.1.1 c.26.1.1 3 15 Right 0 0.47 25
a.29.3.1 e.6.1.1 7 1 Left 87.88 0.29 72
a.29.3.1 e.6.1.1 7 1 Right 89.74 0.29 83
a.45.1.1 c.47.1.5 3 3 Right 100 0.46 22
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Family 1 Family 2 Face 1 Face 2 Side Recall Entropy Descriptor
length
a.45.1.1 c.47.1.5 6 1 Right 100 0.48 40
a.60.7.1 c.120.1.2 1 1 Left 100 0.27 64
a.60.7.1 c.120.1.2 1 1 Right 100 0.26 87
a.83.1.1 d.128.1.2 4 1 Left 100 0.19 48
a.83.1.1 d.128.1.2 4 1 Right 100 0.16 52
b.1.1.2 d.19.1.1 30 22 Left 0 0.13 8
b.1.1.2 d.19.1.1 30 22 Right 0 0.19 4
b.1.1.2 d.19.1.1 30 23 Left 0 0.19 14
b.1.1.2 d.19.1.1 30 23 Right 40 0.26 11
b.1.1.2 d.19.1.1 30 32 Left 29.03 0.18 18
b.1.1.2 d.19.1.1 30 32 Right 100 0.24 19
b.1.1.2 d.19.1.1 30 36 Left 100 0.16 13
b.1.1.2 d.19.1.1 30 36 Right 100 0.23 14
b.1.1.2 d.19.1.1 31 32 Left 100 0.07 23
b.1.1.2 d.19.1.1 31 32 Right 97.78 0.24 42
b.1.1.2 d.19.1.1 31 33 Left 100 0.17 22
b.1.1.2 d.19.1.1 31 33 Right 100 0.22 32
b.19.1.2 h.3.1.1 6 1 Left 100 0.19 83
b.19.1.2 h.3.1.1 6 1 Right 0 0.12 116
b.34.3.1 c.37.1.9 2 8 Left 100 0.21 18
b.34.3.1 c.37.1.9 2 8 Right 100 0.16 28
b.35.1.2 c.2.1.1 6 5 Left 85.91 0.34 14
b.35.1.2 c.2.1.1 6 5 Right 0 0.35 16
b.35.1.2 c.2.1.1 8 1 Left 0 0.41 80
b.35.1.2 c.2.1.1 8 1 Right 63.84 0.43 65
b.40.2.2 d.15.6.1 6 9 Left 100 0.41 61
b.40.2.2 d.15.6.1 6 9 Right 100 0.38 63
b.43.3.1 b.44.1.1 4 1 Left 69.7 0.25 21
b.43.3.1 b.44.1.1 4 1 Right 8.89 0.3 13
b.43.4.2 c.25.1.1 5 1 Left 78.57 0.24 44
b.43.4.2 c.25.1.1 5 1 Right 100 0.26 50
b.47.1.2 g.3.2.1 18 1 Left 100 0.16 47
b.47.1.2 g.3.2.1 18 1 Right 100 0.13 20
b.47.1.2 g.68.1.1 18 5 Left 0 0.18 40
b.47.1.2 g.68.1.1 18 5 Right 100 0.28 26
b.47.1.2 g.8.1.1 18 7 Left 0 0.2 37
b.47.1.2 g.8.1.1 18 7 Right 100 0.1 19
b.52.2.2 c.81.1.1 3 4 Left 98.39 0.39 77
b.52.2.2 c.81.1.1 3 4 Right 83.12 0.39 88
b.58.1.1 c.1.12.1 1 1 Left 100 0.2 22
b.58.1.1 c.1.12.1 1 1 Right 90.12 0.13 31
c.1.14.1 d.58.9.1 9 1 Left 100 0.22 49
c.1.14.1 d.58.9.1 9 1 Right 100 0.22 54
c.1.8.5 d.26.3.1 11 1 Left 100 0.33 54
c.1.8.5 d.26.3.1 11 1 Right 100 0.34 48
c.2.1.3 d.81.1.1 25 8 Left 80.31 0.24 22
c.2.1.3 d.81.1.1 25 8 Right 100 0.2 19
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Family 1 Family 2 Face 1 Face 2 Side Recall Entropy Descriptor
length
c.2.1.3 d.81.1.1 26 3 Left 4.07 0.25 13
c.2.1.3 d.81.1.1 26 3 Right 100 0.2 9
c.2.1.3 d.81.1.1 4 7 Left 0 0.43 30
c.2.1.3 d.81.1.1 4 7 Right 52.15 0.38 46
c.2.1.3 d.81.1.3 5 6 Left 0 0.18 33
c.2.1.3 d.81.1.3 5 6 Right 96.43 0.18 24
c.2.1.4 c.23.12.1 5 1 Left 0 0.32 13
c.2.1.4 c.23.12.1 5 1 Right 59.09 0.36 15
c.2.1.5 d.162.1.1 2 3 Left 86.67 0.38 29
c.2.1.5 d.162.1.1 2 3 Right 100 0.41 45
c.2.1.5 d.162.1.1 3 1 Left 83.91 0.38 65
c.2.1.5 d.162.1.1 3 1 Right 89.15 0.39 67
c.2.1.7 c.58.1.1 7 1 Left 100 0.31 48
c.2.1.7 c.58.1.1 7 1 Right 94.17 0.29 43
c.3.1.4 d.168.1.1 8 5 Left 90 0.22 78
c.3.1.4 d.168.1.1 8 5 Right 93.02 0.22 52
c.3.1.5 d.87.1.1 3 3 Left 48.65 0.4 34
c.3.1.5 d.87.1.1 3 3 Right 84.78 0.4 32
c.3.1.5 d.87.1.1 5 8 Left 0 0.36 41
c.3.1.5 d.87.1.1 5 8 Right 26.51 0.36 18
c.3.1.5 d.87.1.1 9 6 Left 60.34 0.38 36
c.3.1.5 d.87.1.1 9 6 Right 85.33 0.39 24
c.31.1.3 c.36.1.9 10 1 Left 66.67 0.39 36
c.31.1.3 c.36.1.9 10 1 Right 93.44 0.36 49
c.36.1.5 c.36.1.9 9 2 Left 90.7 0.28 38
c.36.1.5 c.36.1.9 9 2 Right 93.44 0.31 40
c.55.1.1 d.109.1.1 14 8 Left 100 0.04 31
c.55.1.1 d.109.1.1 14 8 Right 94.12 0 43
c.55.3.5 e.8.1.1 5 7 Left 0 0.24 35
c.55.3.5 e.8.1.1 5 7 Right 100 0.22 42
d.175.1.1 e.3.1.1 4 3 Left 100 0.15 55
d.175.1.1 e.3.1.1 4 3 Right 100 0.24 51
Table A.3: Cross validation results for each of the 90 face types.
Family 1 and Family 2 are named with their SCOP family identi-
fiers. The recall values are averaged over all cross validation cycles.
A.5 Identified sequences with ATP-binding site motif not
annotated previously
Entrez-ID Definition Kingdom Motif Position
84355382




COG1192: ATPases involved in chromosome partitioning
[Lactococcus lactis subsp. cremoris SK11]
Bacteria IKGGVGKT 1-10
48787610




A.5. IDENTIFIED SEQUENCES WITH ATP-BINDING SITE MOTIF NOT ANNOTATED
PREVIOUSLY
23012009




COG1192: ATPases involved in chromosome partitioning








COG1192: ATPases involved in chromosome partitioning
[Anabaena variabilis ATCC 29413]
Bacteria MKGGVGKT 29-38
45507146
COG1192: ATPases involved in chromosome partitioning
[Anabaena variabilis ATCC 29413]
Bacteria FKGGVGKS 15-24
27350044 bll1791 [Bradyrhizobium japonicum USDA 110] Bacteria DKGGVGKT 10-19
27350748 bll2492 [Bradyrhizobium japonicum USDA 110] Bacteria DKGGVGKT 10-19
77377729 ParA [Neisseria meningitidis] Bacteria TKGGVGKT 10-19
69926216 conserved unknown protein [Nitrobacter hamburgensis X14] Bacteria DKGGVGKT 10-19
69930274
Cobyrinic acid a,c-diamide synthase [Nitrobacter hambur-
gensis X14]
Bacteria QKGGVGKT 32-41
69930419 ParA protein [Nitrobacter hamburgensis X14] Bacteria QKGGVGKT 6-15
27358691 Multidrug resistance efflux pump [Vibrio vulnificus CMCP6] Bacteria PKGGVGKT 9-18
29606192 hypothetical protein [Streptomyces avermitilis MA-4680] Bacteria LKGGVGKT 458-467
68567478 conserved protein [Sulfolobus acidocaldarius DSM 639] Archaea VKGGVGKS 8-17
70880931 trans-sialidase, putative [Trypanosoma cruzi] Eukaryota DKGGSGKS 385-394
71551086
Cobyrinic acid a,c-diamide synthase [Nitrosomonas eu-
tropha C71]
Bacteria QKGGSGKT 7-16
54638237 GA11133-PA [Drosophila pseudoobscura]1 Eukaryota KKGGVGKS 338-347
75814797








septum formation inhibitor-activating ATPase [Ther-
moanaerobacter ethanolicus ATCC 33223]
Bacteria PKGGVGKT 6-15
77690931
conserved hypothetical protein [Rhodopseudomonas palus-
tris BisB5]
Bacteria DKGGVGKT 10-19
24376237 ParA family protein [Shewanella oneidensis MR-1] Bacteria QKGGVGKT 28-37
50901712




putative MRP protein (ATP/GTP-binding protein) [Oryza
sativa (japonica cultivar-group)]
Eukaryota CKGGVGKS 179-188
59938904 probable MobD [Xanthomonas axonopodis pv. glycines] Bacteria SKGGVGKS 9-18
78494881
Nitrogenase cofactor biosynthesis protein NifB [Rhodopseu-
domonas palustris BisB18]
Bacteria SKGGSGKS 50-59
78693790 conserved hypothetical protein [Bradyrhizobium sp. BTAi1] Bacteria DKGGVGKT 10-19
78699623 putative partition protein [Bradyrhizobium sp. BTAi1] Bacteria QKGGVGKT 6-15
78699684 conserved hypothetical protein [Bradyrhizobium sp. BTAi1] Bacteria DKGGVGKT 9-18
78699971
ParA-like ATPase, probably involved in plasmid partition-
ing [Bradyrhizobium sp. BTAi1]
Bacteria QKGGVGKT 7-16
79042258




















similar to ATPases involved in chromosome partitioning
[Frankia sp. CcI3]
Bacteria LKGGVGKT 512-521
68174430 Cobyrinic acid a,c-diamide synthase [Frankia sp. CcI3] Bacteria QKGGVGKT 96-105
68174522 Cobyrinic acid a,c-diamide synthase [Frankia sp. CcI3] Bacteria YKGGVGKT 5-14
67986777












similar to ATPases involved in chromosome partitioning
[Moorella thermoacetica ATCC 39073]
Bacteria NKGGVGKT 278-287
68544617
Cobyrinic acid a,c-diamide synthase [Shewanella baltica
OS155]
Bacteria QKGGVGKT 8-17
127221 Protein mobD Bacteria SKGGVGKS 9-18




ATPase, ParA FAMILY [Fusobacterium nucleatum subsp.
vincentii ATCC 49256]
Bacteria NKGGVGKS 7-16
7299716 CG11670-PA [Drosophila melanogaster] Eukaryota KKGGVGKS 407-416
66809035
nucleotide binding protein 1-like protein [Dictyostelium dis-
coideum AX4]
Eukaryota SKGGVGKS 241-250
6425159 RepA [Rhizobium etli] Bacteria FKGGSGKT 129-138
17135760 all7222 [Nostoc sp. PCC 7120] Bacteria DKGGVGKS 97-106
15159368 AGR L 1843p [Agrobacterium tumefaciens str. C58] Bacteria FKGGSGKT 99-108
15163513 AGR pTi 93p [Agrobacterium tumefaciens str. C58] Bacteria FKGGSGKT 133-142
54013779 hypothetical protein [Nocardia farcinica IFM 10152] Bacteria LKGGVGKT 272-281
17430349




















In the following, UML models are provided for the code that implements the structural classifi-
cation of interfaces (SCOPPI), the search for convergently evolved motifs and the They reflect
exactly the code as provided on the accompanying CD. All core programs and modules provided













Figure A.1: UML diagram for the classes used to create SCOPPI, see Chapter 3. Most functionality is in the Family class, since interface
clusterings are calculated per family. Interactions and InteractionPairs are merely associated data containers, were the latter can


















Figure A.2: UML diagram for the classes used to create the ABAC database, see Chapter 4. The main class is Abac and contains the most
important functions. Multiprot is a wrapper class around the MultiProt software. ReadOutAbac is a subclass that has extended database
communication; it is initiallized with data from a database query and its method geometry allows it to write to the geometry information
table of the ABAC database. SwissProtScopDomain is a versatile subclass of ScopDomain (not shown) that retieves information for a













Figure A.3: UML diagram for the main classes used to create interface descriptors, see Chapter 5. FamilyFamilyInteractionType is
the central classthat contains many wrapper classes for methods in Facetype. Moreover it contains the list of interfaces that are stored
in the interfacesRepository. These interfaces carry references to the involved domains, instances of the class FeaturedDomain. These
in turn contain as the central data source alignedResidueList, a list of HsspResidues. HsspResidue is a subclass of Residue, with the


















Figure A.4: UML diagram for the auxiliary classes used to create interface descriptors
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